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Summary
B: e functional annotation and identification of genes involved in vari-
ous biological processes is a cumbersome and non trivial task that oen requires investi-
gating and understanding interactions and collective behaviour of hundreds of cellular
components. anks to tenological advances of recent years, it is now possible to
simultaneously study complete genomes, transcriptomes and proteomes, or to image
hundreds of organelles at a time, giving researers an opportunities of making rapid
discoveries in a highly parallel way.
M: Although various high-throughput tenologies provide a lot of valuable
information, ea of them is giving an insight into different aspects of cellular activity
and ea has its own limitations. us, a complete and systematic understanding of
the cellular mainery can be aieved only by a combined analysis of results coming
from different approaes. However, methods and tools for integration and analysis of
heterogenous biological data still have to be developed.
R: is work presents systemic analysis of basic cellular processes, i.e. cell viabil-
ity and cell cycle, as well as embryonic stem cell pluripotency and differentiation. ese
phenomena were studied using several high-throughput tenologies, whose combined
results were analysed with existing and novel clustering and hit selection algorithms.
is thesis also introduces two novel data management and data analysis tools. e first,
called DSViewer, is a database application designed for integrating and querying results
coming from various genome-wide experiments. e second, named PhenoFam, is an
application performing gene set enriment analysis by employing structural and func-
tional information on families of protein domains as annotation terms. Both programs
are accessible through a web interface.
C: Eventually, investigations presented in this work provide the resear
community with novel and markedly improved repertoire of computational tools and
methods that facilitate the systematic analysis of accumulated information obtained
from high-throughput studies into novel biological insights.
Keywords: data integration, data analysis, bioinformatics, systems biology, high-throughput screening,
RNA interference
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Chapter 1
Introduction
Cells are the basic building blos of all living organisms. ey are very complex and
dynamic systems. To understand the interactions between cellular elements (molecules
and organelles), biological resear employs two principal strategies. e first, reduc-
tionist approa focuses on selected components of the cell at a time, studied in a greater
detail. While molecular biology has proved fundamental to our understanding of ba-
sic laws governing interactions between single cellular components, it does not decode
their collective behaviour. Answering this need, biology adopts the second, holistic
approa. Here, multiple cellular components are studied systematically, leading to a
quantitative and integrated description of biological processes.
Systems biology has begun to flourish thanks to tenological advances of recent
years. It is now possible to simultaneously study complete genomes, transcriptomes
and proteomes, or to image hundreds of organelles. Performing massive amounts of
experiments, known under the term high-throughput biology, gives researers oppor-
tunities of making rapid discoveries in a highly parallel way. However, with the increase
of experimental throughput, the amount of generated data rises as well and brings new
allenges associated with data handling and computational analysis.
In this thesis, I present systemic analysis of basic cellular processes, i.e. cell viability
and cell cycle, as well as embryonic stem cell pluripotency and differentiation. ese
phenomena were studied using several high-throughput tenologies, namely gene ex-
pression profiling, romatin immunoprecipitation and RNA interference screening,
whi are described in the first part of the Introduction. In the second part, I review
1
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current methodology that I applied, and further developed, to analyse the experimental
results.
1.1 High-throughput tenologies
1.1.1 Gene expression profiling
Gene expression profile
e collection of genes that are actively transcribed, called a ‘transcriptome’, is a major
determinant of a cellular state. Differences in gene expression are responsible for mor-
phological and physiological differences between various cell types of a multicellular
organism. Also, alterations in gene expression underlie responses of cells to environ-
mental stimuli or regulation of its temporal transitions, su as progression through the
cell cycle. Hence, knowing expression paern of a gene oen provides a strong clue as
to its biological role. Time-course measurements of gene expression can also give an
insight into dynamics of cellular processes su as differentiation (Lu et al., 2009), or
even whole organism development (Arbeitman et al., 2002).
On a lower scale relative levels of gene expression, or expression profiles, can be
assayed by quantitative PCR that measures relative abundance of transcribed mRNAs.
However, to be able to identify all genes whose transcription is influenced by a stimulus,
high-throughput DNAmicroarray tenologywas developed (DeRisi et al., 1997; Sena
et al., 1995).
Microarray tenology
Microarray teniques have become one of the most widely used functional genomics
tools (reviewed by Hegde et al., 2000; Lohart & Winzeler, 2000; Young, 2000). A vari-
ety of microarray platforms exist that have been developed to systematically measure
gene expression. e basic idea of this tenology is simple: a glass or a silicon slide
(known as gene ip) is spoed or ‘arrayed’ with DNA fragments or oligonucleotides
that represent specific gene coding regions. Purified RNA from cells is then reversely
transcribed to cDNA, fluorescently labeled and hybridized to the slide. Ea cDNA
strand should preferably bind to a complementary spot on the array. In some cases,
2
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hybridization is done simultaneously with reference RNA (labeled with a different dye)
to facilitate comparison of data across multiple experiments. Measured intensity of dye
fluorescence at ea spot reflects the amount of respective mRNA in the input sample
(Slonim & Yanai, 2009).
1.1.2 Dissecting protein-DNA binding
Gene expression microarrays allow us to measure the outcome of the transcriptional
regulation, whi, in turn, is aieved by interactions between nuclear proteins and
genomic DNA. Chromatin immunoprecipitation (ChIP) is widely used for determining
the location of DNA binding sites in the genome for a protein of interest (reviewed by
Collas, 2010). Genome-wide, ChIP can be combined with microarray tenology, being
referred to as ChIP-on-Chip or simply ChIP-Chip (Birney et al., 2007; Blais & Dynlat,
2005; Carey et al., 2009; Horak et al., 2002; Ren et al., 2000). e principle underlying
this tenique is described in Figure 1.1. Importantly, the identification of a genomic
fragment that the investigated protein was bound to does not necessarily imply direct
regulatory functions of that protein on the expression of ‘neighbouring’ genes. A deeper
insight into transcriptional regulation can only be obtained by integration of ChIP data
with gene expression profiling.
1.1.3 RNA interference screenings
One possible way of investigating functions of genes is by analyzing effects caused by
their inactivation. A tenology that allows rapid investigation of phenotypes caused
by gene silencing is RNA interference (RNAi) screening, also called loss-of-function
screening.
RNA interference
RNAi, first discovered as an ancient anti-viral response (Fire et al., 1998), is now rec-
ognized as a conserved biological meanism of inhibiting gene expression at a post-
transcriptional level. It is triggered by short double-stranded RNA (dsRNA) from en-
dogenous or exogenous origin (the meanism is described in Figure 1.2). Since it was
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Figure 1.1: Identification of protein-DNA interaction regions using ChIP-Chip
DNA-binding proteins (including transcription factors and histones) in living cells are cross-linked to the
DNA whi they are bound to. Following crosslinking, the cells are lysed and the DNA is broken into
pieces of approximately 0.2 kb. Using an antibody that is specific to a given DNA binding protein, one can
immunoprecipitate the protein-DNA complex out of the cellular lysates. Aerwards, the cross-linking
is reversed, allowing the DNA to be separated from proteins. As the control condition, an unspecific
antibody can be used for romatin precipitation.
e identity and quantity of the isolated DNA fragments can then be determined by specially designed
microarrays, called tiling arrays (Nègre et al., 2006; Yoder & Enkemann, 2009). Classical DNAmicroarrays
contain up to a few probes per transcript or per gene, whereas tiling arrays cover the complete genome
or its selected parts (e.g. promoter regions) with resolution of approximately 35 bp (Moler et al., 2005).
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Figure 1.2: Meanism of RNA interference
e key components of RNAi are small (≈20 bp long) double-stranded small interfering RNA molecules
(siRNA). One of the two strands (a ‘guide strand’) is incorporated into the RNA-induced silencing complex
(RISC) (A). e RISC complex with a bound siRNA strand recognizes complementary messenger RNA
(mRNA) molecules and degrades them, resulting in substantially decreased levels of protein translation
and effectively turning off the gene (B). If the homology between siRNA and mRNA fragment is not
perfect, the mRNA is not degraded. However, the RISC complex remains bound to mRNA and inhibits
the mRNA translation (C).
Transient effect of RNAi can be obtained by delivering siRNA into cells in various forms. Directly, by
emically synthetised siRNA or endoribonuclease-prepared pools of siRNA (esiRNA) that target common
transcript (Buholz et al., 2006; Yang et al., 2002a) (D). In invertebrates, whi are laing interferon
reponse meanism, it is possible to deliver long double-stranded RNA (dsRNA) molecules that are then
digested by Dicer into a pool of siRNA (Chen et al., 2007). Permanent and inheritable silencing can be
aieved by integrating a fragment of DNA encoding for short hairpin RNA (shRNA) into the genome.
e expressed RNA fragment forms a hairpin structure and aer being exporting into cytoplasm and
processed by Dicer, it forms a double-stranded siRNA (Paddison et al., 2002) (E).
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discovered that RNAi can be applied selectively, in experimental conditions, it became
a powerful tool for silencing gene expression in eukaryotes (reviewed in He et al., 2009).
Systematic screening
e high-throughput application of RNAi allows systematical seares for genes whose
silencing leads to a specific phenotype, su as impaired development or reduced via-
bility.
Su studies can be carried out by employing two different paradigms. e first is
called a selection-based screening in whi cells are infected with a pooled library of
shRNA (Figure 1.2) where optimally ea cell should integrate a single copy of shRNA.
Further selection steps enri for cells with a desired phenotype and by sequencing of
the DNA fragments with the integrated shRNA, it is possible to identify genes whose
silencing results in the phenotype. e second paradigm is termed systematic screening.
Su screens are typically carried out in arrayed formats using microwell plates with 96
or 384 wells, where cells in ea well are transfected with RNAi triggers targeting indi-
vidual genes. Compared to selection-based, systematic screening offers the possibility
of observing phenotypes of all knodowns individually.
Depending on the assay, phenotypes are quantified by using different tenolo-
gies (e.g. flow or laser-scanning cytometry, fluorimetry, microscopy). e typical RNAi
high-throughput screening project starts with a genome-wide primary screen and the
effective RNAi silencers, whi are called ‘hits’, are investigated using further validation
procedures, for example secondary screens.
Depending on the number of variables that compose a phenotype, systematic screens
can be divided into two subcategories. If a phenotype carries a single or small number of
values, for example quantified information about cell viability, growth rate or measured
fluorescence intensity of a reporter protein, then su screens are termed low-content or
low-dimensional. If a screen measures morphological features of cells and subcellular
compartments, a number of values per phenotype can easily rea 100. RNAi screen-
ings resulting in su high-dimensional phenotypes are called high-content screens (re-
viewed by Zanella et al., 2010).
Regardless of the class of a systematic screen, the main allenge of the further data
analysis is the optimal classification of phenotypes, whi should result in a reliable
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identification of hits for follow-up studies. Due to tenical and biological variations,
phenotypes are subject to strong noise and to identify genes involved in a process of
interest, data analysis teniques must cope with high rates of false positive and false
negative results. Another intrinsic problem of a systematic high-throughput screen is
connected with a structure of protein-protein interaction networks and cellular regula-
tory meanisms. Due to redundancy of functions or presence of regulatory feedba
loops, silencing of a gene that originally takes part in a process of interest may not lead
to a significant ange of a phenotype. And in consequence, su a gene may not be
identified as a hit.
1.1.4 Meta-analysis
As explained above, ea high-throughput methodology is providing an insight into
different aspects of cellular activity. Since ea of the single experimental teniques has
its limitations, a complete and systematic overview can be aieved only by a combined
analysis of results coming from different approaes.
By definition, meta-analysis is the statistical synthesis of the results of several stud-
ies that address a shared resear hypotheses (O’Rourke, 2007). It is usually applied
to increase statistical power to detect an effect and to reduce any bias or noise in the
underlying data sets.
Previous studies have shown that meta-analysis of various gene expression microar-
ray datasets helps in forming biological hypothesis and leads to novel discoveries (Grütz-
mann et al., 2005; Ramasamy et al., 2008; Rhodes et al., 2004; Silva et al., 2007). Similar
principles of combined analysis were also sucessfully applied to large-scale gene expres-
sion and ChIP data (Foltz et al., 2009; Wu et al., 2008).
Applications of meta-analysis for numerous RNAi screening data combined with
protein localization, gene expression and romatin immunoprecipitation are described
in the following apters of this thesis.
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1.2.1 Databases
Recent years have seen an explosion in the amount of available biological data. More
and more genomes are being sequenced and annotated, information about transcrip-
tomes and proteomes are accumulating. Biological databases are indispensable and in-
valuable tools for managing these data and for making them accessible (Corane &
Galperin, 2010). Modern database systems provide efficient meanisms for storing,
managing and querying large amount data, making them exceptionally useful for the
high-throughput analysis. Below, I mention some biological databases relevant to my
work.
Ensembl
Ensembl (Hubbard et al., 2009) is a joint project between the European Bioinformat-
ics Institute (EBI) and the Wellcome Trust Sanger Institute to develop a soware sys-
tem that produces and maintains automatic annotation on selected eukaryotic genomes.
Ensembl automatically annotates genes and predict new ones, by integrating data from
other biological data sources (i.e. InterPro, OMIM, SAGE). Currently, Ensembl contains
sequences and annotations for over 50 metazoan genomes as well as genomes of plants,
fungi and procaryotes.
Ensembl is a comprehensive and easily accessible source of data for any high-throughput
approaes. It is available not only as an interactive website but also via Perl and Java
programming interfaces, allowing simple scripts to be wrien to retrieve data of interest.
In addition, all data is provided without any restriction in a form of an SQL database.
InterPro
InterPro (Hunter et al., 2009) is a EBI-developed integrated database of predictive pro-
tein ‘signatures’ used for the classification and automatic annotation of proteins and
genomes. InterPro classifies sequences at superfamily, family and subfamily levels, pre-
dicting the occurrence of functional domains, repeats and important sites.
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InterPro constitutes a repository that integrates the most well established sources of
data (referred to as member databases): PROSITE, HAMAP, Pfam, PRINTS, ProDom,
SMART, TIGRFAMs, PIRSF, SUPERFAMILY, Gene3D and PANTHER.
Gene Ontology
eGene Ontology (GO) project (Ashburner et al., 2000) is a major bioinformatics initia-
tive with the aim of standardizing the representation of gene and gene product aributes
across species and databases. e project provides a controlled vocabulary of terms for
describing gene productaracteristics and gene product annotation data fromGOCon-
sortium members. e use of GO terms by collaborating databases facilitates uniform
queries across them.
Gene Ontology vocabulary contains three separate, hierarically organized sets of
annotations referring to cellular component, biological process and molecular function
of any gene product. Ea set forms a tree-like structure, in whi on top of the tree
there are the most general terms (e.g. ‘developmental process’) and the leafs of the tree
containmore detailed annotations (e.g. ‘positive regulation of embryonic development’).
Controlled vocabularies of annotations are indespensable tools in any automated
analysis of high-throughput data. Together with manual curration and other gene anno-
tation methodologies (e.g. text mining), they allow introduction of previously gathered
knowledge into computational algorithms.
PANTHER
e PANTHER (Protein ANalysis THrough Evolutionary Relationships) Classification
System (Mi et al., 2007; omas et al., 2003) is a resource developed by the Evolution-
ary Systems Biology Group at SRI. PANTHER classifies genes by their functions, us-
ing published scientific experimental evidence and evolutionary relationships to predict
function even in the absence of direct experimental evidence. Proteins are classified by
expert biologists into families and subfamilies of shared function, whi are then cat-
egorized by molecular function and biological process ontology terms. e PANTHER
ontology is a controlled vocabulary arranged in a similar fashion to the Gene Ontology,
but greatly abbreviated and simplified to facilitate high-throughput analyses.
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BioMart
BioMart (Haider et al., 2009; Kasprzyk et al., 2004; Smedley et al., 2009) is a query-
oriented data management system developed jointly by the Ontario Institute for Cancer
Resear (OICR) and the European Bioinformatics Institute (EBI). e system can be
used with any type of data and is particularly suited for providing data mining seares
of complex descriptive and sequential data.
BioMart web page offers a centralized access to a set of biological databases. ese
include major biomolecular sequence, pathway and annotation databases su as En-
sembl, Uniprot, Reactome, HGNC, Wormbase and PRIDE (Haider et al., 2009). More-
over, BioMart system can also be customized to manage any user-provided data, and
thanks to a built-in support for data federation, it is possible to integrate it with other
databases already configured for use with BioMart.
1.2.2 Analysis of systematic RNAi screens
ality control
ality control is a crucial step of any systematic RNAi screen analysis. It allows to
identify problematic plates that need to be repeated and helps with making a oice of
further analysis methods and is a necessary prerequisite for an integrative analysis of
phenotypic profiles from multiple screens (Boutros et al., 2006).
Usually ea plate contains few wells with negative and positive controls (explicit
controls). However, assuming that the majority of samples on a plate are irrelevant to
the investigated biological process, it is possible to use samples from the whole plate for
estimating the distribution of negative controls (implicit controls).
A popular measure to assess the quality of individual plates, or the whole screen,
is called 𝑍-factor (Zhang et al., 1999). It is an estimate of a dynamic range of the as-
say, whi is based on the values of explicit controls. Given the means and standard
deviations of negative (𝑛) and positive (𝑝) controls, it is calculated as follows:
𝑍 = 1 −
3 ⋅ 􏿴𝜎𝑝 + 𝜎𝑛􏿷
􏿗𝜇𝑝 − 𝜇𝑛􏿗
(1.1)
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According to Zhang et al. (1999), the values between 0.5 and 1.0 indicate an excellent
assay and values below 0.0 suggest that the overlap between positive and negative con-
trols is too big for a reasonable detection of phenotypes. However, it must be noted that
this interpretation assumes a normal distribution of controls. If this criteria is not met,
then despite low quality of an assay, the 𝑍-factor may give misleadingly favourable
results (Sui & Wu, 2007). us, it would be advisable to replace mean and standard
deviation with more robust estimators, su as median and median absolute deviation
(Zhang et al., 2006).
Results normalization
Normalization is a data analysis step intended to remove systematic errors and to allow
combination and comparison of results of different plates and replicates of the screen.
eallenge of normalization is to remove asmuof the tenical variation as possible
while leaving the biological variation untoued.
To perform a genome-wide screen targeting approximately 20 000 human genes and
an assay performed in 384-well plates, it is necessary to use over 50 plates. Moreover,
assuming two replicates of the screen, the total number of plates that must be processed
is over 100. Even with current advances in automation and robotics, the first and the last
plate of the screen might be processed in different bates separated by hours or even
days. is might introduce a strong variability between results obtained from different
plates (Coma et al., 2009). A solution of this problem is to treat ea plate as a separate
unit and normalize results on different plates separately (normalization per-plate).
However, in cases of non-random distribution of phenotypes among plates, normal-
ization per-plate may lead to an increased number of false positives (on plates laing
true-positives) and false negatives (on plates enriedwith true positives). us, it might
be necessary to treat the whole screen as one bat, and normalize all results together
(per-bat normalization).
Standard score. e most frequent way of normalizing the high-throughput assay
readouts is a conversion of raw values into their standard scores widely known as 𝑧-
scores (Boutros et al., 2006). A standard score of a raw value 𝑥 is calculated as
𝑧 = 𝑥 − 𝜇𝜎 (1.2)
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where 𝜇 is a mean and 𝜎 is a standard deviation of all raw values taken from the same
plate (in case of per-plate normalisation) or the same bat (per-bat normalisation). In
case of a screen in whi explicit negative controls are used, the raw values of samples
can be normalized to the mean and standard deviation of the negative controls.
is procedure is also called ‘zero mean and unit variance standardization’, because
it ensures that all readouts are transformed in su a way that the mean value of the
normalized readout is zero, whereas the standard deviation and the variance of whole
sample are equal to unity. e value of 𝑧-score represents the distance between the raw
score and the population mean in units of the standard deviation. In the RNAi screens,
this value shows how significantly the kno-down result differ from negative controls
(explicit or implicit).
One way of making the standard score normalization more robust against outliers
or strong hits, whi may bias the mean and standard deviation, is to calculate 𝑧-score
using mean and standard deviation estimates based on the fraction of the sample (a
trimmedmean and a trimmed standard deviation) (Weisberg, 1991). e fraction is build
by discarding a certain number of the lowest and the highest values from the sample,
usually 5 % of ea end. In case of calculating a mean of 384 samples, one would discard
20 lowest and 20 highest values.
e trimmed mean and trimmed standard deviation produce unbiased estimators
only if the underlying distribution is symmetric. An alternative and more robust esti-
mator of the population mean is trimean (Tukey, 1977). It is calculated as an weighted
average of the samples’s median and its two quartiles:
TM = 𝑄􏷠 + 2𝑄􏷡 + 𝑄􏷢4 (1.3)
An advantage of the trimean as a measure of the center of a distribution is that it
combines the median’s emphasis on center values with the midhinge’s (average of the
first and third quartiles) aention to the extremes (Weisberg, 1991).
Robust 𝑚-score. is method is an improvement on the 𝑧-score normalization ap-
proa by making it even more robust against the outliers that may significantly affect
values of the mean and the standard deviation. A formula for an𝑚-score (also known as
12
1.2 Data analysis methods
‘robust 𝑧-score’) is derived by replacing mean (𝜇) and standard deviation (𝜎) in formula
1.2 by median (?̃?) and median absolute deviation (MAD), respectively (Chung et al.,
2008; Zhang et al., 2006).
𝑚 = 𝑥 − 𝑐?̃?MAD (1.4)
where
MAD = median(|𝑥 − ?̃?|) (1.5)
e equation contains an additional scale factor 𝑐, whi is used for ensuring that
𝑚-scores calculated for normally distributed variables (perfect case) are equal to their
𝑧-scores. is criteria is met if
𝑐MAD = 𝜎 (1.6)
and
?̃? = 𝜇 (1.7)
In case of normally distributed data (𝜇 = 0 and 𝜎 = 1), the median is equal to the mean
(equation 1.7) and the criteria 1.6 is met if the scale factor 𝑐 ≈ 1. 4826. is value can
be obtained by the following calculation:
𝜎 = 𝑐MAD (1.8)
𝑐 = 𝜎MAD (1.9)
𝑐 = 1
Φ−􏷠(0. 75)
(1.10)
𝑐 ≈ 1. 4826 (1.11)
whereΦ−􏷠 is the quantile function of a normal distribution. By substituting 𝑐 in equation
1.4 by value calculated in 1.11, we obtain the final equation for calculating 𝑚-scores:
𝑚 = 𝑥 − 1.4826?̃?MAD (1.12)
In general, for RNAi screens,𝑚-score calculation is preferred over 𝑧-scores (Chung et al.,
2008).
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Hits selection
e goal of any primary RNAi screen is to identify ‘screening positives’ or ‘hits’. Hits
selection is essentially a process of deciding whi results differ significantly from neg-
ative controls. ere are various teniques ranging from the simplest selection of a
predefined number of top-scoring samples to the most elaborate, knowledge-based al-
gorithms. A list of hits forms a basis for further validation experiments.
e aim of any hit selection algorithm is to minimize the false negative rate while
keeping the false positive rate possibly low (Figure 1.3). e minimization of false neg-
ative rate is prioritized because the false positives can be filtered out by subsequent
validation steps, whereas, any false negatives are already lost in the primary screen
analysis.
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Figure 1.3: False positives and false negatives in threshold-based hits selection.
e plot contains an example of two hypothetical probability density functions representing screening
negatives and screening positives (a standard normal distribution and a normal distribution with 𝜇 = 3
and 𝜎 = 0. 5 mixed with proportion 10 ∶ 1). By applying a hits selection threshold (dashed vertical line),
a list of hits is generated. e list contains true positives and false positives. All screening positives that
are not considered hits are false negatives. By adjusting the threshold, one can reduce the false negatives
rate with a trade-off of increasing the false positives rate.
reshold-based criteria. e most commonly used approa of hits selection in-
volves selecting a 𝑧-score or𝑚-score threshold and identifying positives as samples that
surpass this threshold. An advantage of this method is that it is very easy to imple-
ment. Moreover, assuming a normal distribution of samples, the value of an upper or
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a lower cut-off can be derived from an expected statistical significance level (𝛼), using
the following formula:
𝑧􏸂􏸔􏸓 = ±􏿖Φ−􏷠(𝛼/2)􏿖 (1.13)
For a commonly used significance level 0.05, a 𝑧-score or 𝑚-score threshold is approxi-
mately equal to 2. Figure 1.4 shows the difference between thresholds based on 𝑧-score
and 𝑚-score normalization. Due to the fact that MAD is more robust against outliers,
thresholds based on𝑚-score normalization ensure a lower false negative rate (Fig. 1.4B).
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Figure 1.4: Comparison of hit selection thresholds based on 𝑧-scores and 𝑚-scores.
Both plots display the same probability density function build as a mixture of two normal distribution
(Figure 1.3). Blue areas indicate values identified as hits. (A) Using the 𝑧-score normalization and thresh-
old of 2 standard deviations. (B) Using 𝑚-score normalization and threshold of 2 MADs.
Robust methods. If a distribution of the screening results is highly asymmetrical, a
simple threshold-based criteria cannot be applied. is is caused by to the fact that in
su cases, the mean and the standard deviation cannot be estimated accurately. e
quartile-based approa sets an upper or lower thresholds based on number of interquar-
tile ranges (IQR) above or below the first and the third quartile of the data.
is method has been shown to outperform the threshold-based criteria. However,
the improvement over the hits selection based on 𝑚-scores is rather moderate (Zhang
et al., 2006). Additionally, because the expected significance level can not be easily
transformed into a quartile-based thresholds, the method has not been widely used.
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Other teniques. Other hit selection methods rely on clustering teniques (Gagarin
et al., 2006) or Bayesian frameworks (Zhang et al., 2008). Clustering algorithms, instead
of relying on defined thresholds, identify hits based on their separation from the distri-
bution of other values. Bayesian statistics use Bayes theorem to calculate the likelihood
that a particular sample is beer described by the positives-samples model versus the
negative-samples model. A strength of this approa is that may incorporate both plate-
wide and experiment-wide information as well as information from both implicit and
explicit negative controls.
1.2.3 Gene expression data analysis
Baground correction
Analysis of the microarray data begins with the acquisition of the fluorescence intensity
values for ea probe. ose probes on the array that are hybridized to a higher number
of labeled fragments result in the higher intensity of the signal. e main source of
variability caused by the microarray tenology is introduced by nonspecific binding of
oligonucleotides and optical noise (Sui et al., 2009).
Various approaes have been taken to estimate and adjust for baground noise in
oligonucleotide arrays. e most popular algorithms include MAS 5.0 (Hubbell et al.,
2002), Robust Multiarray Analysis (RMA) (Irizarry et al., 2003a,b) and Variance Stabi-
lization Normalization (VSN) (Huber et al., 2003).
MAS 5.0 is an algorithm designed especially for Affymetrix arrays containing addi-
tional ‘mismat probes’ that differ frommain probes by only one nucleotide. Intensities
reported by mismat probes are used byMAS to estimate non-specific binding and cor-
rect for it. Despite its strength, this baground adjustment turned out to introduce a lot
of variability in the log transformed gene expression measures (Irizarry et al., 2003b).
RMA estimates the baground noise by analyzing all probes across all arrays in
the same hybridization bat and VSN extends the RMA methodology by introducing a
simple model to predict the affinity of probes toward nonspecific binding based on the
sequence composition of the probes. Presently, both methods became a standard for the
baground correction.
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Microarray data normalization
Normalization of probe intensity values obtained from DNA microarrays is a critical
step for obtaining data that are reliable and usable for subsequent analysis su as iden-
tification of differentially expressed genes and clustering. A variety of normalization
methods have been proposed over the past few years (reviewed in Bolstad et al., 2003;
Slonim & Yanai, 2009).
Scaling. Scaling is themost straightforward normalization procedure that shis trimmed
mean or median of values (𝑥) from ea microarray (𝑖) to a trimmed mean or median
of the ‘baseline’ microarray 𝑗. e baseline microarray can be either one of the input
microarrays or it can be calculated as an average of all microarrays from the study.
Normalized probe intensities (𝑥′) of a microarray are calculated in the following
way:
𝛽𝑖 =
􏾪𝑥𝑗
􏾪𝑥𝑖
(1.14)
𝑥′𝑖 = 𝛽𝑖𝑥𝑖 (1.15)
antile normalization. e goal of the quantile method is to make the distribution
of probe intensities for ea array in a set of arrays the same. is result is aieved by
first associating raw values from ea microarray with their ranks within a microarray.
en, for ea rank, an average raw value is calculated. is value is then used as a
replacement for values in all microarrays associated with mating ranks. As a result,
eamicroarray contains the same set of normalised values and thus, ea array has the
same distribution.
Spike-in normalization. Spike-in normalization is based on the presence of known
and equally-abundant oligonucleotide (called spike-in) in all samples used for hybridiza-
tion. Aer obtaining the raw data, results of different microarrrays are centered around
the spike-in probe. is normalization method removes the error associated with shi
of the dye intensity. e scale can be also corrected by introducing spike-ins of different
concentrations.
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Many other normalization teniques exist, including non-parametricmethods (Troy-
anskaya et al., 2002) that are especially useful for the analysis of two-color microarrays
(Do & Choi, 2006). However, the analysis of two-color microarrays is not in the scope
of this thesis.
1.2.4 ChIP-Chip Tiling Array Analysis
e analysis of ChIP-Chip data is a process that requires the identification of positive
probes and ChIP-enried binding regions, the mapping of those regions to the genes,
and potential protein bindingDNA sequencemotif discovery (Yoder & Enkemann, 2009).
Peak detection
Peak detection is a proces of identifying genomic regions where ChIP-ip probes are
bound by the protein of interest at levels significantly above baground (control con-
dition samples).
First methods developed to identify regions enried by ChIP on Affymetrix tiling
arrays are based on statistics that compare ChIP array data with one or more control
samples. e Mann–Whitney 𝑈 test is applied to ChIP-ip data by ranking of ChIP
and control probe signals within 1 kb sliding windows (Cawley et al., 2004).
However, the most effective algorithm for peak-finding on Affymetrix tiling mi-
croarrays is MAT (model-based analysis of tiling arrays) (Johnson et al., 2006). By using
a linear model, MAT estimates the baseline probe behavior based on probe sequence
aracteristics and genome copy number. Calculated baseline model is used then to
standardize the probes and filter out the noise in the data.
Mapping of bound regions to genomic elements
Identification of genes, whi potenially have their expression altered by bounding of a
protein of interest, is an essential part of the ChIP-Chip analysis workflow. Association
of identified peaks with genomic elements (i.e. transcription start sites, UTRs, introns)
is performed by either automatic or manual inspection of romosomes in the closes
proximity of the peak summit.
For manual inspection, genome browsers are powerful tools that allow the visual-
ization of ChIP-Chip experimental data as a tra against an annotated genome. e
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UCSC Genome Browser is a commonly used web-based genome browser that is avail-
able at http://genome.ucsc.edu/ (Karolik et al., 2009). e proces of annotating
peaks with genes can be automated by exploiting genomic databases and comparing
romosomal positions of peak summits with positions of transcription start sites (TSS)
or other genomic elements of interest (Tompa et al., 2005).
1.2.5 Enriment analysis
Enriment analysis is one of widely used bioinformatics methods for a systematic dis-
section of large genes lists, su as hits from systematic RNAi screens or lists of dif-
ferentially expressed genes. anks to the biological knowledge gathered in various
databases (e.g. Gene Ontology), the enriment analysis makes it possible to assemble a
summary of various biological annotations that could be associated with the given set of
genes. Su annotations may include not only Gene Ontology terms but also pathways,
transcription factor binding sites, epigenetic markers, structural properties of proteins
or any other annotations derived from previous studies.
All currently available enriment analysis tools can be classified into four cate-
gories, depending on the algorithm they use: singular enriment analysis (SEA), gene
set enriment analysis (GSEA), modular enriment analysis (MEA) (all three reviewed
in Huang et al., 2009) and model-based gene set analysis (MGSA). Some tools have im-
plemented several algorithms so they may belong to more than one class.
Singular Enriment Analysis (SEA)
is is the most commonly used approa in whi a list of hits is iteratively tested
for the enriment of ea annotation term one-by-one in a linear mode. ereaer,
the individual, enried annotation terms passing the enriment 𝑝-value threshold are
reported in a tabular format ordered by the enriment probability (enriment 𝑝-value).
e enriment 𝑝-value calculation, i.e. number of genes in the list that are annotated
with a given annotation as compared to pure random ance, can be performed with
the aid of some common and well-known statistical methods, including 𝜒􏷡 test, Fisher’s
exact test, Binomial probability and Hypergeometric distribution, etc.
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Gene Set Enriment Analysis (GSEA)
SEA approa strongly relies on aosen hit selection algorithm and user-defined thresh-
olds. Moreover, the experimental results (i.e. level of expression or phenotype strength)
are not considered. To overcome these limitations, a gene set enriment analysis
(GSEA) method was developed (Mootha et al., 2003). GSEA sorts a complete list of
experimental results and seares for annotations enried on its top or boom. is
allows even mild effects to contribute to the overall enriment score. To calculate the
significance of association, the Kolmogorov–Smirnov or the Mann–Whitney U -test are
used (Keller et al., 2008; Subramanian et al., 2005).
However, tools in the GSEA class are also associated with some common limitations.
First, the ‘no-cutoff’ strategy is the key advantage of GSEA, but is also becoming its
major limitation in some biological studies. e GSEA method requires a summarized
biological value (e.g. fold ange) for ea of the genes in the input. Despite that, in case
of quantitative studies, su as cell-based RNAi screens, this limitation is not a problem.
A more extensive introduction to GSEA methods is given in Chapter 5.
Modular Enriment Analysis (MEA)
MEA inherits the basic enriment calculation found in SEA and incorporates addi-
tional algorithms considering the relationships between annotation terms. An exam-
ple of su algorithm is implemented in the ProfCom tool (Antonov & Mewes, 2006;
Antonov et al., 2008), whi has an ability to profile enriments of whole subgroups of
available GO terms assembled in a Boolean fashion. is and other tools, su as On-
tologizer (Bauer et al., 2008), topGO (Alexa et al., 2006), GENECODIS (Carmona-Saez
et al., 2007; Nogales-Cadenas et al., 2009), ADGO (Nam et al., 2006) claim to improve
discovery sensitivity and specificity.
Model-based Gene Set Analysis (MGSA)
MGSA is a newly emerged class of methods that analyze all annotation categories at
once by embedding them in a Bayesian network (Bauer et al., 2010; Zhang et al., 2010).
Gene response is modeled as a function of the activation of biological categories. Prob-
abilistic inference is used to identify the active categories. e Bayesian modeling ap-
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proa naturally takes category overlap into account and avoids the need for multiple
testing correction.
Multiple testing correction
Most enriment analysis teniques require multiple statistical tests and thus, the prob-
ability of making at least one false discovery (i.e. that a given set of genes is enried for
a specific term) increases significantly. In statistics, this probability is called the family-
wise error rate (FWER). In general, all multiple testing correction teniques aempt
to reduce FWER while keeping the testing power at the same time. e reduction of
FWER is aieved by requiring a stronger level of evidence to be observed in order for
an individual enriment to be called ‘significant’ (Lehmann & Romano, 2005).
e most commonly used multiple hypothesis correction method is the Bonferroni
correction. Assuming 𝑛 independent statistical tests and the given significance level for
the whole family of tests to be (at most) 𝛼, ea of the individual test should be tested
at the level of 𝛼/𝑛. So all individual 𝑝-values should be multipled by 𝑛 before applying
the significance threshold selection. It is considered to be the most conservative among
all multiple testing correction teniques (Rice et al., 2008).
is tenique profides themaximum FWER control, but it is considered to be too re-
strictive for practical use in bioinformatics. An alternative to the Bonferroni correction
was designed by Banjamini and Hoberg (Benjamini & Hoberg, 1995). It is the false
discovery rate (FDR) control algorithm, whi correct for the expected number of false
discoveries (in contrast to Bonferroni method that assumes the worst-case scenario). It
was shown (Benjamini & Yekutieli, 2001; Williams et al., 1999) that their approa yields
mu greater power than the Bonferroni tenique. e corrected 𝑝-value (𝑝􏸂􏸎􏸑􏸑) can be
calculated from the following formula:
𝑝􏸂􏸎􏸑􏸑 =
𝑝 ⋅ 𝑛
𝑟 (1.16)
where 𝑛 is the total number of statistical tests performed and 𝑟 is a rank of the 𝑝-value
(𝑝) in a list of all obtained 𝑝-values sorted in the ascending order.
Other multiple testing correction algorithms are based on various permutation ap-
proaes (Boyle et al., 2004). Boyle’s algorithm repeats the enriment analysis on ran-
domly pied lists of genes that are of the same size as the original list. Obtained results
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are used for generating null distributions of 𝑝-values for ea annotation term. e null
distribution can be constructed from at least 100 permutations. Finally, for a given term,
a corrected 𝑝-value is calculated as a fraction of 𝑝-values from the null distribution that
are the same or lower than the observed 𝑝-value.
Examples of application of enriment analysis are given in following apters, and
especially in Chapter 5, whi is exclusively describing a novel GSEA algorithm utilising
protein structure-derived information as annotation terms.
1.2.6 Cluster analysis
Cluster analysis has become a standard computational method for gene function dis-
covery as well as for more general explanatory data analysis. e objective of cluster
analysis is the assignment of a set of observations into subsets (called clusters) so that
observations in the same cluster are similar in some sense. In the analysis of RNAi
screens, clustering is used to group genes giving similar phenotypes. In transcriptomics,
cluster analysis is applied to group genes based on their expression paerns.
Clustering algorithms can be divided into three categories: hierarical, partitional
and model-based. Hierarical algorithms find successive clusters using previously es-
tablished clusters. ese algorithms can be either agglomerative (‘boom-up’) or divi-
sive (‘top-down’). Partitional algorithms typically determine all clusters at once. Model-
based algorithms assume that the data were generated by a model and tries to recover
the parameters describing it. Calculated parameters are then used to define clusters and
the assignment of observations.
Regardless of the used method, the final number of clusters must be decided at some
point. Algorithms helping in taking the right decision are described in the last part of
this section.
Hierarical clustering
Hierarical clustering creates a hierary of clusters that may be represented in a bi-
nary tree data structure called a dendrogram. A ‘root’ of the tree consists of a single
cluster containing all observations, and the ‘leafs’ correspond to individual observations.
e final grouping of observations is obtained by cuing the dendrogram at a specified
‘height’ (se Figure 1.5).
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Figure 1.5: Hierarical clustering dendrogram
Observations 1 to 5 belong to their own clusters - ‘leafs’ of the dendrogram. Observations 2 and 3 are
the most similar to ea and thus, they are merged at the lowest ‘height’ into one cluster (B). Sucesive
merging of observations and formed clusters lead to the final single cluster called ‘root’. Application of
a similarity cut-off allows a final definition of clusters. In this example, three clusters are defined: A,
containing a single observation 1; B with observations 2 and 3; C with observations 4 and 5.
A dendrogram can be constructed either by iterative division of bigger clusters into
two subclusters or by merging two subcluster into one bigger. In order to decide whi
clusters should be combined (for agglomerative clustering), or where a cluster should be
split (for divisive), a measure of dissimilarity between sets of observations is required.
In most methods of hierarical clustering, this is aieved by use of an appropriate
metric (a measure of distance between pairs of observations), and a linkage criteria that
specifies the dissimilarity of sets as a function of the pairwise distances of observations
in the sets.
In the analysis of high-throughput data, the commonly used metrics include the
Euclidean distance, Mahalonobis distance and other metrics based on correlation coef-
fitients (i.e. Pearson product-moment correlation, uncentered correlation).
A dissimilarity between sets of observations can be computed using different linkage
criteria (for visual interpretation, see Figure 1.6):
Complete linkage (furthest neighbor). A distance between sets is defined as the
maximum distance between any observation from one set, to any observation from
the second set. is method usually performs quite well in cases when the samples are
naturally separated into distinct groups.
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Single linkage (nearest neighbor). As opposite to the previousmethod, single linkage
takes the minimum distance between any two observations from two sets. is method
is suitable for more diffused or elongated clusters.
Unweighted pair-group average (UPGMA). In this method, the distance between
two clusters is calculated as the average distance between all pairs of objects in the
two different clusters. UPGMA is a compromise between the two previous methods,
performing well in cases of well defined and difused clusters of data. It is the most
commonly used linkage tenique.
Weighted pair-group average (WPGMA). ismethod is identical to the unweighted
pair-group average method, except that in the computations, the size of the respective
clusters (i.e., the number of observations contained in them) is used as a weight. us,
this method (rather than the previous method) should be used when the cluster sizes are
suspected to be greatly uneven.
Unweighted pair-group centroid (UPGMC). e distance between clusters is de-
fined as the distance between their centroids, defined as an average of all objects in the
cluster.
Weighted pair-group centroid (WPGMC). is method is identical to the previous
one, except that weighting is introduced into the computations to take into consideration
differences in cluster sizes (i.e., the number of objects contained in them). us, when
there are (or we suspect there to be) considerable differences in cluster sizes, this method
is preferable to the previous one.
Ward’s method. is method is distinct from all other methods because it uses an
analysis of variance approa to evaluate the distances between clusters. In short, this
method aempts to minimize the Sum of Squares (SS) of any two (hypothetical) clusters
that can be formed at ea step. is method is regarded as very efficient, however, it
tends to create clusters of small size.
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.
Single linkage Complete linkage
Pair-group average Pair-group centroid
Figure 1.6: Hierarical clustering linkage criteria.
Calculation of distances between two clusters according to different linkage criteria. Dots represent obser-
vations in two-dimensional feature space and ellipses indicate observations belonging to a single cluster.
Lines show distances taken into consideration for calculating distances between clusters. Crosses in the
‘Pair-group centroid’ axis represent centroids of the clusters.
Partitional clustering
emost widely used partitional clustering method is a 𝑘-means algorithm (Maceen,
1967). is algorithm divides a given set of observations 𝑋 = 𝐱􏷠, 𝐱􏷡, … , 𝐱𝑛), where ea
is a 𝑑-dimensional vector, into an a priori decided 𝑘 sets (𝑘 < 𝑛) {𝑆􏷠, 𝑆􏷡, … , 𝑆𝑘}. e aim
is to minimize the within-cluster sum of squares:
argmin
𝐒
𝑘
􏾜
𝑖=􏷠
􏾜
𝐱𝑗∈𝑆𝑗
‖𝐱𝑗 − 𝝁𝑖‖
􏷡 (1.17)
where 𝝁𝑖 is the mean of all observations in 𝑆𝑖 and the ‖ • ‖ operator represents any
distance metric (e.g. Euclidean distance).
A derivative of the 𝑘-means algorithm is the fuzzy 𝑐-means clustering (Bezdek, 1981).
In the fuzzy clustering, ea observation has a degree of belonging to clusters, rather
than belonging completely to just one cluster. e fuzzy logic equations are used in the
processes of finding the optimal solution. en, the cluster space is discretized and ea
observation is associated with a single cluster.
25
1.2 Data analysis methods
Model-based clustering
In model-based methods (Villarroel et al., 2009), ea observation 𝐱𝑖 is modelled by a
finite mixture distribution with the prior probability 𝜶𝑗 that every sample 𝐱𝑖 is a mem-
ber of only one mixture component 𝑗, and the conditional probability modelling ea
component 𝑗 by the parametrized probability density function 𝑃𝑗􏿴𝐱𝑖|𝚯𝑗􏿷 (usually the
multivariate Gaussian distribution). e finite mixture model expresses the probability
of observing the sample 𝐱𝑖 as a sum of individual components:
𝑃(𝐱𝑖|𝚯) =
𝑘
􏾜
𝑗=􏷠
𝜶𝑗𝑃𝑗􏿴𝐱𝑖|𝚯𝑗􏿷 (1.18)
e aim of this clustering tenique is to find su parameters𝚯𝑗 and 𝜶𝑗, that maximize
the joint probability of observing the data set 𝐱. is goal is usually obtained by apply-
ing Expectation-Maximization (EM) algorithms. e number of mixture components is
analogous to the number of clusters and the association between an observation 𝐱𝑖 and
a cluster is based on the final probability 𝑃𝑗􏿴𝐱𝑖|𝚯𝑗􏿷 (whi should be maximal for the
cluster 𝑗).
e main advantage of all partitional and model-based clustering teniques, com-
pared to hierarical clustering, is that they aempt to find centers of natural clusters
in the data set. However, their drawba is that an inappropriate oice of the number
of clusters 𝑘 may yield misleading results.
Optimizing number of clusters
e best method of determining the optimal number of clusters is to partition data into
𝑘 clusters and measure the quality of this clustering. e final partitioning is found
by comparing quality measures for different values of 𝑘. However, the goal of cluster
analysis is not to find the best partitioning of the given sample, but to approximate the
true partitions of the underlying space. In the analysis of biological data, usually, the
best quality measures are obtained for very large number of clusters. is is the classical
overfiing problem, whi can be overcame by taking the smallest 𝑘 yielding reasonably
good clustering quality and for whi an increase of 𝑘 would not significantly imrpove
the clustering. is criterion is called an ‘elbow’ method (Van Ryzin, 1995).
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e most straightforward method of measuring how well the clusters are formed is
by calculating the average silhouee of all observations (Rousseeuw, 1987). A silhouee
𝑠 of an observation 𝑖 is calculated with the following formula:
𝑠𝑖 =
𝑏𝑖 − 𝑎𝑖
max{𝑎𝑖, 𝑏𝑖}
(1.19)
where 𝑎𝑖 denotes the average dissimilarity of 𝑖 with all other observations belonging to
the same cluster, and 𝑏𝑖 is the average dissimilarity of 𝑖 with all observations belonging
to the closest cluster to 𝑖. e closets cluster is defined by having the smallest average
dissimilarity with 𝑖. Values of 𝑠𝑖 can range between -1 and 1, with -1 meaning that the
observation 𝑖 should rather be a member of the closest cluster and 1 meaning that the
observation 𝑖 fits well to its cluster. An average 𝑠𝑖 for a single cluster tells how compact
the cluster is, and the average 𝑠𝑖 for all observations defines the whole clustering quality.
Evaluation of model-based clusters can be based on the likelihood that the obtained
clustering model describes the data well. e likelihood is one of the parameter calcu-
lated by expectation-maximization (EM) clustering algorithms and reported as one of
the clustering results.
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1.3 Objectives
e main objective of this thesis was to develop and apply a set of methods and tools
aiding in meta-analysis of phenotypic data obtained from systematic RNAi screens. e
goal of this thesis is to show that combined analysis of this data with other sources of
biological information (e.g. gene expression and romatin immunoprecipitation data
as well as existing functional and structural annotations), may bring a deeper insight
into function of genes.
ere are three specific aims of the systematic approaes presented in the following
apters. e first goal was to develop a tool and methodology for efficient organization
and systematic integration of phenotypic data from multiple systematic RNAi screens.
e soware must provide a unified web-based interface to all high-throuput data gen-
erated in a laboratory. A novel application providing this functionality is described in
Chapter 2.
e second goal was to establish meta-analysis algorithms for studying results of
multiple genome-wide data sets and to apply them to investigations of su biological
process as cell cycle, cell viability and self-renewal of embryonic stem cells. Results
covering this objective of the thesis are presented in Chapter 3 and 4.
e last goal was to develop an enriment analysis tool that facilitates analysis
of results obtained from genome-wide studies, by employing structural annotation of
proteins. A novel GSEA application and an example of its application are described in
Chapter 5.
In summary, these investigations provide the resear community with tools, meth-
ods and guidelines for analyzing various types of high-throughput data that ultimately
lead to a beer functional aracterisation of genes.
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DSViewer–a database of systematic
RNAi screens
With an increase of availability of large data-sets of RNAi-induced phenotypes, an im-
portant step is the organization and systematic integration of this functional informa-
tion. us, a pressing need exists for tools simplifying storage and analysis of the large
amount of phenotypic information generated. is apter describes DSViewer, a new
web-accessible and user-friendly database application designed for efficient storage, in-
tegration and querying of large-scale data sets generated by high-throughput experi-
ments.
2.1 Baground
e deluge of data generated by genome-scale RNAi screens resulted in a growing num-
ber of repositories of phenotypic data. Most of the databases tend to be species-specific,
like RNAiDB (Gunsalus et al., 2004), whi stores phenotypic data from large-scale RNAi
analyses in C. elegans, or Drosophila-specific repositories su as FlyBase (Drysdale,
2008), FLIGHT (Sims et al., 2006) and FlyRNAi (Flohart et al., 2006), whi contain a
variety of curated data including annotated genomes, expression paerns, mutant phe-
notypes, genetic interactions and anatomy images. Databases providing access to data
from mammalian systems include MPD (Bogue & Grubb, 2004), whi contains phe-
notypic data on commonly used inbred mouse strains, and GenomeRNAi (Horn et al.,
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2007), whi is a database providing access to RNAi phenotypes obtained from cell-
based screens in Homo sapiens and Drosophila.
Since the databases and resources containing phenotypic data tend to be species-
specific, cross-species comparative phenomic analysis oen remains an impossible task.
Moreover, data filtering possibilities of their web-based interfaces are limited to sin-
gle gene or single phenotype queries, making them difficult to be integrated into high-
throughput analysis pipelines. Most of the publicly-available repositories are designed
for serving results of finalised projects (i.e. fully analysed and published). Hence mak-
ing them unavailable for integration into local laboratory information management sys-
tems.
Although the analysis of results of a single RNAi screening experiment can be done
by utilizing spreadsheet applications (e.g. Microso Office Excel, OpenOffice.org Calc),
more complicated tasks involving data integration and meta-analsysis require an appli-
cation of a professional statistical computing soware, su as R/BioConductor (Dur-
in et al., 2009), coupled with database management systems (e.g.MySQL, PostgreSQL,
SQLite). ese solutions require extensive knowledge about programming environ-
ments and are not intuitive to use. erefore, an application that combines user-friendliness
of web-accessible repositories with flexibility of statistical soware is needed.
2.2 Implementation
DSViewer is a J2EE (Java 2, Enterprise Edition) web application running on a Tom-
cat 5.5 server and using MySQL as a database management system. To ensure stability
and scalability of the tool, the model-view-controller is implemented using the Spring
framework (Johnson, 2005). In order to ensure high responsiveness of the user interface,
parts of the application are scripted using Asynronous JavaScript and XML (AJAX)
tenology, whi allows replacing fragments of the user interface without the need of
reloading the complete web page.
2.2.1 Data management
In order to be able to store results of various systematic RNAi screening assays, the
database seme must be flexible enough to allow storage of different types of phe-
30
2.2 Implementation
group
group_id INT(10)
name  VARCHAR(255)
path
path_id INT(10)
name  VARCHAR(255)
parent_path_id  INT(10)  (FK)
perturbator
perturbator_id INT(10)
acc  VARCHAR(255)
set_id  INT(10)  (FK)
ensembl_gene  VARCHAR(40)
sequence  TEXT
description  TEXT
perturbator_xref
xref_id  INT(10)
perturbator_id INT(10)  (FK)
xref_db_id  INT(10)  (FK)
xref VARCHAR(255)
primary TINYINT(1)
property_data
property_data_id  INT(10)
set_data_id  INT(10)  (FK)
property_id INT(10)  (FK)
value_integer  INT(11)
value_double  DOUBLE
value_varchar  VARCHAR(255)
value_text  TEXT
value_time  DATETIME
property_description
property_id INT(10)
name  VARCHAR(255)
description  VARCHAR(255)
type ENUM(...)
priority INT(11)
editor VARCHAR(127)
fetch_values  TINYINT(1)
js_send_all_to  VARCHAR(127)
hidden TINYINT(1)
set
set_id  INT(10)
name  VARCHAR(255)
path_id INT(10)  (FK)
perturbator_set_id  INT(10)  (FK)
public TINYINT(1)
ncbi_taxon_id  INT(10)
creation_time  TIMESTAMP
set_access
set_access_id  INT(10)
set_id  INT(10)  (FK)
group_id INT(10)  (FK)
set_data
set_data_id  INT(10)
set_id  INT(10)  (FK)
perturbator_id INT(10)  (FK)
user
user_id  INT(10)
name  VARCHAR(255)
password  BINARY(40)
group_id INT(10)  (FK)
serialized_object  BLOB
timestamp TIMESTAMP
xref_db
xref_db_id  INT(10)
name  VARCHAR(255)
property_id INT(10)  (FK)
1..*
0..1
1..*0..1
1..*
1
1..* 1
1..*
1
1..*
1
1..*
0..1
1..*
0..1
1..*
1
1..*
1 1..*
1
1..*
1
1..*1
1..*
0..1
Figure 2.1: DSViewer database seme.
Ea data set stored in the database is represented by an entry in the set table. Data sets are orga-
nized as a tree, whose structure is managed by the path table. Ea data set consists of a list of ‘entries’
(table set_data), ea associated with an individual RNAi trigger (table perturbator). An ‘entry’ rep-
resents a set of experimental readouts or annotations. Ea value, depending on its type, is stored in
one of the value_* fields of the property_data table. Names and types of possible properties are stored
in the property_description table. RNAi triggers are organized in libraries, whi are also stored as
separate data sets. Ea perturbator is annotated with a gene name and other identifiers stored in the
perturbator_xref table. To facilitate unified querying interface, identifiers are also recognized as prop-
erties. Access to different data sets is secured at a ‘user’ and a ‘group’ levels (tables set_access, group
and user).
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notypic information (i.e. quantitative and qualitative), as well as genetic annotations.
Prioritizing this requirement, DSViewer was designed to allow storage of results of any
gene-centered high-throuthput experiment.
e underlying database seme (Figure 2.1) treats all numerical and textual values
associated with a gene as its ‘properties’. A property can be defined as any raw or
normalized value reported by an experimental assay or any phenotypic or functional
annotation (i.e. gene description). Properties provided by different data-sets are stored
centrally, in a single database table (see property_data on Figure 2.1). Initial transfer of
experimental results into the database is performed by a standalone application, whi
accepts Excel or comma- or tab-separated files as an input.
Different data-sets can be integrated with ea other on different levels. If both
data sets are results of RNAi screenings performed using the same library of silencing
triggers, the results are automatically joined by a trigger identifier. If experiments were
performed using different libraries but on the same species, the results are joined by
the common gene identifiers. Results of experiments carried out on different species are
joined by best-best orthology associations acquired from the Ensembl Compara database
(Hubbard et al., 2009).
2.2.2 User interface
DSViewer allows users to merge multiple data sets, filter them for combinations of phe-
notypes and display or save the results in a form of a table. A typical user session starts
with an authorisation screen followed by a welcome page, whi contains a short users’
guide (Figure 2.2). In order to integrate and view results of multiple experiments, a user
selects one or more data sets displayed in a navigation tree located in the le panel of
the web page. Aer accepting the selection, the main panel is replaced by the properties
selection window, whi displays all variables provided by the selected data sets (Fig-
ure 2.3). Using the window controls, the user selects properties that should be displayed
in the final results table. Numerical properties of the same type can be combined pro-
ducing a new variable calculated as an average of the respective values of the combined
variables. is feature is especially useful for generating new data sets that are sum-
marizing multiple replicates of the same experiment. When the properties selection is
confirmed, the selection panel is replaced by the results viewer (Figure 2.4).
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About
Browsing results of selected experiments
    1.   Select tables from the left pane tree
    2.   Click button "Display" (in the tree legend box above the tree). A new page should appear in the main pane
    3.   Select variables that you want to display or use in your search queries and press "Add" button. It is also possible to calculate an average of identicall
          properties from dierent data sets (e.g. measured value from two replicates) by selecting these properties and pressing "Add mean".
Methods used for joining data sets
    a.   Each data set is associated with a list of used perturbators (RNAi library). If selected data sets come from experiments in which same perturbators 
          were used then results are joined based on a common perturbator identier.
    b.   If selected data sets are linked to dierent perturbators lists but still are associated with the same organism then experimental results are linked
          through a common Ensembl identier.
    c.   If selected data sets are linked to dierent species then results are linked through homology pairs dened in Ensembl Compara database.
Searching for genes
    1.   Just paste your genes list to a text box in the left pane.
    2.   Make sure that a proper identier type is selected in the box above.
    3.   Press "Search" button.
Additional tools
               Enrichment analysis
         Paste a list of Ensembl names (Human) into a genes box, pick a condence threshold, genes ontology type and nally submit.
Data Sets
Ensembl (Human)
Search for genes
Data sets
        RNAi Libraries
        RNAi Screens
Property description
Hover mouse over a property
to get its descriuption
Display
Logout
Search
Tree legend
    - Project/subproject folder
    - Data set
    - Available properties
Select data sets and
click here:
Data sets
         RNAi Libraries
         RNAi Screens
                   Cell Viability & Apoptosis Screen
                           Cell Viability
                                    Primary
                                                      Primary Viability (Homo sapiens)
                                                      Plate
                                                      Row
                                                      Column
                                                      Control
                                                      Intensity
                                                      Z-Intensity
                                    Secondary
                           Apoptosis
                  P53 Interactors Screen
                  Cell Dierentiation Screen
                  STAT5 Phosphorylation
                  Cell Cycle Screen
                           Primary
                                             Expression status in HeLa (Homo sapiens)
                                             Cell Cycle Primary, Rep. A (Homo sapiens)
                                             Cell Cycle Primary, Rep. B (Homo sapiens)
                           Secondary
                  DS DNA Break Repair Screen
DSViewer       RNAi   Data Sets Viewer
Figure 2.2: DSViewer main page.
emain page of the DSViewerweb application. It consists of the short users guide and a data set selection
tree (expanded in the blow-up) with a genes sear box located below the tree. All available data sets are
organized in a structure resembling file system directories. Here, ea bran represents a project or a set
of replicates. Results of different experiments can be merged by selecting multiple data sets.
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Figure 2.3: DSViewer properties selection panel.
e panel contains two lists of properties. A list in the le side shows all variables provided by the selected
data sets. Properties selected for displaying in the results panel are shown in the right side. Numerical
variables of the same type can be averaged, allowing a summarization of multiple replicates of the same
experiment.
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Figure 2.4: DSViewer results panel.
e results panel contains a query builder, whi allows data filtering, and a sortable table with the results
of data sets integration.
e most important feature of the panel used for displaying results is the query
builder (Figure 2.4), whi allows constructing and editing complex selection criteria
containing filtering statements joined by logical operators ‘and’ and ’or’. Precedence
of the logical expressions can be altered by enclosing them with parenthesis. Results
of the filtering are either presented as a table or can be downloaded as a spreadsheet
file containing genes or RNAi reagents in rows and selected variables (phenotypes) in
columns. In case of specific gene list query, the database retrieves all mapped RNAi
triggers and information of phenotypes that were reported, dispaying them as separate
tables, one for ea data set.
Additional features of the web-based results viewer are table sorting, link-outs to
external databases and identifiers extraction, whi allows copying of selected gene
identifiers into external applications (i.e. enriment analysis tools).
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2.3 Current content
Currently, the database integrates information about two in-house produced genome-
wide libraries of esiRNA reagents targeting mouse and human genomes (Buholz et al.,
2006; Ding et al., 2009) and results of numerous primary and secondary systematic RNAi
screens performed in our laboratory (Table 2.1).
Table 2.1: Systematic genome-wide RNAi screens accessible through DSViewer inter-
face
Investigated process Species Reference
Cell cycle Human Kiler et al. (2007b)
Pluripotency of mouse embryonic stem
cells
Mouse Ding et al. (2009)
Cell viability Human eis et al. (2009)
Synthetic lethality of TP53 interactors in
cancer cells
Human Unpublished data
Double-stranded DNA repair through ho-
mologous recombination
Human Unpublished data
2.4 Conclusions
DSViewer is a computational tool developed for rapid and effortless integration of re-
sults obtained from high-throughput experiments. anks to an advanced querying ca-
pabilities, DSViewer can facilitate selection of candidate genes that share user-specified
combination of phenotypes (e.g. ‘cell-cycle arrest in G1 phase’ and ‘increased metabolic
activity’ or ‘increased cell size’). e main feature of DSViewer is flexibility of its
database seme, whi allows storage of any type of the phenotypic data, as well as
result of DNA microarrays or other gene-centered data-sets. DSViewer was a primary
application employed by data analysis pipelines described in the following apters of
this thesis.
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Chapter 3
Comparative profiling identifies
C13orf3 as a component of the Ska
complex required for mammalian cell
division
Proliferation of mammalian cells requires the coordinated function of many proteins to
accurately divide a cell into two daughter cells. Several RNAi screens have identified
previously unaracterised genes that are implicated in mammalian cell division. e
molecular function for these genes needs to be investigated to place them into pathways.
Phenotypic profiling is a useful method to assign putative functions to unaracterised
genes.
is apter shows the meta-analysis of two loss-of-function screens combined with
protein localisation data. e utility of this approa is shown by defining a function
of the previously unaracterised gene C13orf3 during cell division. C13orf3 localises
to centrosomes, the mitotic spindle, kinetoores, spindle midzone, and the cleavage
furrow during cell division and is specifically phosphorylated during mitosis. Further-
more, C13orf3 is required for centrosome integrity and anaphase onset. Depletion by
RNAi leads to mitotic arrest in metaphase with an activation of the spindle assembly
epoint and loss of sister romatid cohesion.
Proteomic analyses identify C13orf3 (Ska3) as a new component of the Ska com-
plex and show a direct interaction with a regulatory subunit of the protein phosphatase
PP2A. All together, these data identify C13orf3 as an important factor for metaphase
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to anaphase progression and highlight the potential of combined RNAi screening and
protein localisation analyses.
My main contribution to this work is presented in section 3.2 of this apter, whi
describes a novel methodology for a combined hit selection analysis based on multiple
RNAi screens. Results of my analysis established foundations for further experimental
studies, whose results are reported in section 3.3.
3.1 Introduction
Cell division and mitosis of eukaryotic somatic cells require the coordinated function
of many proteins in a temporally and spatially well-orestrated process (Nasmyth,
2002; Nigg, 2001; Varei & Musacio, 2008). Mitosis can be subdivided into differ-
ent phases mainly depending on morphological features. e purpose of early mitosis
from prophase to metaphase is the establishment of a bipolar spindle with all kineto-
ores aaed amphitelic to spindle microtubules (Musacio & Salmon, 2007). Proper
aament and the creation of tension at the kinetoores are believed to be the key
factors for silencing of the spindle assembly epoint (SAC).
Silencing of the SAC leads to the activation of the E3 ubiquitin–protein ligase, APC/C
(Sullivan & Morgan, 2007). e APC/C is a multiprotein complex composed of at least
12 subunits, of whi, among others, the subunits Cdc16 and Cdc27 are crucial for its
activity (Peters, 2006;ornton et al., 2006); it promotes execution of anaphase by polyu-
biquitylation of its main substrates cyclin B1 and securin, thereby targeting them for
destruction by the proteasome. Degradation of cyclin B1 results in a decrease in Cdk1
activity that is required for entry into the late phases of mitosis. Loss of securin al-
lows activation of separase required for sister romatid separation (Sullivan &Morgan,
2007).
In vertebrate cells, arm cohesion is largely lost during prophase and prometaphase in
a separase-independent pathway requiring polo-like kinase 1 (Plk1) and aurora kinase
B (AurkB) activity to facilitate sister romatid resolution (Waizenegger et al., 2000;
Watanabe, 2005). In contrast, centromeric cohesion is preserved until anaphase by the
protein shugoshin-like 1 (SGOL1), whi recruits protein phosphatase 2A (PP2A) to cen-
tromeric cohesion, thereby counter-acting phosphorylation by Plk1.
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Although parts of the genes and the meanisms that guard mammalian cell divi-
sion have been identified, others remain elusive. e complexity of mammalian cell
division calls for a systems-level approa to understand the sophisticated interaction
and regulation of proteins involved (Kiler et al., 2008). Loss-of-function screening by
RNAi is a valuable strategy for the systematic analysis of genes implicated in cell-cycle
regulation, and different methods to carry out RNAi experiments in mammalian cells
are available (Sase & Eeverri, 2004). We and others have developed and success-
fully utilised endoribonuclease-prepared short interfering RNAs (esiRNAs) as mediator
for RNAi (Fazzio et al., 2008; Galvez et al., 2007; Kiler et al., 2004, 2007b; Yang et al.,
2002b). As esiRNAs are highly specific, they are well suited for RNAi experiments,
especially for large-scale RNAi screens (Kiler et al., 2007c). A previously conducted
genome-scale esiRNA screen on cell-cycle progression in mammalian cells (Kiler et al.,
2007b) identified many previously unaracterised genes implicated in this process. e
use of multiparametric analysis in combination with hierarical clustering allowed the
placement of some of these genes into pathways (Kiler et al., 2007b). However, it re-
mains allenging to interpret multiparametric phenotypic data to build valid biological
hypotheses, and for many unaracterised genes the molecular role during cell division
remains elusive.
Localisation is an independent indicator of gene function (Wang et al., 2008c), whi
may provide valuable information in addition to loss-of-function data. Antibodies are
useful to determine the localisation paern of proteins, and are commercially avail-
able for many known cell-cycle proteins. However, generating antibodies for unarac-
terised genes is time-consuming and cost-intensive. Tagging of genes with fluorescent
proteins is a rapid and cost-effective alternative to antibodies, whi also allows the
dynamic localisation of proteins in living cells, and collections of tagged genes based
on cDNA constructs have been assembled (Pepperkok & Ellenberg, 2006). However, ex-
pression of tagged genes from cDNA constructs can be problematic because the genomic
context of the gene is not preserved. As a consequence, the gene is oen expressed at
nonphysiological levels, whi can lead to mislocalisation of the protein. Recently, the
TransgeneOmics approa has been developed to allow rapid tagging of many genes
that preserves the genomic context (Poser et al., 2008). Using recombineering tenol-
ogy (Muyrers et al., 2001) to tag genes, encoded on a bacterial artificial romosome
(BAC), allows the expression of genes close to the endogenous level. As a BAC usually
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contains all cis-regulatory elements of the promoter, 3’-UTR, and the coding region, the
transgene maintains its physiological expression levels and splicing paern (Poser et al.,
2008), a feature especially interesting for genes implicated in cell-cycle control.
To test whether localisation data help to refine phenotypic profiles, I exemplified the
analysis of a subcluster derived from two RNAi screens that were enried for known
regulator proteins of mitosis by using the TransgeneOmics approa. I nominated the
previously unaracterised protein, C13orf3 (also known as Rama1), to exhibit a similar
localisation paern and phenotypic features to the protein Ska1 (spindle and kineto-
ore associated protein 1). A detailed aracterisation identified a direct interaction
of C13orf3 with members of the Ska complex, described as a two-component complex,
composed of Ska1 (C18orf24) and Ska2 (Fam33a), with a critical role in the maintenance
of the metaphase plate and progression through mitosis (Hanis et al., 2006).
Investigation reported in this apter showed that C13orf3 (Ska3) is an integral part
of the Ska complex and localises to the mitotic spindle, kinetoores, and cleavage fur-
row during mitosis. In addition, it was shown that C13orf3 is required for the mainte-
nance of a bipolar spindle. Depletion of C13orf3 leads to an arrest in a metaphase-like
state with an activation of the SAC and sister romatid separation. ese findings un-
derline the importance of C13orf3 in the mitotic progression of mammalian cells and
show that the combination of phenotypic profiling and localisation data improves the
predictive power helping to identify pathways for genes with important roles during
cell division.
3.2 Comparative profiling of phenotypes from system-
atic RNAi screens
To predict functions of previously unaracterised mitosis-related genes, I utilized a
data set from a cell-cycle esiRNA screen carried out previously in my laboratory (Kiler
et al., 2007b). To refine this data, a genome-wide cell viability screen was performed.
Both screens were done in the same cell line (HeLa) and with the same library of gene
silencing triggers, thereby reducing between-experiment variability.
40
3.2 Comparative profiling of phenotypes from systematic RNAi screens
3.2.1 Data combination and normalization
Input data
In the cell-cycle screen, an analysis of genes implicated in the cell-cycle progression
was carried out using DNA content analysis combined with laser-scanning cytometry.
Phenotypes were expressed as proportions of cells in different phases of the cell cycle
(G1, S, G2/M) and cells with polyploidy phenotype for ea knodown (Kiler et al.,
2007b). e final result was calculated as an average from two replicates. In the cell
viability screen, cellular metabolic activity was measured with alamarBlue® assay. For
ea knodown, it returned a single value corresponding to fluorescent intensity of a
reporter dye. Since both screens were performed using the same library of esiRNA com-
pounds, the data sets were joined by unique esiRNA identifiers. e final list comprised
16 363 combined phenotypes.
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Figure 3.1: Distribution of cell-cycle phenotypes.
(A) e violin plot shows distributions of fractions of cells in cell-cycle phases aer the genome-wide
esiRNA treatment (average of two replicates). White dots represent median values, upper and lower
bounds of bla boxes represent 1st and 3rd quartiles, vertical lines extend 1. 5IQR beyond the box bound-
aries. (B) Comparison of 𝑧-score and𝑚-score normalization vs. percentile rank normalization of fractions
of cells in G1 phase. Ea dot represent a phenotype of a single gene kno-down.
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Table 3.1: Skewness and kurtosis of the cell-cycle phenotypes
Raw values􏷠 log􏷡 transformed
Variable Skewness􏷡 Kurtosis Skewness Kurtosis
G1 −0.36 7.10 −2.28 29.41
S 1.02 10.42 −0.54 5.16
G2/M 0.54 7.61 −0.53 6.48
Polyploid 7.51 198.42 −0.06 3.81
􏷪 Ratio of cells compared to total.
􏷫 e normal distribution has both skewness and kurtosis equal to zero.
Originally, ea variable of the cell-cycle data set was normalized using 𝑧-scores
(Kiler et al., 2007b). However, the percentages of cells in ea phase of te cell cycle
are not normally distributed (Lillefors normality test) and their distributions are highly
skewed (Table 3.1 and Figure 3.1A). e same results were obtained for a hypothesis
of a log-normal distribution. us, the 𝑧-score normalization of the cell-cycle-related
variables would lead to a strong bias in the further analysis and increase the false dis-
covery rate. In addition, the analysis of variance (ANOVA) did not indicate a significant
between-plate variability making the within-plate normalization not necessary.
To normalize all variables in the study, I applied a non-parametric approa and
converted all variables from the study into their respective percentile ranks. e per-
centile rank of a score is the percentage of scores that are the same or lower (Croer
& Algina, 2006) and can be easily calulated from the empirical distribution as a rank of
the score divided by the total number of observations:
𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑖𝑙𝑒 𝑟𝑎𝑛𝑘(𝑥) = 𝐵 + 0. 5𝐸𝑛 ⋅ 100% =
𝑟 − 0. 5
𝑛 ⋅ 100% (3.1)
where 𝐵 is a number of scores lower than 𝑥, 𝐸 is the number of scores equal to 𝑥 and 𝑟
is rank of the score.
Compared to 𝑧-score or𝑚-score normalization, percentile ranks reduce the influence
of extreme values and introduce higher separation of mild scores (Figure 3.1B). is
effect gives an advantage during detection of weakly-scoring genes, whi due to lower
𝑧-scores would be missed during classical threshold-based hits selection.
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3.2.2 Clustering of phenotypes
Phenotypic signature of a gene can be used as a reporter of the gene function in the
cell cycle and, as a consequence, genes showing similar phenotypes upon knodown
might participate in the same biological processes (Kiler et al., 2007b). To group genes
by their phenotypic signature, I applied hierarical clustering.
e essential part of the hierarical clustering algorithm is an appropriate oice
of a metric used for measuring distances between phenotypic signatures of two genes.
Because a complete phenotypic signature consists of variables obtained from two ex-
periments, I used a weighted euclidean metric:
‖𝐱 − 𝐲‖ =
􏽱
𝑛
􏾜
𝑖=􏷠
𝑤𝑖􏿴𝑥𝑖 − 𝑦𝑖􏿷
􏷡
(3.2)
𝑛
􏾜
𝑖=􏷠
𝑤𝑖 = 1 (3.3)
Weights were osen to ensure equal influence of both experiments in the calculated
distance: 𝑤 = 0. 5 for the viability variable and 𝑤 = 0. 125 for ea of the four cell-
cycle variables. e final tree was constructed with the UPGMA linkage.
3.2.3 Cluster selection
To identify a set of genes potentially involved in progression through mitosis, I seared
for a cluster with a significant enriment of known genes annotated with Gene Ontol-
ogy terms ‘mitosis’ and ‘cell cycle’. Su an enriment suggests that unaracterized
genes within the same cluster may also be related to biological processes described by
the selected GO terms.
For ea bran of the tree, I selected genes belonging to its all subclusters. If the
number of genes exceeded 10, I calculated an enriment of the two GO terms. e
main advantage of my enriment-based approa of cluster selection procedure is that
it does not require the tree-cuing step. e optimal number of cluster does not have
to be calculated because the algorithm is analyzing the whole dendrogram in sear for
a cluster of interest.
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Figure 3.2: Strategy of phenotypic profiling.
Genome-scale RNAi data from a cell cycle and a viability screen were combined for multiparametric
hierarical clustering. Values for five parameters, that is, proportions of cells in phases G1, S, G2/M, and
aneuploid cells (8N), as well as cell viability (decreased: blue, increased: red), were converted in percentile
ranks and used to build a hierarical tree sorting the genes by similarity of their phenotype. A subcluster
enried with genes with important mitotic functions is shown in the blow-up.
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As a result, the highest scores were obtained for the cluster containing 154 genes and
the enriment values were 3.0-fold of cell-cycle genes and 5.5-fold of mitosis-related
genes (e.g. CENP-E, SGOL1, Eg5, Ska1, Plk1). is cluster was selected for further ex-
perimental validation (Figure 3.2).
3.2.4 Addition of cell viability data refines the clustering results
To test wether combination of different RNAi screens increases the predictive power to
nominate annotations for unaracterized genes, I performed an analogous analysis for
the cell-cycle data alone. In the clustering without the viability data, the enriment
of selected GO terms in the highest scoring cluster, whi contained 1069 genes, was
only 1.6-fold and 2.2-fold for cell cycle and mitosis associated genes, respectively, com-
pared to enriment of 3.0-fold and 5.5-fold in the cluster obtained from the analysis of
combined data (Figure 3.3). is result implied that combination of data derived from
independent RNAi screens using different assays reduced the noise and improve the
data quality.
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Figure 3.3: Enriment of ontology terms aer introducing cell viability data.
Hierarical clustering of cell-cycle data alone followed by the cluster selection procedure resulted in a
cluster comprising 1069 genes, among whi 122 (1%) were annotated with the ‘cell cycle’ and 24 (2%)
with the ‘mitosis’ GO term. Aer merging with the cell viability data, the clustering algorithm reported
a refined cluster comprising 154 genes, among whi 44 (29%) and 7 (5%) were annotated with the ‘cell
cycle’ and ‘mitosis’ terms respectively.
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3.3.1 Combining phenotypic profiling with protein localisation
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Figure 3.4: Localisation of selected BAC transgenic cell lines.
Selected examples of imaged BAC transgenic cell lines stained for 𝛼-tubulin (red), DNA (blue), and LAP-
tag (green).
To further refine the profile within the cluster, the protein localisation in mitotic cells
for known cell-cycle genes and previously unaracterised genes was determined using
the BAC-based TransgeneOmics approa (Kiler et al., 2005b; Poser et al., 2008). BAC
constructs maintain the genomic context of a gene and usually contain all cis-regulatory
elements for gene expression. Furthermore, they typically integrate at low copy number,
thereby allowing physiological expression of the tagged proteins (Kiler et al., 2005b;
Poser et al., 2008). Amodified version of the ‘localisation and affinity purification’ (LAP)
tag (Cheeseman & Desai, 2005) consisting of an EGFP and an S-peptide sequence was
used. e analysis of images from these BAC-transgenic HeLa cell lines during mi-
tosis confirmed the known localisation of cell-cycle-relevant proteins su as CENP-
E (kinetoores), SGOL1 (centromeres), Eg5 (centrosomes, mitotic spindle), and Ska1
(kinetoores, mitotic spindle) (Figure 3.4), showing the utility of the TransgeneOmics
approa. To improve the phenotypic profiling, we determined the localisation of 52
known and unaracterised BAC-tagged proteins from the subcluster comparing their
localisation with ea other to identify proteins with similar localisation paerns. Inter-
estingly, the analysis of the unaracterised protein, C13orf3, showed a spindle and kine-
toore localisation during mitosis, most similar to the localisation paern of Ska1 in the
subcluster (Figure 3.4) (Hanis et al., 2006; Rines et al., 2008). Although the phenotypic
data alone were insufficient to link C13orf3 to Ska1, the combination with the localisa-
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tion data predicted that Ska1 and C13orf3 might physically and/or genetically interact.
To test this hypothesis, C13orf3 was selected for an in-depth analysis. Comparative se-
quence analysis identified putative C13orf3 orthologues in mammals, birds, amphibians,
and bony fish (e.g., mouse: ENSMUSG00000021965, ien: ENSGALG00000017128,
frog: ENSXETG00000009595, and zebrafish: ENSDARG00000067746, respectively), but
not in invertebrates. Structure-based bioinformatics analyses (Godzik, 2003; Sippl &
Flöner, 1996) identified aGle2-binding sequencemotif (GLEBSmotif) at the C-terminal
region of C13orf3 (aa 345–382). Interestingly, an additional putative GLEBS motif has
been proposed in the N-terminal region (aa 17–51) of C13orf3 by Gaitanos et al. (E Nigg,
personal communication, 2008). GLEBS motifs are present in Bub1 and BubR1 and have
been structurally aracterised to mediate binding to Bub3 (Larsen et al., 2007), substan-
tiating a potential role of C13orf3 in mitosis.
3.3.2 C13orf3 localises to prominent structures during mitosis
To analyse the dynamic localisation of C13orf3 during cell division and to substanti-
ate the overlapping localisation with Ska1 observed in the profiling study (Figure 3.4),
the C13orf3 BAC-transgenic HeLa cell line was used and dividing cells were imaged
using fluorescence time-lapse microscopy. e protein was predominantly cytoplas-
matic during interphase, with a noticeable concentration around the nuclear envelope
(Figure 3.5Aa, j). In prophase, just before the nuclear envelope breakdown, an accu-
mulation of C13orf3 at the centrosomes was readily detectable (Figure 3.5Ab and B).
During prometaphase and metaphase, C13orf3 localised to the mitotic spindle as well as
to the kinetoores (Figure 3.5Ac, d and B). Upon entry into anaphase, the fusion pro-
tein was enried at the spindle (Figure 3.5Ae and B) and at the spindle midzone in late
anaphase and telophase (Figure 3.5Af, g, and B). During cytokinesis, C13orf3 was found
at the cleavage furrow (Figure 3.5Ah, i, and B). e localisation to important mitotic
structures and the overlap with the localisation paern of Ska1 (Hanis et al., 2006)
underlines a potential interaction of these proteins.
3.3.3 C13orf3 is required for anaphase onset
e prominent localisation of C13orf3 suggested to carry out a more detailed pheno-
typic analysis. To confirm and validate findings from the genome-wide RNAi screens
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Figure 3.5: Localisation paern of C13orf3 in HeLa cells
(A) Selected frames from fluorescence time-lapse microscopy of HeLa cells expressing LAP-tagged
C13orf3 at indicated time points are shown in interphase (a, j), prophase (b), prometaphase (c), metaphase
(d), early anaphase (e), late anaphase (f), telophase (g), early cytokinesis (h), and late cytokinesis (i).
(B) Immunofluorescence microscopy of LAP-C13orf3 co-stained with pericentrin, CREST, and alpha-
tubulin antibodies during indicated cell cycle phases. Arrows and blow-ups point to areas of colocalisa-
tion.
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(Figure 3.2), first a repeated DNA content analysis by flow cytometry was performed
with two independent esiRNAs targeting C13orf3. For both esiRNAs, a significant cell-
cycle arrest in the G2/M phase was observed 42 h post transfection. To ensure efficient
knodown of the intended target genes by RNAi, Q-PCR and western blot analyses
were conducted. For all esiRNAs, a knodown of at least 80 % was aieved at the
mRNA level 24 h post transfection and a knodown of at least 85 % at the protein
level 42 h post transfection, showing the efficacy of the employed esiRNAs. As the
DNA content for cells in G2 phase and mitosis is 4 N, it is not possible to distinguish
these two phases by DNA content measurements. To distinguish between a G2- and
M-phase arrest, C13orf3 was depleted by RNAi and, 42 h post transfection, the mitotic
index was determined by staining for the phosphorylation of serine 10 of histone H3,
a mitotic marker for romatin condensation (Goto et al., 1999). Immunofluorescence
microscopy showed an increase in the mitotic index to 26.2 % upon C13orf3 depletion
(3.6 % for mo control), of whi 80.5 % of the cells were arrested in a metaphase-like
state (36.1 % for mo control) (Figure 3.6A and C). ese data suggest that C13orf3
is required for anaphase onset. In addition to the metaphase arrest, we observed a
significant increase in cells with tripolar and tetrapolar spindles (19 % versus 2 % for
mo-transfected cells) (Figure 3.6D and E), indicating that C13orf3 might also have
a function in centrosome duplication or maintenance. To obtain a dynamic descrip-
tion of the phenotypic consequences upon C13orf3 depletion, time-lapse microscopy
analyses was carried out in a cell line expressing a histone(H2B)–GFP fusion protein.
ese analyses showed an apparently normal romosome congression and a proper
establishment of the metaphase plate (Figure 3.6F, H). However, as early as 30 h post
transfection, cells failed to maintain the metaphase plate, with individual romosomes
exiting from the aligned romosomes (Figure 3.6F) causing a mitotic arrest, whi ul-
timately led to cell death through caspase-dependent apoptosis. Closer analysis of the
first mitosis aer C13orf3 depletion in the histone(H2B)-GFP cell line showed that af-
fected cells first form a straight metaphase plate, indicative of a bipolar spindle with
two centrosomes. At later stages, the metaphase suddenly became kinked, indicating
that the bipolar spindles had reverted to a tripolar spindle, likely through fragmenta-
tion of one centrosome. is observation confirms the results from the phospho-histone
H3 (pS10) and anti-pericentrin immunofluorescence stains (Figure 3.6A, C, D, and E)
and provides a possible explanation for the frequent appearance of tripolar and tetrap-
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olar spindles. Staining of C13orf3-depleted cells with antibodies against the mitotic
epoint proteins, Bub1 (Figure 3.6G) and Mad2 (data not shown), showed that the
detaed kinetoores were positive for both proteins, suggesting that the mitotic ar-
rest is caused by the activation of the SAC. Other kinetoore proteins su as CASC5,
Mis12, or NDC80 did not loose their localisation, showing that the overall structure of
the kinetoores is not affected upon C13orf3 depletion. Co-depletion of Mad2 together
with C13orf3 rescued the mitotic arrest (Figure 3.6B, C), showing that the activation of
the SAC is indeed the primary cause of the mitotic arrest. Together, the comparison of
the RNAi phenotype with the described Ska1 RNAi phenotype, that is, mitotic arrest in
metaphase, SAC activation (Hanis et al., 2006), andmitotic centrosome fragmentation,
substantiated a possible functional link between these two proteins.
Next, we wanted to investigate whether C13orf3 is required for romosome seg-
regation. Onset from metaphase to anaphase with romosome segregation during
anaphase requires, among others, the inhibition of the kinase activity of Cdk1 (Sulli-
van & Morgan, 2007). Furthermore, Cdk1 activity is necessary for mitotic entry and
maintenance of the mitotic state in early mitosis (Vassilev et al., 2006). Consequently,
an inhibition of Cdk1 kinase activity during early mitosis, for example, by the small
molecular inhibitor, RO-3306, results in mitotic exit(Vassilev et al., 2006). In contrast,
inhibition of Cdk1 activity in interphase prevents mitosis entry and induces an arrest
in the G2 phase. Accordingly, mitotic arrest in prometaphase by nocodazole could be
released by RO-3306 treatment, leading to mitotic exit without romosome segrega-
tion. To investigate possible differences of RO-3306-induced mitotic exit in metaphase,
cells were arrested through RNAi against the APC/C subunits Cdc16 and C13orf3. Aer
treatment with RO-3306, the exiting cells were imaged by fluorescence time-lapse mi-
croscopy. Although Cdc16 depletion leads to a metaphase arrest with the formation of a
metaphase plate and a bipolar spindle, the release by RO-3306 treatment does not result
in romosome segregation (Figure 3.6I), inter alia because sister romatids are still
held together at the centromeres by cohesin. In contrast, a release from the metaphase
arrest aer C13orf3 depletion by RO-3306 resulted in anaphase onset and romosome
segregation with high statistical significance (Figure 3.6I, J). Consequently, C13orf3 is
not per se required for anaphase execution or romosome segregation. To exclude ef-
fects caused by tagging with GFP and Cherry, we repeated these assays with unlabelled
cells leading to the same conclusion.
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Figure 3.6: RNAi phenotypes upon C13orf3 depletion
51
3.3 Experimental results and discussion
Figure 3.6: cont.
(A) C13orf3-depleted cells arrest in metaphase. Anti-phospho-histone H3 (pS10) (green), DAPI (blue), and
𝛼-tubulin (red) stains are shown of HeLa cells treated with esiRNAs as indicated. Representative images
of three independent experiments are shown. (B) Metaphase arrest upon C13orf3 depletion is dependent
on spindle-assembly epoint integrity. Anti-phospho-histone H3 (pS10) (green), DAPI (blue), and 𝛼-
tubulin (red) stains of HeLa cells treated with indicated mixtures of esiRNAs are shown. (C) C13orf3
depletion results in a SAC-dependent metaphase arrest with high statistical significance (𝑝 < 0. 001).
antitative evaluation of phospho-histone H3 (pS10) stains (as in panels A and B) are shown. e mi-
totic index is shown with the percentages of cells arrested in metaphase indicated above the bars. At
least 200 cells were counted for ea experiment. Error bars indicate the standard deviation of three
independent experiments. Significance tests were carried out with differences calculated between mi-
totic and metaphase indices of cells treated with C13orf3 or C13orf3/Mad2 esiRNAs versus controls by
a two-tailed 𝑡-test. (D) Cells arrested by C13orf3 depletion show an increased frequency of multipolar
spindles compared with control cells. Representative cells stained with antibodies against 𝛼-tubulin (red),
pericentrin (green), and DAPI (blue) are shown. (E) Depletion of C13orf3 increases the number of mul-
tipolar spindles with high statistical significance (𝑝 < 0. 001). antitative evaluations of pericentrin
stains (as in panel D) are shown. At least 80 metaphases were evaluated for ea value. Significance tests
were carried out with differences calculated between percentages of multipolar spindles of cells treated
with C13orf3- versus Rn-Luc esiRNAs by a Pearson’s 𝜒􏷡 test with Yates’ correction for continuity (**).
(F) C13orf3 is necessary for metaphase plate maintenance. HeLa cells stably expressing histone(H2B)-
GFP depleted of C13orf3 followed by fluorescence time-lapse microscopy for the indicated periods are
shown. Arrows indicate unaligned romosomes. Representative images from a total of 45 cells filmed
by time-lapse microscopy are presented. (G) Immunofluorescence staining of LAP-Bub1 in mitotic HeLa
cells aer depletion of C13orf3 by RNAi. e single arrow (le panel) points to detaed paired sis-
ter kinetoores, and the two arrows (right panel) point to separated sister kinetoores. Representa-
tive images are depicted from a total of 56 mitotic cells evaluated from two independent experiments.
(H) C13orf3 depletion leaves the timing of metaphase plate formation unaltered. Measurement of the
time from nuclear envelope breakdown to metaphase plate formation is shown. For every RNAi treat-
ment, the average time and standard deviation of 15 cells are shown. e experiment was repeated three
times independently. Average and standard deviations are given for every replicate separately. (I) Cdk1
inhibition promotes anaphase entry in arrested cells aer C13orf3 depletion. HeLa cells stably express-
ing Cherry-histone(H2B) and GFP-tubulin arrested by RNAi against C13orf3, Cdc16, or nocodazole are
shown (𝑇 = 0). Selected frames from time-lapse microscopy aer the addition of the Cdk1 inhibitor,
RO-3306, are presented (𝑇 = 27–156). Arrows tra cells exiting from mitosis. (J) Statistical quan-
tification shows significant differences in mitotic exit upon C13orf3-RNAi, Cdc16-RNAi, or nocodazole
treatments. Cells arrested in mitosis aer indicated treatments were analysed with respect to mitotic
release by RO-3306 with progression to anaphase (bla) or without anaphase (white). Arrested cells that
could not be released by RO-3306 are shown in grey. Error bars indicate standard deviation for 200 eval-
uated cells from three independent experiments. (K) Sister romatids are separated aer mitotic arrest
by C13orf3 or SGOL1 depletion. Representative romosome preparations for HeLa cells treated with
indicated esiRNAs are shown. Cells treated with the negative control Rn-Luc were arrested by nocoda-
zole treatment before harvesting. RNAi against the APC/C component, Cdc16, was used as a control for
metaphase-arrested cells with X-shaped romosomes. Individual romosomes are shown as blow-ups.
(L) antitative evaluation of metaphase spreads shows significant increase in single romatids upon
treatment with esiRNA for SGOL1 and C13orf3 compared with Cdc16 or Rn-Luc RNAi (𝑝 < 0. 001). For
ea treatment, 40–60 metaphases from two independent experiments were evaluated. Significance tests
were carried out with differences calculated between the percentage of cells showing single romatids
treated with C13orf3, Cdc16, or SGOL1 and Rn-Luc esiRNA by a Pearson’s 𝜒􏷡 test with Yates’ correction
for continuity (**).
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Figure 3.6: cont.
(M) C13orf3 protein stability is dependent on Ska1 and SGOL1. Western blot analysis of extracts from
mitotic cells transfected with indicated esiRNAs and stained with indicated antibodies are shown. Size
standards are depicted on the le. antifications of the band intensities by densitometry are shown
below the western blot. Numbers indicate the protein levels in percent aer RNAi treatment, normalised
to GAPDH. e intensity for the mo control (i.e., Rn-Luc esiRNA) was used as reference. (N) SGOL1
protein stability and localisation is not dependent on C13orf3. Immunofluorescence stains of LAP-SGOL1
in mitotic HeLa cells aer treatment with esiRNAs against C13orf3 or Rn-Luc are shown. Representative
images are depicted from a total of 48 mitotic cells evaluated from two independent experiments.
Together, these data identify C13orf3 as an essential protein to satisfy the SAC but
not for romosome segregation during anaphase. Beside the inhibition of Cdk1 activ-
ity, the separation of sister romatids is an important step before execution of anaphase
(Sullivan & Morgan, 2007; Yamagishi et al., 2008). erefore, we asked whether cells
arrested in metaphase aer C13orf3 depletion have intact sister romatid cohesion.
e protein SGOL1 is implicated in the protection of centromeric sister romatid co-
hesion during early mitosis mainly by recruiting PP2A to the centromeric region of
romosomes. Hence, knodown of SGOL1 leads to mitotic arrest due to premature
sister romatid separation (Riedel et al., 2006; Waizenegger et al., 2000). Observation
of romosome spreads prepared from cells arrested by nocodazole treatment or RNAi
against Cdc16, C13orf3, and SGOL1 revealed X-shaped romosomes in the cases of
Cdc16 RNAi and nocodazole treatment (Figure 3.6K). It indicates that the sister ro-
matid cohesion is still intact. In contrast, single sister romatids were observed with
high statistical significance for RNAi of C13orf3 and SGOL1 (Figure 3.6K and L), in-
dicating that the phenotypic consequences of the depletion of these two proteins may
be similar. Interestingly, on closer inspection of the RNAi phenotype of SGOL1, other
striking similarities to the C13orf3 depletion were seen, for example, exiting romo-
somes from the metaphase plate and centrosome fragmentation without alteration on
timing of early mitosis (Nakajima et al., 2007; Wang et al., 2008b) (Figure 3.6H). Similar
to the C13orf3 knodown, the RNAi depletion of SGOL1 does not alter the localisation
of kinetoore proteins su as CASC5, Mis12, or NDC80, showing that the overall kine-
toore structure stays intact. To further investigate a potential connection of SGOL1
and Ska complex, Ska1 and SGOL1 were depleted in the C13orf3 BAC-tagged HeLa cell
line and possibleanges in C13orf3 protein levels were monitored by western blot anal-
ysis. Strikingly, both knodowns greatly reduced protein levels of C13orf3 in mitotic
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cells (Figure 3.6M), corroborating the link between C13orf3, Ska1 and SGOL1 and indi-
cating that C13orf3 requires Ska1 and SGOL1 for its stability. To test whether the loss of
sister romatid cohesion phenotype upon C13orf3 depletion (Figure 3.6K) might be due
to loss of SGOL1 protein or mislocalisation, C13orf3 was depleted in a BAC transgenic
HeLa cell line expressing LAP-tagged SGOL1. No significant loss in SGOL1 protein level
or mislocalisation was observed upon C13orf3 depletion compared with the mo con-
trol (Figure 3.6N). ese results suggest that there is no mutual dependency of C13orf3
and SGOL1 protein levels and places C13orf3 downstream of SGOL1.
3.3.4 C13orf3 is differentially phosphorylated during mitosis
Western blot analysis of lysates isolated from asynronously growing LAP-taggedC13orf3
cells identified a single band of the predicted size. However, cell extracts prepared from
mitotic cells showed an additional band of higher molecular weight (Figure 3.7A), sug-
gesting that C13orf3 is modified in mitosis. Treatment of mitotic extracts with calf in-
testine phosphatase led to the disappearance of the slower migrating band (Figure 3.7A),
showing that C13orf3 is phosphorylated during mitosis. Furthermore, the mass spec-
trometry analysis identified a C13orf3 peptide that was specifically phosphorylated at
threonine 190 or 193 during mitosis (Figure 3.7B). To study phosphorylation of C13orf3
during mitosis in more detail, the protein Eg5 (kinesin 11, depletion produces monopoles
and causes a prometaphase arrest) and the APC/C subunit Cdc27 (depletion of impor-
tant APC/C subunits cause a metaphase arrest) were depleted by RNAi. Protein extracts
isolated from these cells showed that C13orf3 is phosphorylated during prometaphase
and metaphase (Figure 3.7C). To identify potential kinases implicated in C13orf3 phos-
phorylation, the selected kinases with prominent roles during mitosis were depleted by
RNAi in the LAP-tagged C13orf3 BAC-transgenic HeLa cells and mitotic cell lysates
were analysed by western blot. is analysis showed that depletion of AurkB, but not
Plk1, abolished phosphorylation of C13orf3 (Figure 3.7D), indicating that C13orf3 phos-
phorylation is AurkB-dependent. Interestingly, in addition to the reduced protein lev-
els, no band of higher molecular weight was visible in mitotic extracts upon Ska1 RNAi
treatment (Figure 3.6M), indicating that C13orf3 phosphorylation was also dependent
on Ska1. Given the differential phosphorylation of C13orf3 in interphase and mitosis,
it appeared likely that C13orf3 is dephosphorylated by a protein phosphatase at the end
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of mitosis. To test this hypothesis, HeLa cells stably expressing LAP-tagged C13orf3
were released from nocodazole arrest and treated with okadaic acid, an inhibitor of the
phosphatase activity of PP2A and PP1 (Mailhes et al., 2003). e phosphorylation of
C13orf3 persisted in the presence of okadaic acid (Figure 3.7E), indication that either
PP2A or PP1 activity is required to remove C13orf3 phosphorylation at the end of mi-
tosis. e conclusions is that C13orf3 is differentially phosphorylated during the cell
cycle, with AurkB and PP2A or PP1 being potential candidates that phosphorylate and
dephosphorylate the protein, respectively.
3.3.5 C13orf3 forms a complex with Ska1, Ska2 and PPP2R2B
To identify protein interaction partners of C13orf3, immunoprecipitation assays were
performed and followed by mass spectrometry using the LAP-tagged C13orf3 HeLa cell
line. ese analyses showed interactions of C13orf3 with the Ska complex proteins Ska2
(Fam33A) and Ska1 (C18orf24) (Table 3.2). Mass spectrometry analyses utilising LAP-
tagged BAC-transgenic Ska1 and Ska2 cell lines validated the physical interaction of
these three proteins (Table 3.2). Hence, these studies identify C13orf3 as a new member
of the Ska complex. Based on this data, we propose to rename C13orf3 into Ska3. In
contrast to the Ska protein interactions, a direct interaction of C13orf3 with SGOL1 was
not detected by mass spectrometry. However, a global proteomic study with subunits of
PP2A showed a physical interaction of C13orf3 and Ska1/2 with PPP2R2B (Glaer et al.,
2009) (Table 3.2). e interaction with PPP2R2B indicates that PP2A is the phosphatase
that dephosphorylates C13orf3 at the end of mitosis (Figure 3.7E) and also provides a
possible link to SGOL1 through the regulation of PP2A activity. To map the interaction
domains of Ska proteins, different protein fragments were tested in yeast two-hybrid
assays (Boxem et al., 2008). ese analyses showed an interaction of the N-terminal
part of C13orf3 (aa 1–159) with the N-terminal part of Ska1 (aa 1–84) (Figure 3.8A and
B), as well as with Ska2 at the two terminal regions of C13orf3 (aa 1–87 and aa 303–412).
In addition, these assays defined a minimal motif for binding of Ska1 and Ska2 at the
N-terminal side of Ska1 (aa 1–63) (Figure 3.8A and B). Hence, all Ska complex proteins
interact directlywith eaother (Figure 3.8B). Bioinformatic analysis (threading) of Ska1
predicts a three-helical bundle at the N-terminus that is structurally homologous to a
Spectrin repeat-like fold (SCOP-ID: 46965), followed by a KEN box (Figure 3.8B), a short
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Figure 3.7: C13orf3 is phosphorylated during mitosis
(A) C13orf3 is phosphorylated in mitotic cells but not in interphase. Extracts from cells stably express-
ing LAP-tagged C13orf3 and treated with indicated reagents were analysed by western bloing with an
anti-GFP antibody (CIP, calf intestine phosphatase). (B) Identification of a cell-cycle-dependent phos-
phorylation site in C13orf3. HeLa cells expressing LAP-C13orf3 were treated with nocodazole and har-
vested for analysis by mass spectrometry. Asynronously growing cells served as reference. e mono-
phosphorylated peptide detected and quantified by mass spectrometry is shown (either position T190
(bla) or T193 (grey) is phosphorylated). Peak areas from the ion romatogram for the phosphorylated
and unphosphorylated peptides were used for given ratios. Error bars represent the standard deviation
of three independent replicates. (C) C13orf3 is phosphorylated in different phases of mitosis. BAC-
transgenic HeLa cells expressing LAP-C13orf3 arrested in prometa- (RNAi: Eg5) or metaphase (RNAi:
Cdc27) analysed by western bloing are presented. (D) C13orf3 is not phosphorylated in AurkB-depleted
cells. HeLa cells expressing LAP-C13orf3 treated with esiRNA against Plk1 or AurkB are shown. Mitotic
cells were harvested by meanical shake-off and analysed by western blot. (E) C13orf3 phosphorylation
persists in the presence of okadaic acid. BAC-transgenic HeLa cells expressing LAP-C13orf3 released
from nocodazole arrest and treated with okadaic acid for indicated time periods are shown. Cell lysates
were analysed by western bloing with indicated antibodies. Markers are shown in the le of western
blots.
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motif found in many proteins involved in cell-cycle regulation and mitosis (Miael
et al., 2008). ree helical bundles are known to mediate protein–protein interactions
(Fridmann-Sirkis et al., 2006). Hence, the observed interaction of Ska1 with C13orf3
might bemediated through the three-helical bundle region. In summary, the two-hybrid
assays validate the observed interaction of C13orf3 with Ska1 and Ska2, and define the
minimal motifs for these interactions (Figure 3.8A and B).
Table 3.2: Results of pulldown assays and mass spectrometry
Bait Interaction Ensembl Gene International Protein Detected peptides:
partner Identifier Identifier unique coverage (%)
C13orf3 — ENSG00000165480 IPI00333014 20 46
C13orf3 Ska1 ENSG00000154839 IPI00059912 13 40
C13orf3 Ska2 ENSG00000182628 IPI00103149 10 66
Ska1 — ENSG00000154839 IPI00059912 13 41
Ska1 C13orf3 ENSG00000165480 IPI00333014 14 39
Ska1 Ska2 ENSG00000182628 IPI00103149 9 58
Ska2 — ENSG00000182628 IPI00789882 4 58
Ska2 C13orf3 ENSG00000165480 IPI00333014 10 29
Ska2 Ska1 ENSG00000154839 IPI00059912 6 21
PPP2R2B — ENSG00000156475 IPI00020850 70 55
PPP2R2B C13orf3 ENSG00000165480 IPI00333014 10 28
PPP2R2B Ska1 ENSG00000154839 IPI00059912 2 20
PPP2R2B Ska2 ENSG00000182628 IPI00103149 4 29
Baits are shown in bold aracters.
In conclusion, the data onC13orf3 show that the combination of phenotypic profiling
with protein localisation data is a useful approa to predict functions of unaracterised
genes. Large-scale tagging of proteins at endogenous expression levels is possible in
yeast, and comprehensive protein localisation (Huh et al., 2003) and protein interaction
network studies (Gavin et al., 2006; Krogan et al., 2006) have been carried out in this
organism. To broaden this approa, systematic BAC tagging (Poser et al., 2008) of
most proteins would allow similar studies in mammalian cells. In a test study, applying
this tenology in small scale, we identified C13orf3 as a new interaction partner of the
Ska complex. is study provides a first link between the Ska complex and regulation
of sister romatid cohesion possibly through SGOL1 and PP2A pathways.
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Figure 3.8: Identification of minimal binding motifs and model of interaction
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Figure 3.8: cont.
(A) Yeast two-hybrid analysis of Ska complex protein interactions. Ska proteins were shortened from both
termini (fragment sizes are given as numbers of amino acids) and combined for yeast two-hybrid analyses
(AD, activation domain; BD, binding domain). (B) Model for Ska complex interactions. Minimal binding
motifs derived from panel A are indicated as grey bars. Phosphorylated residues are indicated (Brill et al.,
2004; Cantin et al., 2008; Nousiainen et al., 2006; Rush et al., 2005). Newly identified phosphorylation at
threonine 190 or threonine 193 are highlighted in red. Predicted GLEBS motifs, three-helical bundle (3
HB), or KEN-box motifs are shown in blue, green, and red, respectively. Numbers indicate the amino
acid positions.
3.4 Methods
3.4.1 Genome-wide cell-viability RNAi screen
EsiRNAs were synthesised as described previously (Kiler et al., 2005a, 2007c) and, aer
normalisation, arrayed into 384-well plates. Briefly, esiRNAs are silencing triggers for
RNAi in mammalian cells prepared by enzymatic digestion (bacterial RNase III) of long
dsRNA (300 bp–600 bp, derived from target mRNA). esiRNAs were osen in this study
in favour of emically synthesised siRNAs because they were shown to produce less
off-target effects (Kiler et al., 2007c). All esiRNAs used in this study were designed
to target all splicing variants of their target genes, respectively. For the genome-scale
viability screen, esiRNAs (15 ng ea) were reversely transfected into HeLa cells with
Oligofectamine (Invitrogen) in bla, tissue culture plates (Greiner) and incubated for
72 h. For viability analysis, the cell culture mediumwas supplemented with AlamarBlue
dye (Serotec) and aer 3 h incubation the fluorescence intensities (excitation: 535 nm;
emission: 590 nm) were measured using a plate reader (GENiosPro, Tecan).
3.4.2 BAC TransgeneOmics
BACs harbouring the genes of interest were obtained from the BACPACResource Center
(http://bacpac.chori.org). A LAP cassee (Cheeseman & Desai, 2005) was inserted
as a C-terminal fusion using recombineering (Zhang et al., 2000) (Gene Bridges). Isolated
BAC DNA was transfected and selected for stable integration as described (Poser et al.,
2008).
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3.4.3 Immunofluorescence microscopy
Cells were grown on coverslips in 12-well plates, transfected with 300 ng esiRNAs, fixed
in cold methanol at −20 ∘C for 8min, and bloed with 0.2 % gelatin from cold-water
fish skin (Sigma) in phosphate buffered saline (PBS) (PBS/FSG) for 10min, 36 h–48 h
post transfection for Ska complex esiRNAs and SGOL1 esiRNA. Staining was carried
out by incubation with the following primary antibodies for 20min in PBS/FSG: goat
anti-GFP (1:4000, MPI-CBGAntibody Facility), mouse anti-𝛼-tubulin (1:2000, MPI-CBG
Antibody Facility), human anti-CREST (1:500, Cortex Bioem), rabbit anti-pericentrin
(1:5000, Abcam). Aer washes with PBS/FSG, the cells were incubated with fluores-
cently labelled secondary antibodies (donkey anti-mouse Alexa594, Molecular Probes;
donkey anti-goat FITC,Molecular Probes; donkey anti-rabbit Alexa594, Molecular Probes;
and goat anti-human Alexa594, Invitrogen). Aer washing with PBS/FSG, the cover-
slips were mounted on glass slides by inverting them in the mounting solution contain-
ing 4’,6-diamidino-2-phenylindole (DAPI, ProLong Gold antifade, Invitrogen). Images
were taken on an Axioplan II Microscope (Zeiss) operated by MetaMorph (Molecular
Devices) or on Olympus IX70 (Olympus) equipped with the imaging system DeltaVi-
sion RT using x40/1.00 or x63/1.40 Plan-Aporomat oil immersion objectives. Z-stas
(0.2 µm optical sections) were collected, deconvolved, and projected into one picture us-
ing soWoRx soware (Applied Precision). Acquired images were cropped and contrast
adjusted in Adobe Photoshop 8.0 (Adobe Systems) and then sized and placed in figures
using Corel Draw 11.633 (Corel Corporation).
3.4.4 Live-cell imaging
HeLa cells stably expressing LAP-tagged proteins or histone(H2B)-GFP or Cherry-histone(H2B)
and GFP-tubulin were grown in 96-well tissue culture plates and transfected with 40 ng
esiRNAs. Images were obtained 12 h–36 h aer transfectionwith a ScanR system (Olym-
pus) placed in a heated amber (37 ∘C) with 5 % CO􏷡 and filmed for 1 h–36 h as indi-
cated. If appropriate, cells were arrested by treatment with 50 ng/ml nocodazole (Sigma)
for 12 h and/or treated with 9 µ of RO-3306 (Mer Biosciences). For high-resolution
time-lapse imaging, the cells were grown on eight-well LabTek ambered cover glasses
(Nalge Nunc). Before imaging, the medium was anged to CO􏷡-independent medium
(Invitrogen), and the cell culture amber was placed onto a heated sample stage within
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a heated amber (37 ∘C). Images were acquired with an Olympus IX70 DeltaVision RT
system (Olympus).
3.4.5 Cell-based assays
For cellular DNA content analysis, esiRNA-transfected cells were fixed and stained with
propidium iodide (Molecular Probes) and scanned with a FACSCalibur flow cytometer
(BD Biosciences) 42 h post transfection. e resulting DNA content histograms were
manually gated to determine the percentage of cells in G2/M phase. For determin-
ing the mitotic index, esiRNA-transfected cells were fixed and incubated with mouse
anti-𝛼-tubulin (1:2000; MPI-CBG Antibody Facility) and rabbit anti-phospho-histone
H3 Ser10 antibodies (1:10, conjugated to Alexa488, Cell Signaling Tenologies) 42 h post
transfection. Subsequently, the cells were incubated with fluorescently labelled donkey
anti-mouse Alexa594 antibody and DAPI; images were obtained as described above.
For romosome preparations, HeLa cells were treated with esiRNA (42 h: C13orf3
and SGOL1; 96 h: Cdc16) and/or nocodazole (50 ng/ml for 14 h). Aer harvesting, the
cells were resuspended in hypertonic solution (30m sodium citrate) and incubated for
35min–45min at 37 ∘C. Subsequently, the cells were fixed with ethanol/acetic acid (3:1),
spread onto a coverslip, rehydrated for 15min with PBS and fixed again with formalde-
hyde (4 %). Aer washing for three times with PBS, the cells were dehydrated by wash-
ing with stepwise increasing concentrations of ethanol (70 %–100 % in four steps). Aer
drying, the coverslips were mounted on glass slides by inverting them in the mounting
solution containing DAPI (ProLong Gold antifade, Invitrogen). Images were taken on
an Axioplan II Microscope (Zeiss) as described above.
3.4.6 antitative PCR and apoptosis assays
To ensure an efficient silencing for all prominent esiRNAs used in this study, we con-
ducted mRNA quantification by quantitative-PCR (Q-PCR). HeLa cells were transfected
in 12-well cell culture dishes using 300 ng esiRNA and 4.2 µl Oligofectamine (Invitrogen)
per well. Aer 24 h incubation, the cells were harvested and total mRNA was extracted
using the RNeasy Mini Kit (Qiagen) including an on-column DNaseI digest as given in
the manufacturer’s manual. Subsequently, total mRNA was reverse transcribed using
SuperScript III reverse transcriptase (Invitrogen) and oligo (dT)12–18 primers (Invitro-
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gen). antification of the targeted mRNA was conducted using the Absolute qPCR
SYBR Green Kit and an Mx3000p (Stratagene) real-time PCR maine. For apoptosis as-
says, HeLa cells were transfected with esiRNA (30 ng) in 96-well cell culture dishes. Af-
ter 24 h incubation, the caspase inhibitor, z-VAD-FMK (Mer Biosciences), was added
to the cell culture supernatant (50 n) or to 1 % DMSO as vehicle control. e cells
were harvested and stained 48 h aer transfection with fluorescently labelled Annexin-
V (APC-conjugated, Becton Diinson) and propidium iodide (Molecular Probes) and
analysed by flow cytometry on a FACSCalibur system (BD Biosciences). Cells that
stained positive for Annexin-V but negative for propidium iodide were considered apop-
totic.
3.4.7 Western blot analysis
Whole-cell lysates or mitotic cells (meanical shake-off) stably transfected with differ-
ent BAC constructs and treated with esiRNAs, nocodazole (50 ng/ml, Sigma), or okadaic
acid (250 n; Sigma) were subjected to SDS–PAGE (NuPage 4 %–12 % Bis-Tris; Invitro-
gen), bloed to nitrocellulose (Protran, Sleier & Suell) and incubated with pri-
mary antibodies (mouse anti-GFP, 1:5000, Roe; or mouse anti-GAPDH, 1:20 000, Acris
Antibodies). Subsequently, the membranes were incubated with goat anti-mouse an-
tibody conjugated to horseradish peroxidase (1:4000, Bio-Rad); bands were visualised
with enhanced emiluminescence Western Bloing Detection Reagents (GE Health-
care). As a molecular weight standard, the Full-Range Rainbow ladder 10 kDa–250 kDa
(GE Healthcare) was used. Films were scanned and images were cropped and contrast
adjusted in Adobe Photoshop 8.0 (Adobe Systems) and then sized and placed in fig-
ures using Corel Draw 11.633 (Corel Corporation). For phosphatase assays, nocodazole-
arrested cells were harvested by meanical shake-off, and lysates were incubated with
calf intestinal phosphatase (New England Biolabs) for 15min at 37 ∘C or le untreated.
Subsequently, all lysates were analysed by western bloing as described above. All
band intensities of western blot images were quantified with ImageJ 1.40 g (National
Institutes of Health).
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3.4.8 Immunoprecipitation and mass spectrometry
Transgenic cells expressing LAP-tagged or Strep-HA-tagged versions of the proteins of
interest were harvested and, aer lysis, cleared from insoluble material by ultracen-
trifugation (100 000 g for 20min at 2 ∘C). Immunoprecipitation was carried out by in-
cubation with goat anti-GFP antibody (MPI-CBG Antibody Facility, 1 h at 4 ∘C) immo-
bilised on G-protein sepharose (FastFlow, GE Healthcare, 200 µg antibody per 100 µl
matrix) or on 200 µl Strep-Tactin beads (IBA TAGnologies). Specificity of the goat anti-
GFP antibody in immunoprecipitation assays was extensively validated (Poser et al.,
2008). Aer washing, elution from the affinity beads was carried out with 100 µl of
glycine (100m, pH 2.0), whi was subsequently neutralised with 1.5  Tris at pH
8.0 or 100m NH􏷣HCO􏷢. Strep-HA-tagged proteins were eluted with TNN-HS buffer
with 2m biotin and immunoprecipitated with 100 µl anti-HA agarose (Sigma) before
glycine elution. Modified porcine trypsin (Promega) was added (16 ng/µl) and proteins
were digested overnight. e tryptic peptides were analysed by mass spectrometry.
3.4.9 antification of phosphorylation
Peak areas of extracted ion romatograms (XICs) corresponding phosphorylated and
non-phosphorylated precursors at 2+/3+ arge states were determined using Xcalibur
2.0 soware (ermo Fisher Scientific), assuming beer than 10 ppmmass accuracy and
<1min retention time variation within multiple runs. Survey spectra were examined to
make sure no peaks of the same mass were co-eluted with the quantified peptides. Phos-
phorylation was calculated as a ratio of the peak areas of phosphorylated precursors to
the sum of peak areas of phosphorylated and non-phosphorylated forms and averaged
between four repetitive runs for arrested cells and duplicated samples for non-arrested
cells. When calculating phosphorylation of the peptide, the peak areas of the partially
miscleaved form (both in phosphorylated and in non-phosphorylated states) were con-
sidered.
3.4.10 Yeast two-hybrid analysis
Yeast two-hybrid analysis was carried out using a system described previously (Vidal
et al., 1996). Full-length proteins and fragments of Ska1, Ska2, and C13orf3 were fused to
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Gal4 DNA-binding domain (BD, aa 1–147) or Gal4 activation domain (AD, aa 768–881)
as indicated in Figure 3.8A. Clones growing on media laing uracil were streaked out
on selective media laing histidine and containing 50m 3-amino-1,2,4-triaziole (MP
Biomedicals). Positive clones were further analysed for 𝛽-galactosidase activity.
3.4.11 Sequence analysis and comparative modelling
Sequence analyses were carried out with the ELM server (Puntervoll et al., 2003). Sec-
ondary structure predictions were carried out with Jpred (Cole et al., 2008). reading
analysis of the Ska protein sequences was carried out with the program Prohit (Pro-
ceryon GmbH) and a fold library containing 20 008 ains from the Brookhaven Protein
Data Bank (PDB). GO terms according to the observed RNAi phenotype were used to
distinguish possible true hits from false positives in the fold hit list. e N-terminal
region of Ska1 was modelled as a Spectrin repeat-like fold using the sequence–structure
alignment obtained from threading and the X-ray structure of SNARE Tlg1 at 2.05 Å res-
olution as template (PDBId 2c5k, ain T; Fridmann-Sirkis et al., 2006). e C-terminal
region of Ska3 was modelled as a GLEBS motif using the X-ray structure of the yeast
Bub1-GLEBS/Bub3 at 1.9Å resolution as template (PDBId 2i3s, ain B; Larsen et al.,
2007). e human Bub3 was modelled by homology based on the ain A of the yeast
complex X-ray structure. e Discovery Studio paage (v1.7, Accelrys, San Diego, CA)
was used for model construction and refinement. e RoseaDo Server (Lyskov &
Gray, 2008) was used to do the modelled human Ska3-GLEBS and Bub3 structures,
and the complex with the highest score was selected aer visual inspection.
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Chapter 4
A genome-scale RNAi screen for Oct4
modulators defines a role of the Paf1
complex for embryonic stem cell
identity
Pluripotent embryonic stem cells (ESCs) maintain self-renewal while ensuring a rapid
response to differentiation cues. e identification of genes maintaining ESC identity is
important to develop these cells for their potential therapeutic use. is apter reports
a genome-scale RNAi screen for a global survey of genes affecting ESC identity via al-
teration of Oct4 expression. Factors with the strongest effect on Oct4 expression include
components of the Paf1 complex, a protein complex associated with RNA polymerase
II. Using a combination of proteomics, expression profiling, and romatin immunopre-
cipitation, it was demonstrated that the Paf1C binds to promoters of key pluripotency
genes, where it is required to maintain a transcriptionally active romatin structure.
e Paf1C is developmentally regulated and blos ESC differentiation upon overexpres-
sion, and the knodown in ESCs causes expression anges similar to Oct4 or Nanog
depletions. As an outcome of this study, it was proposed that the Paf1C plays an im-
portant role in maintaining ESC identity.
Mymain contribution to this work is described in section 4.2, whi contains a novel
methodology and results of combined analysis of phenotypic and gene expression data.
Additional gene expression and transcription factor binding analyses, whi I performed
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as crucial parts of the follow-up studies, are presented in subsections 4.3.3, 4.3.5 and 4.3.7
of this apter.
4.1 Introduction
Embryonic stem cells (ESCs) have unlimited capacity for self-renewal and can be kept
undifferentiated for many passages under appropriate conditions while maintaining the
competence to generate a wide range of cell types upon differentiation (Chambers &
Smith, 2004). Because of these distinctive properties, ESCs are widely used for studies
of developmental processes (O’Shea, 2004). e potential to differentiate into many cell
types also makes ESCs a starting point for potential cell-based therapies (Keller, 2005).
However, a systematic molecular understanding of self-renewal and differentiation is
required to harness the full potential of ESCs.
Several transcription factors that contribute to the regulation of self-renewal and
differentiation of ESCs have been identified. Oct4, Nanog, and Sox2 form a transcrip-
tional core unit upon whi ESC pluripotency is critically dependent (Silva & Smith,
2008). Recently, an RNAi analysis of 70 candidate transcription factors identified roles
for additional genes, including Tbx3, Esrrb, Tcl1, and Dppa4, in the maintenance of
ESC pluripotency (Ivanova et al., 2006). Depletion of these genes negatively affected
self-renewal, and induced ESC differentiation.
Several signaling pathways including the LIF/Stat3, PI3K,Wnt, and Bmp/Smad path-
ways also contribute to the regulation of self-renewal and differentiation of ESCs. For
example, the PI3K pathway regulatesmultiple cascades including Ras/MAPK andmTOR
pathways, whi are essential for proliferation of mouse ESCs (Takahashi et al., 2005).
In addition to transcription factors and signaling pathways, a defined epigenetic
state has been shown to be essential to maintain ESC identity (Pietersen & van Lohuizen,
2008). Accordingly, many promoters of key developmental genes including Sox, Hox,
Pax, and Pou gene family members display both an activating (H3K4me) and a repres-
sive (H3K27me) histone mark on the nucleosomes at their promoters in ESCs (Bernstein
et al., 2006). is ‘bivalent’ histone code silences lineage-control gene expression due to
the dominant effect of H3K27me over H3K4me, while preserving their potential to be
rapidly activated upon differentiation stimuli via the removal of the H3K27me mark. It
is therefore not surprising that proteins, whi regulate romatin structure, are impor-
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tant for ESC identity, as recently shown by a focused RNAi screen of not similar 1000
romatin proteins (Fazzio et al., 2008).
e work performed on transcription factors, signaling, and romatin has substan-
tially improved our understanding of ESCs. However, our knowledge of how these
processes are connected is still limited. A global survey of genes essential for ESC self-
renewal and identity would not only advance our understanding of this fundamental
biological process but should also help to develop beer protocols for directed differen-
tiation of ESCs for their potential therapeutic use.
To obtain a more systematic understanding of the genes associated with ESC iden-
tity, a genome-scale RNAi screen in mouse ESCs was performed by using an Oct4 re-
porter assay as a surrogate for ESC identity. It identified many novel genes that affected
Oct4 expression and therefore ESC identity and one group of genes, whi form the
Paf1 complex (Paf1C), was analyzed in more detail. is work therefore expands the
inventory of genes required to maintain ESC identity and defines a role of the Paf1C in
maintaining active transcription of pluripotency genes in ESCs.
4.2 Analysis of the RNAi screen for Oct4 modulators
4.2.1 Primary screen
To perform an RNAi screen in mouse ESCs, a genome-scale mouse endoribonuclease
prepared (e)siRNA library containing 25 057 esiRNAs was generated using the estab-
lished esiRNA synthesis protocol (Kiler et al., 2005a). EsiRNAs have proven efficacy
and specificity in human cells (Kiler et al., 2004, 2007b,c), suggesting that this resource
should be useful for RNAi screening in mouse cells. To identify genes essential for the
maintenance of ESC identity, a rapid and robust assay amenable to high-throughput de-
tection of differentiation triggered by RNAi was developed (Figure 4.1A). Oct4 expres-
sion is a hallmark of ESC identity, and constant expression levels of Oct4 are required
for self-renewal of ESCs (Niwa et al., 2000). Depletion of Oct4 in ESCs via knoout
or RNAi leads to exit from self-renewal and to differentiation (Carpenter & Zernia-
Goetz, 2004; Niols et al., 1998). In turn, the expression of Oct4 is rapidly swited off
in differentiating cells during embryonic development (Pesce & Söler, 2001). Hence,
Oct4 expression levels can be used to monitor the differentiation status of ESCs.
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Figure 4.1: Genome-Scale esiRNA Screen
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Figure 4.1: cont.
(A) Flow diagram of the screening strategy to identify genes essential for mouse ESC identity. Eight
negative controls (boxed in green), eight positive controls (four GFP esiRNA, red; and four Sox2 esiRNA,
orange), three primary hits (blue), and one random well without a phenotypic consequence (bla) are
highlighted. e red color intensity reflects the strength of phenotypes observed in ea well, whi
is illustrated by FACS readouts for two exemplified wells (boxes below the plates). (B) Dot plot of the
primary screen results. e average 𝑧-scores of the GFP readouts are shown. e doed lines indicate
𝑧-score > 2 or < −2. e solid line marks 𝑧-scores > 4. Validated genes with 𝑧-scores > 3 with a second,
independent esiRNA are shown as red squares. Selected pluripotency genes that scored with a 𝑧-score> 2
are shown as blue triangles.
AnOct4 reporter cell line (Oct4-Gip) was used in whi the expression of GFP is con-
trolled by Oct4 regulatory elements to establish an assay for analyses of ESC identity
(Ying et al., 2002). antification of GFP fluorescence faithfully reflects the self-renewal
and differentiation status in individual cells and was thus used as a rapid and accurate
readout to identify genes required for ESC identity (Figure 4.1A). To test the reliability
of this assay, we transfected the Oct4-Gip cells with control esiRNA (Luc) and esiRNAs
directed against known pluripotency genes, including Sox2, Stat3, and Oct4. e ratio
of GFP-positive versus GFP-negative cells was determined by microscopy and by flow
cytometry 96 h posransfection. In both cases, a loss of GFP expression was readily
detected upon Sox2, Stat3, and Oct4 depletion, whi coincided with differentiation of
these cells. In contrast, no loss of GFP expression or differentiation was observed when
the cells were transfected with the control esiRNA. To rule out the possibility that es-
sential genes that are not required for ESC self-renewal, but are required for general
cell growth and viability, would score in this assay, the Oct4-Gip cells were transfected
with esiRNAs targeting genes with housekeeping functions, su as ribosomal, protea-
somal, mitoondrial, and Pol II subunits. As expected, depletion of housekeeping genes
strongly affected cell viability. However, none of these esiRNAs caused a significant loss
of GFP-positive cells, demonstrating that this assay is highly specific to identify genes
affecting ESC identity.
e screen was carried out in duplicate using a high-throughput FACS-based read-
out. I nominated 296 esiRNAs, whi significantly regulated GFP expression (𝑧-score>
2, or 𝑧-score< −2) from the primary screen (Figure 4.1B). GO term analysis indicated
that transcription factors (25 genes) and gene expression regulators (51 genes) were sig-
nificantly enried in the primary hit list (𝑝 < 0. 05), suggesting that this subset of
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genes can be a ri starting point to dissect the regulation of self-renewal and early
differentiation of mouse ESCs.
4.2.2 e screen identified known and discovered novel candidate
pluripotency genes
Many known pluripotency-controlling genes including Oct4, Sox2, Stat3, PI3K, Set1b,
andWdr5 scored with significant 𝑧-scores, demonstrating the effectiveness of the screen.
e screen also identified many additional genes that have been linked to ESC biology,
su as direct Oct4 and Nanog target genes (Cxxc1, Vti1a, Nfix, Etv1, Rad21, Ina, Cdh4,
Spred2, Ba2, Myh9, Map3k7, Tcf12) (Fouse et al., 2008) and genes that are regulated
by Oct4 and Nanog (Rnf2, Ncl, Ina, Spred2, bs3, Ell2, Tmem4, Etv1, Foxp1) (Loh et al.,
2006). Some known pluripotency genes, including Esrrb, Tbx3, and Klf4, did not score
significantly in the primary screen, possibly reflecting insufficient knodown, redun-
dancy, or that their roles in ESC identity are not reflected in Oct4 expression levels.
Further study concentrated on the genes with the strongest phenotypic scores (𝑧-
score > 4) and validated the phenotype of these candidates with a second, independent
esiRNA. Twenty-nine independent esiRNAs were successfully synthesized and trans-
fected into the Oct4-Gip ESCs. Twenty-one of these caused a reduction of GFP expres-
sion greater than two times the standard deviation, validating their role in maintaining
Oct4-driven GFP expression. Sixteen hits with 𝑧-scores above three were further an-
alyzed. Gene ontology analyses placed these genes into different functional classes,
including transcription regulation (Nfya, Ptbp1, Ctr9, Rtf1, Wdr61, Cpsf3, Fip1l1, Iws1,
oc2), romatin modulation (Rnf2, Cxxc1, Cnot1, Rtf1, Ctr9, Wdr61, Ncl), signaling
(Apc), and protein degradation/DNA repair (Ube2m, Shfdg1).
4.2.3 Meta-analysis of phenotypic and gene expression data refines
screening results
Because perturbations of many pathways in ESC lead to differentiation, many hits from
the RNAi screen may not be directly involved in pluripotency maintenance. To refine
results of the RNAi screen, I utilized a microarray data that measured time-course gene
expression during the first 7 days of ESC differentiation into embryonic bodies. Genes,
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whose silencing leads to decreased levels of Oct4 and are being downregulated dur-
ing the phases of early development, are more likely to be implicated in pluripotency
maintenance.
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Figure 4.2: Combined analysis of RNAi and time-course microarray data
(A) Changes of expression of two selected genes during the process of differentiation and embryonic
body formation. Expression levels are shown in a logarithmic scale, relative to the expression level in day
0. Slopes of the linear regression (solid lines) were used to quantify the ange of expression over time.
Fibroblast growth factor receptor 3 (Fgfr3) is amembrane protein that interacts with growth hormones and
activates signalling cascades responsible for mitogenesis and differentiation. Its expression is swited on
during early development (Keegan et al., 1991). Developmental pluripotency associated protein 4 (Dppa4)
inhibits ESC differentiation into ectoderm and its expression has to be reduced to continue development
(Masaki et al., 2007). (B) Graphic representation of 𝑧-scores from the Oct4 modulators screen (𝑦-axis)
ploed against 𝑧-score normalized anges of expression during ESC differentiation (𝑥-axis). Dashed
lines indicate hit selection thresholds applied to results of individual experiments. e solid line curve
represents a function used for selecting hits based on data from both experiments (see Equation 4.1).
Selected pluripotency maintenance (quadrant I) and developmental genes (quadrant IV) are shown as red
dots. (C) Gene set enriment analysis of hits from the Oct4 modulators screen, genes being significantly
downregulated during ESC differentiation and genes selected from the combined analysis of the two
experiments. Resuls of enriment of selected pluripotency- and differentiation-related terms show an
increased sensitivity of the combined selection compared to selection based on individual experiments.
To evaluate temporal anges of gene expression, I calculated a linear regression for
ea time-course expression profile. e slope coefficient of the regression was used as a
measure of expression ange over time (Figure 4.2A). To make possible the comparison
with the phenotypic data, I converted regression coefficients into 𝑧-scores, taking mean
and standard deviations of complete data set as basis for the normalization. I formulated
a new statistic that combines the results of both experiments as a function that multiplies
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respective 𝑧-scores:
𝑧􏹔􏸎􏸌􏸁􏸈􏸍􏸄􏸃 = 𝑧􏹖􏸗􏸏􏸑􏸄􏸒􏸒􏸈􏸎􏸍 ⋅ 𝑧􏹠􏸂􏸓􏷣 (4.1)
To select genes putatively involved in pluripotency maintenance, I applied the following
selection criteria (Figure 4.2B):
𝑧􏹠􏸂􏸓􏷣 > 0 (4.2)
𝑧􏹖􏸗􏸏􏸑􏸄􏸒􏸒􏸈􏸎􏸍 < 0 (4.3)
𝑧􏹔􏸎􏸌􏸁􏸈􏸍􏸄􏸃 > 4 (4.4)
e threshold of 4 was selected arbitrarily, based on visual inspection of the plot in
Figure 4.2B.
A list of hits obtained from themeta-analysis of phenotypic and gene expression data
shows an increased enriment of annotation terms related to stem cell maintenance,
compared to lists of genes obtained from the individual analysis of the two experiments
(Figure 4.2C). In the list obtained by applying criteria 4.3–4.4, I found developmental
repressors and transcription factors that were not identified by the primary RNAi screen
as well as few genes of unknown function (Table 4.1).
Results of our meta-analysis opened new directions for further resear. By alter-
ing the threshold criteria and selecting genes having their expression increased during
differentiation and whose silencing leads to upregulation of Oct4, I obtained a list of
genes containing developmental markers (e.g. Fgfr3, Cspg2, Plac1). Further analysis of
this data set may lead to discovery of novel genes that could be targets for cellular fate
reprogramming.
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Table 4.1: Genes nominated as ‘hits’ by the combined analysis but not detected by the
primary RNAi screen.
Ensembl Gene ID Gene 𝑧􏹺􏸜􏸭􏷭 𝑧􏹸􏸢􏸜􏸫􏸨􏸚􏸫􏸫􏸚􏸲 Annotation
ENSMUSG00000002980 Bcam 􏷢.􏷥􏷤 −􏷠.􏷤􏷡 Cell adhesion
ENSMUSG00000028655 Mfsd2 􏷢.􏷡􏷠 −􏷠.􏷥􏷟
ENSMUSG00000012443 Kif11 􏷡.􏷨􏷥 −􏷠.􏷧􏷤 Mitotic centrosome separation
ENSMUSG00000041846 1110034C04Rik 􏷡.􏷨􏷟 −􏷠.􏷥􏷟
ENSMUSG00000028047 bs3 􏷡.􏷦􏷣 −􏷠.􏷤􏷡 Cell adhesion
ENSMUSG00000019773 Fbxo5 􏷡.􏷤􏷧 −􏷡.􏷠􏷨 Regulation of mitotic cell cycle
ENSMUSG00000026917 Wdr5 􏷡.􏷤􏷟 −􏷡.􏷦􏷟 Regulation of transcription, development
ENSMUSG00000018740 Slc25a35 􏷡.􏷣􏷠 −􏷢.􏷥􏷢 Transmembrane transport
ENSMUSG00000024287 oc1 􏷡.􏷢􏷧 −􏷠.􏷧􏷤 Regulation of apoptosis, RNA splicing
ENSMUSG00000021532 Fastkd3 􏷡.􏷡􏷡 −􏷠.􏷨􏷣 Apoptosis
ENSMUSG00000036202 Rif1 􏷡.􏷡􏷟 −􏷤.􏷡􏷢 Stem cell maintenance
ENSMUSG00000022208 Jph4 􏷡.􏷠􏷦 −􏷡.􏷡􏷧
ENSMUSG00000021906 Oxnad1 􏷠.􏷨􏷨 −􏷡.􏷠􏷨 Oxidation reduction
ENSMUSG00000027559 Car3 􏷠.􏷨􏷦 −􏷢.􏷟􏷣 Response to oxidative stress
ENSMUSG00000024376 Epb4.1l4a 􏷠.􏷨􏷟 −􏷢.􏷟􏷣
ENSMUSG00000019590 Cyb561 􏷠.􏷧􏷦 −􏷢.􏷨􏷥 Electron transport ain
ENSMUSG00000024078 Ttc27 􏷠.􏷧􏷥 −􏷡.􏷥􏷠
ENSMUSG00000044224 4930461P20Rik 􏷠.􏷧􏷢 −􏷢.􏷢􏷦
ENSMUSG00000021018 Polr2h 􏷠.􏷧􏷡 −􏷡.􏷤􏷢 Transcription
ENSMUSG00000040370 4930469P12Rik 􏷠.􏷧􏷟 −􏷡.􏷦􏷟
ENSMUSG00000019977 Hbs1l 􏷠.􏷦􏷢 −􏷡.􏷧􏷦 Translation
ENSMUSG00000041020 2900002G04Rik 􏷠.􏷥􏷨 −􏷤.􏷧􏷡
ENSMUSG00000034336 Ina 􏷠.􏷤􏷨 −􏷧.􏷦􏷦 Nervous system development
ENSMUSG00000020705 Ddx42 􏷠.􏷤􏷧 −􏷢.􏷥􏷢 DEAD box protein
ENSMUSG00000033294 Noc4l 􏷠.􏷤􏷥 −􏷡.􏷦􏷧
ENSMUSG00000057531 Dtnbp1 􏷠.􏷤􏷢 −􏷡.􏷧􏷦 Actin cytoskeleton reorganization
ENSMUSG00000024683 Mrpl16 􏷠.􏷤􏷡 −􏷡.􏷦􏷟 Translation
ENSMUSG00000021953 Tdh 􏷠.􏷤􏷡 −􏷤.􏷨􏷟
ENSMUSG00000051316 Taf7 􏷠.􏷣􏷥 −􏷢.􏷟􏷣 Regulation of transcription
ENSMUSG00000024827 Gldc 􏷠.􏷢􏷦 −􏷤.􏷤􏷥 Glycine metabolism
ENSMUSG00000030505 Prmt3 􏷠.􏷡􏷠 −􏷣.􏷤􏷤 Protein amino acid methylation
ENSMUSG00000044149 Nkrf 􏷠.􏷠􏷤 −􏷣.􏷠􏷢 NF-𝜅B repression
ENSMUSG00000000730 Dnmt3l 􏷠.􏷠􏷡 −􏷦.􏷥􏷦 In utero embryonic development
ENSMUSG00000031714 Gab1 􏷠.􏷟􏷤 −􏷣.􏷟􏷤 Epidermis development
ENSMUSG00000025050 Pcgf6 􏷠.􏷟􏷣 −􏷣.􏷢􏷧 Negative regulation of transcription
ENSMUSG00000022272 Myo10 􏷟.􏷨􏷧 −􏷣.􏷢􏷧 Signal transduction
ENSMUSG00000022652 Morc1 􏷟.􏷨􏷦 −􏷧.􏷢􏷤 Cell differentiation
ENSMUSG00000022425 Enpp2 􏷟.􏷨􏷠 −􏷤.􏷢􏷠 Lipid catabolic process
ENSMUSG00000000365 Rnf17 􏷟.􏷧􏷦 −􏷥.􏷣􏷠 Spermatogenesis
ENSMUSG00000050917 Fgf4 􏷟.􏷥􏷠 −􏷧.􏷡􏷥 Stem cell maintenance
4.3 Experimental results
4.3.1 Self-renewal assays
Further work focused on 16 genes nominated by the primary RNAi screen. To substan-
tiate their direct role in ESC identity, three additional, independent self-renewal assays
were performed. First, anges in cell morphology and alkaline phosphatase (AP) stain-
ing aer esiRNA transfection were evaluated. For the negative control (Luc)-transfected
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ESCs, nearly all of the colonies showed an undifferentiated morphology and highly pos-
itive AP staining (Figure 4.3A). In contrast, knodown of most candidates resulted in
reduced AP staining and obvious morphological anges in the Oct4-Gip cells, demon-
strating the loss of pluripotency along with differentiation (Figure 4.3A). To exclude the
possibility that these effects are Oct4-Gip cell-type specific, the same experiments were
performed in R1/E ESCs and identical results were obtained.
Figure 4.3: Functional Analysis of Validated Hits
(A) AP staining of ESCs 4 days aer treatment with indicated esiRNAs. Note the loss of staining and
the morphological anges of cells transfected with esiRNAs against Wdr61, Ptbp1, Ube2m, Ctr9, Rtf1,
Cpsf3, and Iws1. Scale bars, 200 µm. (B) Cell-cycle analysis of ESCs aer gene knodown. Cell profiles
recorded 4 days aer transfection with indicated esiRNAs are shown. e percentage of cells in S phase is
indicated above ea graph. (C) antification of endogenous Oct4 transcript levels. qRT-PCR analysis
performed 4 days aer esiRNA transfection with indicated esiRNAs are shown. (D) antification of
Nanog transcript levels. qRT-PCR analysis performed 4 days aer esiRNA transfection with indicated
esiRNAs are shown. (E) Analysis of Stat3 and Stat3-P protein levels. Protein extracts prepared from
ESCs 4 days aer transfection with indicated esiRNAs, and analyzed by immunobloing with anti-Stat3,
anti-Stat3-P, and anti-Gapdh (loading control) antibodies are presented. Cells grown for 4 days without
LIF (-LIF) are shown as a positive control. (C and D) All values are means ± SD from at least triplicate
experiments. * indicates significant (𝑝 < 0. 05) and ** highly significant (𝑝 < 0. 01) results based on
Student’s 𝑡-test analyses.
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Second, anges in cell-cycle profiles upon RNAi were analyzed. Transfection of
all tested esiRNAs lead to a reduction of cells in S phase (Figure 4.3B), demonstrating
a ange of cell-cycle regulation and consistent with an exit of these cells from self-
renewal.
ird, endogenous Oct4 and Nanog transcript levels were quantified by qRT-PCR
aer esiRNA transfections. e transfection of all esiRNAs led to a reduction of Oct4
expression with 12 knodowns, resulting in a significant (𝑝 < 0. 05) or highly signifi-
cant (𝑝 < 0. 01) decrease of Oct4 transcript levels (Figure 4.3C), demonstrating that the
Oct4-driven GFP expression closely mimied the endogenous Oct4 expression. Many
candidates also reduced Nanog expression (Figure 4.3D), albeit to a lower extent, possi-
bly reflecting that some knodowns primarily affect Oct4 expression. To test whether
knodown of the candidate genes induced ESC differentiation by interfering with the
LIF/Stat3 cascade, Stat3 and phosphorylated-Stat3 (Stat3-P) levels were analyzed. No
obviousange of Stat3 and Stat3-P protein levels for the knodownswere observed, in-
dicating that the loss of ESC identify was not mediated through perturbing the LIF/Stat3
pathway (Figure 4.3E). Collectively, these results suggest that candidate genes directly
affect ESC identity through reduction of Oct4 levels.
4.3.2 e Paf1C is essential for ESC identity
Among the validated knodowns strongly reducingOctq4 levels in ESCswere the genes
Rtf1 and Ctr9 (Figure 4.1B), two components of the Pol II-associating factor 1 complex
(Paf1C). e Paf1C, minimally composed of Paf1, Ctr9, Cdc73, Rtf1, and Leo1, has been
implicated in multiple processes su as transcription initiation and elongation, tran-
script start site selection, and RNA processing (Costa & Arndt, 2000; Penheiter et al.,
2005; Stolinski et al., 1997). In addition, the Paf1C has been linked to histone modifica-
tions in different organisms (Adelman et al., 2006; Krogan et al., 2003) through a stim-
ulation of H2B ubiquitination (Ng et al., 2003a), coupling Pol II elongation with SET1
and SET2 activities (Carrozza et al., 2005; Krogan et al., 2003; Ng et al., 2003b). Because
of its potential role for the regulation of ESC romatin and because two independent
components of this protein complex were among the top hits, the Paf1C was selected
for further analysis.
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To test whether the whole Paf1C is required for ESC identity, the expression of
the remaining known Paf1C components (Paf1, Leo1, and Cdc73) was knoed down
in ESCs with two independent esiRNAs. Obtained differentiation phenotypes and de-
creased Oct4 expression levels were similar to those observed upon Ctr9 and Rtf1 kno-
down (Figures 4.4A and 4.4B and data not shown), demonstrating that the whole Paf1C
is required to maintain ESC identity.
To further validate the role of the Paf1C for ESC identity, cross-species RNAi rescue
experiments (Kiler et al., 2005b) were performed for three of the Paf1C components
(Figures 4.4C-4.4E). Stable expression at physiological levels of the human Ctr9, Rtf1,
and Leo1 genes in mouse ESCs rendered these cell lines resistant to the corresponding
esiRNAs, but not to the esiRNAs targeting the other Paf1C components. erefore,
the human Ctr9, Rtf1, and Leo1 genes function in mouse ESCs and can substitute their
mouse orthologs. More importantly, these results manifest an essential role of the Paf1C
for ESC identity.
4.3.3 Paf1C affects the expression of pluripotency and lineage-marker
genes
Next, I analyzed global transcript anges upon Paf1C depletion. For this purpose, ESCs
were transfected with esiRNAs targeting Ctr9, a core component of the Paf1C (Adelman
et al., 2006), and control esiRNA (Luc) and anges in the trancriptome were analyzed
using microarrays. I identified a total of 1139 genes whose expression was perturbed sig-
nificantly (𝑝 < 0. 0001) aer treatment with Ctr9 esiRNA, with 529 and 610 genes down-
regulated or upregulated, respectively, suggesting that the Paf1C both activates and re-
presses target genes. GO term analysis of these genes indicated that genes implicated
in biological processes relevant to embryonic development su as cell morphology and
motility, cell-cycle control, cell proliferation and differentiation, oncogenesis, and ec-
toderm and mesoderm formation were highly enried. Intriguingly, most known key
regulators of pluripotency in ESCs, su as Nanog, Oct4, Tbx3, Esrrb Bmp4, Tcl1, Klf4,
and Klf5 were downregulated upon Ctr9 depletion. In contrast, many lineage-control
genes were strongly upregulated (Figure 4.4F), suggesting that the Ctr9 knodown in-
duced extensive differentiation. For example, ectoderm marker Fst increased 2-fold,
and mesoderm markers Lef1 and Mest were upregulated 2.6-fold and 1.8-fold, respec-
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Figure 4.4: Paf1C Affects the Expression of Pluripotency and Lineage-Marker Genes
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Figure 4.4: cont.
(A) RNAi of all Paf1C components leads to downregulation of endogenous Oct4 expression. qRT-PCR
quantifications of Oct4 expression levels 4 days posransfection of indicated esiRNAs are presented.
(B) RNAi of all Paf1C components induces similar lineage-restricted differentiation. qRT-PCR quantifi-
cations of indicated ectoderm (blue), mesoderm (green), and endoderm (light and dark red) markers aer
transfection with indicated esiRNAs are shown. (C) RNAi in human BAC-transgenic ESC lines specifi-
cally depletes the mouse transcripts. PCR fragments digested with a restriction enzyme discriminating
between the human and mouse transcripts are shown for human cells (HeLa), WT ESC (ESC), human
BAC-transgenic ESCs (hBAC_ESC), and human BAC-transgenic ESCs transfected with indicated esiR-
NAs (hBAC_ESC + esiRNA), respectively. Note the reduced band intensities of the mouse product aer
esiRNA transfections in the human BAC-transgenic ESCs. e 500 bp band of the marker is shown on the
le. (D) Oct4 and lineage-marker expression analyses in human BAC-transgenic ESCs. qRT-PCR analysis
of Oct4 (green), Cdx2 (yellow), and Fgf5 (blue) aer transfection of indicated esiRNAs in the indicated
human BAC-transgenic ESC lines are shown. Note the rescue of the phenotypes in cell lines transfected
with the corresponding esiRNAs. (E) Expression of the human gene in the mouse ESCs rescues the phe-
notypes. AP stainings of indicated ESC lines with indicated esiRNAs are shown. (F) Expression anges
of selected genes aer Ctr9 depletion. Pluripotency genes (bla), lineage-marker genes, ectoderm (blue),
mesoderm (green), and endoderm (red) are ploed as log􏷡(Ctr9/Luc) versus − log􏷠􏷟(𝑝). (G) Knodown
of Shfdg1, Cnot1, and Ube2m induces the expression of lineage markers, including endoderm. qRT-PCR
quantifications of indicated genes with indicated esiRNAs are shown. (H) Venn diagram of the number
of genes regulated by Ctr9, Oct4, and Nanog. e diagram shows the overlap of genes affected by Ctr9
(red), Oct4 (green), and Nanog (yellow) knodowns. (A, B, D, and G) All values are means ±SD from at
least triplicate experiments. * indicates significant (𝑝 < 0. 05) and ** highly significant (𝑝 < 0. 01) results
based on Student’s 𝑡-test analyses.
tively, indicating differentiation of the cells toward these lineages. Differentiation of
the cells was also confirmed by monitoring Fgf5 protein levels in cells transfected with
Ctr9 esiRNA, as measured by immunostaining with an Fgf5 antibody and quantified uti-
lizing an Fgf5 reporter cell line. Interestingly, I did not observe an upregulation of any
gene implicated in endoderm development, suggesting lineage-restricted differentiation
upon Ctr9 depletion.
To determine whether depletion of other Paf1C components results in similar ex-
pression anges, a knodown of Paf1, Rtf1, Leo1, and Cdc73 in ESCs was performed
and the expression anges of selected pluripotency and lineage-marker genes were
measured by qRT-PCR. Consistent with the Ctr9 microarray data, the knodown of
all other Paf1C components induced similar expression anges (Figure 4.4B) and hence
validated the downregulation of pluripotency genes and upregulation of specific lineage-
control genes upon Paf1C depletion. e induced expression of trophectoderm, ecto-
derm, and mesoderm, but not endoderm markers, suggests that regulation of the Paf1C
in the early mouse embryo may contribute to lineage specification. To test whether the
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observed lineage-restricted differentiation is Paf1C specific, the regulation of lineage-
control genes was examined by the knodown of three other candidate genes identi-
fied in the primary screen (Shfdg1, Cnot1, and Ube2m). ese three knodowns in-
duced the expression of lineage markers, including endoderm markers Gata6 and Sox17
(Figure 4.4G), indicating that lineage-restricted differentiation is not generally observed
upon knodown of Oct4 modulators. In fact, the knodown of Ube2m showed an up-
regulation of Gata6 and Sox17 only, indicating that the knodown of Ube2m leads to
endoderm-specific differentiation.
Depletion of the Paf1C by RNAi resulted in downregulation of both Oct4 and Nanog,
suggesting that the Paf1C may be part of the Oct4-Nanog transcription circuit. ere-
fore, I compared the gene expression profiles upon Ctr9 knodown to those obtained
for Oct4 and Nanog knodown (Loh et al., 2006). I compared all genes regulated with
a stringent cutoff (𝑝 < 0. 0001) and found a marked overlap between the Ctr9, Oct4,
and Nanog knodown profiles (Figure 4.4H), with Pearson test correlation coefficients
of 0.45 (Ctr9 versus Oct4), 0.50 (Ctr9 versus Nanog), and 0.58 (Oct4 versus Nanog). One
hundred thirty genes were significantly regulated for all three knodowns. Impor-
tantly, genes that were significantly downregulated included the pluripotency genes
Nanog, Esrrb, Tcl1, Bmp4, and Klf4.
4.3.4 Paf1C binds to promoters of pluripotency genes
To further study the function of Paf1C in mouse ESCs, an ES line stably expressing a
location and affinity purification (Cheeseman & Desai, 2005) (LAP)-tagged Ctr9 fusion
protein was generated by using the bacterial artificial romosome (BAC)-based Trans-
geneOmics approa (Kiler et al., 2005b; Poser et al., 2008). Fluorescence microscopy
analysis of cell clones expressing Ctr9-LAP showed a punctate, nuclear localization, con-
sistent with a role of Ctr9 in regulating transcription/romatin. To investigate whether
pluripotency and lineage-control genes differentially regulated upon Paf1C depletion
are direct targets of the Paf1C, I analyzed the binding of the Ctr9-LAP fusion protein
by ChIP-ip and identified 2175 promoter regions that were bound by Ctr9 . GO term
analysis indicated that genes bound by Ctr9 were enried for processes relevant for
ESC biology, su as cell cycle, apoptosis, development, and romatin paaging and
remodeling (Figure 4.5A). Notably, many genes that are highly expressed in ESCs were
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not bound by the Paf1C (e.g., Ubiquitin B, 𝛼-tubulin 2, Enolase 1, Hexokinase 1, Calmod-
ulin 2, etc.), suggesting that the Paf1C is not present at promoters of all actively tran-
scribed genes. A closer inspection of genes falling into the developmental classification
indicated that promoters of many pluripotency genes, su as Oct4, Nanog, and Sox2
were bound by the Paf1C (Figure 4.5B). e comparison of genes that were downreg-
ulated upon Ctr9 RNAi (see Figure 4.4) with genes that are bound by Ctr9 revealed a
highly significant overlap (𝑝 = 3.03 × 10−􏷟􏷦) and included pluripotency genes su as
Oct4 and Nanog. erefore, the Paf1C directly influences the expression of important
pluripotency genes.
To further investigate the binding of the Paf1C to pluripotency and lineage com-
mitment genes, romatin immunoprecipitation followed by quantitative PCR (ChIP-
qPCR) of selected genes. Marked Ctr9-LAP binding was observed 5’ proximal to the
transcription start sites and coding regions of seven out of eight tested pluripotency
genes (Figures 4.5C and 4.5D). is finding suggests that the Paf1C binds close to the
transcription initiation site of pluripotency genes in ESC and likely travels alongside
Pol II during elongation. In contrast, weak or no signals were detected for most lineage-
marker and housekeeping genes. An exception was the gene Gata6, a marker for en-
doderm development (Hay et al., 2004). Although strong Ctr9 binding at the Gata6
promoter was measured, but no signal in the coding region, indicating that the Paf1C
occupies this promoter before the gene is expressed. Collectively, these results suggest
that the Paf1C is a specific regulator of transcription for a subset of genes, whi in ESCs
include many pluripotency genes.
4.3.5 Paf1C is required tomaintain theromatin structure of pluripo-
tency genes in ESCs
A potential meanism for Paf1C action on the promoters of pluripotency genes may be
the modulation of the local romatin structure. In yeast, the Paf1C has been implicated
inmultiple aspects of histonemethylation via the recruitment ofmethyltransferase com-
plexes to Pol II (Krogan et al., 2003). To investigate a potential role of the Paf1C for his-
tone methylation in mouse ESCs, the effects of Ctr9 depletion on histone modifications
associated with actively transcribed (H3K4 trimethylation or H3K4me3) and repressed
(H3K27 trimethylation or H3K27me3) romatin were measured for promoter regions
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Figure 4.5: Ctr9 Binds to Promoters and Coding Regions of Pluripotency Genes and Is
Required to Maintain the Chromatin Structure in ESCs
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Figure 4.5: cont.
(A) ChIP-ip analysis of Ctr9 target genes. GO term enriment analysis of selected overrepresented and
underrepresented categories are presented. (B) Ctr9-binding profiles of selected genes, extracted from the
ChIP-ip experiments. e binding profiles of the pluripotency genes Oct4 and Nanog, the housekeeping
genes 𝛽-actin (Actb) and 𝛼-tubulin (Tuba1a), and the differentiation genes Fgf8 and Nkx2.2 are shown.
Arrows indicate significant enriment peaks for Ctr9 binding. e genomic structure of the genes is
shown below the profiles with an arrow indicating the predicted transcriptional start site. e relative
expression of the genes in ESCs is shown to the right of ea profile. (C) Ctr9-ChIP-qPCR analysis at
the promoter regions of indicated genes grouped for pluripotency (pluri), ectoderm (ecto), mesoderm
(meso), endoderm (endo), and nonlineage (nl) control genes. log􏷡 enriment represents the abundance
of enried DNA fragments over mo controls. (D) Ctr9-ChIP-qPCR analysis at the coding regions of
indicated genes. Np; nonpluripotency genes. (E) Depletion of Ctr9 results in a decrease of H3K4me3
on the promoters of pluripotency genes. ChIP assays for indicated genes are shown. Fold enriment
represents the abundance of enried DNA fragments over mo controls. (F) Depletion of Ctr9 results
in a decrease of H3K27me3 on the promoter of some lineage-control genes. ChIP assays for indicated
genes are shown. (G) Synthetic analysis of Paf1C components with Cxxc1 and Rnf2. FACS quantification
of GFP-negative cells 4 days aer transfection of Oct4-Gip ESCs with indicated esiRNAs are shown. (C,
D, E, F, and G) All values are means ±SD from at least triplicate experiments. * indicates significant
(𝑝 < 0. 05) and ** highly significant (𝑝 < 0. 01) results based on Student’s 𝑡-test analyses.
of selected genes. ChIP-qPCR analyses indicated that H3K4me3 levels on promoters of
pluripotency genes strongly decreased upon Ctr9 depletion, suggesting that the Paf1C is
required for the maintenance of H3K4me3. For the lineage-control genes, the H3K4me3
levels remained essentially unanged, whereas the H3K27me3 levels for the ectoderm
and the mesoderm specification genes decreased markedly (Figures 4.5E and 4.5F). To
substantiate this finding, Paf1C double knodowns were performed together with the
trithorax group-like, Set1 complex subunit gene, Cxxc1 (required for H3K4me3), or with
the polycomb group Pc1 complex subunit gene, Rnf2/Ring1b (required for H3K27me3),
both of whi individually affect ESC pluripotency (Fazzio et al., 2008; Lee & Skalnik,
2005, 4.1B). A robust enhancement of the phenotype was observed when Ctr9 or Rtf1
was cosilenced together with Cxxc1, but no effect when the same Paf1C subunits were
cosilenced together with Rnf2 (Figure 4.5G). Inspection of Oct4 expression levels and
anges in the expression of the differentiation markers Cdx2, Fgf5, and Brayury in-
dicated that the simultaneous depletion of Paf1C with Cxxc1 enhanced the expression
of these differentiation markers. Together, these results indicate that the Paf1C syner-
gizes with the Set1 complex to maintain ESC pluripotency and support a direct role of
the Paf1C in maintaining H3K4me3 at promoter regions of pluripotency genes.
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4.3.6 Proteomic analyses of Paf1C in ESCs
e Paf1C is composed of at least five subunits, Paf1, Ctr9, Rtf1, Cdc73, and Leo1. Re-
cently, the human Paf1C complex has been shown to interact with hSki8, a component
of the SKI complex, whi together with the exosomemediates 3’-5’ mRNA degradation
(Zhu et al., 2005). is interaction suggests a possible link of the human Paf1C to RNA
quality control and extends the proteins that comprise the human Paf1C. Interestingly,
the mouse ortholog of hSki8, Wdr61 was among the 16 validated strongest hits in our
primary screen (Figure 4.1B), suggesting a potential role of this gene in mouse ESCs as
a component of the Paf1C.
To identify potential interaction partners of the Paf1C in ESCs, a proteomic analysis
using the Ctr9-LAP and a Leo1-LAP-tagged ESC lines was performed. Both lines express
similar levels of the LAP-tagged and the endogenous Paf1C transcripts. Aer affinity
purification with an anti-GFP antibody, prey proteins were eluted and analyzed by mass
spectrometry. is analysis revealed most of the known Paf1C components (Table 4.2).
In addition, several Pol II-associated and romatin-modifying proteins were immuno-
precipitated, including Pabc1, Ruvbl1, Ruvbl2, Sfpq, Tceb3, Polr2a, Polr2e, CoREST, and
Smarce1, implying a complex interacting network of Paf1C with other transcriptional
and romatin regulators. Importantly, Wdr61 was identified as a Paf1C interaction
partner by both Ctr9-LAP and Leo1-LAP pulldowns, authenticating the interaction of
this protein with the Paf1C in mouse ESCs (Table 4.2). To validate the interaction of
Wdr61 with Paf1C, a Wdr61-LAP ESC line was generated and its interaction partners
were analyzed via mass spectrometry. e Wdr61-LAP pulldown identified two Paf1C
components, Cdc73 and Leo1, and the Pol II-associated proteins Ruvbl1 and Ruvbl2,
further validating the interaction between Wdr61, the Paf1C, and several other tran-
scriptional regulators (Table 4.2). Similar knodown phenotypes and protein-protein
interactions strongly suggest thatWdr61 functions together with Paf1C to maintain ESC
identity.
Abbreviations: Baits, Bait used for IP; Name, Name of the gene; ACC_NO, acces-
sion number in International Protein Index; Mass, molecular weight of predicted pro-
tein; Score, probability-based MOWSE score of MASCOT soware; Mates, number of
total mated peptides via MASCOT; PEP_UNIQ, number of unique peptide sequences
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Table 4.2: Proteomic Analyses of the Paf1C in ESCs
Baits Name Accession Number Mass Score Mates PEP_UNIQ SEQ_COV (%)
Ctr9 Ctr9 IPI00477468 􏷠􏷢􏷢.􏷣􏷡􏷟 􏷡􏷠􏷦􏷦 􏷤􏷤 􏷣􏷢 􏷣􏷣
Ctr9 Paf1 IPI00331654 􏷥􏷟.􏷣􏷧􏷠 􏷠􏷠􏷣􏷟 􏷡􏷧 􏷡􏷢 􏷤􏷣
Ctr9 Cdc73 IPI00170345 􏷥􏷟.􏷤􏷢􏷨 􏷠􏷠􏷠􏷥 􏷡􏷧 􏷡􏷤 􏷤􏷡
Ctr9 Leo1 IPI00474486 􏷦􏷥.􏷨􏷠􏷡 􏷧􏷠􏷦 􏷠􏷦 􏷠􏷢 􏷡􏷢
Ctr9 Wdr61 IPI00112320 􏷢􏷢.􏷦􏷦􏷧 􏷥􏷣􏷟 􏷡􏷠 􏷠􏷢 􏷤􏷨
Ctr9 Pabpc1 IPI00124287 􏷦􏷟.􏷥􏷡􏷥 􏷣􏷠􏷣 􏷧 􏷧 􏷠􏷦
Ctr9 RuvB-like 1 IPI00133985 􏷤􏷟.􏷠􏷧􏷡 􏷡􏷦􏷡 􏷥 􏷥 􏷠􏷦
Ctr9 COREST IPI00226581 􏷤􏷢.􏷡􏷦􏷡 􏷡􏷟􏷠 􏷣 􏷣 􏷠􏷡
Ctr9 RuvB-like 2 IPI00123557 􏷤􏷟.􏷨􏷣􏷨 􏷠􏷧􏷡 􏷣 􏷣 􏷨
Ctr9 SFPQ IPI00129430 􏷦􏷤.􏷢􏷨􏷣 􏷠􏷣􏷧 􏷢 􏷢 􏷦
Leo1 Leo1 IPI00103090 􏷦􏷤.􏷢􏷤􏷨 􏷦􏷨􏷧 􏷡􏷤 􏷠􏷦 􏷡􏷡
Leo1 Ctr9 IPI00120919 􏷠􏷢􏷢.􏷣􏷡􏷟 􏷨􏷥􏷟 􏷡􏷥 􏷡􏷣 􏷠􏷦
Leo1 Cdc73 IPI00170345 􏷥􏷟.􏷤􏷢􏷨 􏷨􏷟􏷤 􏷡􏷦 􏷡􏷟 􏷢􏷤
Leo1 Paf1 IPI00331654 􏷥􏷟.􏷣􏷧􏷠 􏷦􏷧􏷧 􏷠􏷧 􏷠􏷣 􏷡􏷥
Leo1 Wdr61 IPI00112320 􏷢􏷢.􏷦􏷤􏷡 􏷣􏷦􏷡 􏷠􏷣 􏷠􏷟 􏷡􏷦
Leo1 Tceb3 IPI00317167 􏷧􏷦.􏷠􏷡􏷣 􏷢􏷦􏷧 􏷠􏷠 􏷠􏷟 􏷠􏷢
Leo1 Polr2a IPI00136207 􏷡􏷠􏷦.􏷟􏷢􏷨 􏷠􏷤􏷢 􏷤 􏷤 􏷡
Leo1 Smarce1 IPI00119892 􏷣􏷥.􏷥􏷠􏷟 􏷠􏷠􏷥 􏷡 􏷡 􏷤
Leo1 RuvB-like 2 IPI00123557 􏷤􏷠.􏷟􏷧􏷠 􏷠􏷠􏷠 􏷡 􏷡 􏷣
Leo1 Polr2e IPI00337955 􏷡􏷣.􏷤􏷤􏷤 􏷠􏷟􏷦 􏷢 􏷢 􏷠􏷣
Wdr61 Wdr61 IPI00019269 􏷢􏷢.􏷤􏷤􏷦 􏷧􏷟􏷥 􏷠􏷨 􏷠􏷢 􏷤􏷠
Wdr61 Cdc73 IPI00170345 􏷥􏷟.􏷤􏷢􏷨 􏷡􏷟􏷧 􏷤 􏷤 􏷠􏷢
Wdr61 Leo1 IPI00474486 􏷦􏷤.􏷤􏷨􏷥 􏷠􏷠􏷥 􏷡 􏷡 􏷢
Wdr61 SF3B4 IPI00154082 􏷣􏷣.􏷢􏷡􏷦 􏷠􏷨􏷥 􏷢 􏷢 􏷠􏷟
Wdr61 RuvB-like 1 IPI00133985 􏷤􏷟.􏷠􏷧􏷡 􏷠􏷦􏷤 􏷥 􏷥 􏷠􏷧
Wdr61 RuvB-like 2 IPI00123557 􏷤􏷠.􏷟􏷧􏷠 􏷠􏷟􏷠 􏷢 􏷢 􏷧
identified via MASCOT; SEQ_COV, percentage of predicted protein sequence covered
by mated peptides via MASCOT.
4.3.7 Paf1C is downregulated during embryoid body formation
To analyze possible expression anges of the Paf1C during early development, the ex-
pression of Paf1C subunits were measured during ESC differentiation in embryoid bod-
ies (EBs). For all Paf1C subunits, downregulated expression was observed during the
formation of EBs (Figure 4.6A), indicating that the Paf1C is downregulated during early
embryonic development. To test whether the reduction in Paf1C subunit expression lev-
els is just part of a general decrease in the expression of Pol II-associated protein com-
plexes during differentiation, the expression levels of subunits of the Pol II-associated
mediator complex were measured in EBs (Myers & Kornberg, 2000). In contrast to the
Paf1C, transcript levels of the investigated mediator complex subunits did not ange
significantly during EB formation (Figure 4.6A). Hence, the downregulation of the Paf1C
may be important for proper embryonic development. Support for a role of the Paf1C
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Figure 4.6: Paf1C Is Downregulated during Embryoid Body Formation, and Overexpres-
sion Blos ESC Differentiation.
85
4.3 Experimental results
Figure 4.6: cont.
(A) Expressionanges of indicated genes from the Paf1C and the mediator complex (Srb-Med) during EB
formation are shown. e heat map shows data (log􏷡 values) extracted from gene expression arrays of
RNA hybridized from day 1 to day 10 (1d–10d). (B) Shown are constructs used to transfect the Sox1-GFP
ESCs. Relevant elements and a seme of the function of the inducibility of the expression constructs
by doxycycline (-Dox, +Dox) is presented. A western blot analysis shows the induced expression of
Ctr9 aer doxycycline treatment. CAGGs, ien 𝛽-actin promoter coupled to a CMV early enhancer;
irtTA, reverse-tetracycline repressor; IRES, internal ribosome entry site; neo, neomycin resistance gene;
Ins, ien 𝛽-globin insulator; tet-op, tetracycline operator-binding sites; Hyg, hygromycine resistance
gene; AmpR, ampicillin resistance gene; ori, ColE1 origion of replication. (C) Seme of the differentia-
tion assay. Arrows show possible outcomes aer induced expression of cDNA constructs. e variable
amount of GFP expression in the cells is indicated by different intensities of green. (D) FACS profiles and
the percentage of GFP-positive Sox1-GFP cells without (Ctr9 Un_Induced) and with (Ctr9 Induced) Ctr9
overexpression are presented. (E) Comparison of different genes bloing, or enhancing, differentiation
in the Sox-GFP assay. e percentage of GFP-positive cells aer transfection of cDNA constructs of indi-
cated genes, with and without doxycyline treatment, are presented. (F) Expression anges of indicated
genes upon overexpression of Ctr9 (induced), or without Ctr9 overexpression (Un_induced), are shown.
(G) Model for Paf1C function in ESCs. e model depicts the concerted action of pluripotency transcrip-
tion factors (pTFs), the Paf1C, and the Set1C to maintain active transcription (H3K4me3) of pluripotency
genes. GTFs, general transcription factors; S5-P, phosphorylated serine 5 of the CTD tail of Pol II; S2-P,
phosphorylated serine 2 of the CTD tail of Pol II. Values in (E) and (F) are means ±SD from experiments
done in triplicate. ** indicates highly significant (𝑝 < 0. 01) results based on Student’s 𝑡-test analyses.
during development comes from observations in Drosophila and Zebrafish, in whi a
variety of embryonic developmental defects have been described for Paf1C component
depletions (Akanuma et al., 2007; Tenney et al., 2006), and from Cdc73 knoout mice,
whi develop normally up to E3.5 but then die either at hating or implantation (Wang
et al., 2008a).
4.3.8 Paf1C overexpression blos ESC differentiation
Many pluripotency genes blo differentiation when overexpressed (Chambers et al.,
2003; Turksen, 2001). To test whether overexpression of a Paf1C component can blo
ESC differentiation, a Sox1-GFP reporter cell line (Aubert et al., 2003) was transfected
with tetracycline-inducible Ctr9 and control constructs (Figures 4.6B and 4.6C). Sox1 is
not expressed in undifferentiated ESCs but is strongly induced during neuronal differ-
entiation (Aubert et al., 2003) and during cultivation in a neuronal growth and differen-
tiation medium (Diogo et al., 2008). Because a prominent activation of ectodermal genes
was observed upon Paf1C RNAi, potentially overexpression of a Paf1C component will
blo differentiation, as reported by the acquisition of Sox1-GFP expression. Indeed, a
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marked reduction of GFP-positive cells upon transfection of the Ctr9 construct was only
detected when tetracycline was present in the culture medium (Figures 4.6D and 4.6E).
A blo of differentiation was further supported by analyses of the differentiation mark-
ers Fgf5 and Nestin and the pluripotency factor Oct4 in these cells (Figure 4.6F). ese
data demonstrate that an excess of a Paf1C component can blo the differentiation of
ESCs.
4.4 Discussion
A detailed molecular understanding on how genetic factors influence the balance be-
tween pluripotency and differentiation of mammalian cells is crucial to develop ESCs
for their potential therapeutic use. is understanding is becoming increasingly impor-
tant because it is now possible to generate ESC-like cells from somatic cells via direct
reprogramming (reviewed in Jaenis & Young, 2008), avoiding many ethical issues. In
the future, it seems feasible to bank personalized iPS cells that may be used to generate
differentiated cells to replace damaged tissue in the body when needed. Obviously, this
scenario requires a detailed and systematic understanding of ESC/iPS self-renewal and
differentiation to develop protocols for safe tissue replacement therapies.
To initiate a global survey of genes required to maintain mouse ESC identity, a
genome-scale RNAi screen was performed. is screen identified 296 candidate genes
with numerous functions that may influence Oct4 expression levels, suggesting a com-
plex interplay of several biological processes required to maintain pluripotency. is
data set should present a useful resource to aracterize factors that influence ESC self-
renewal and ultimately may also be useful to improve the reprogramming protocols of
somatic cells. Oct4 is one of the factors used to reprogram somatic cells into iPS cells
(reviewed in Jaenis & Young, 2008). us, identifying the genes that regulate the ex-
pression of Oct4 should be instrumental for understanding the reprogramming process.
Understanding the endogenous regulation of Oct4 may reveal alternative ways to acti-
vate Oct4 expression in somatic cells. As su, the genes that alter the expression of Oct4
upon RNAi present a good starting point to unravel the network of Oct4 regulation.
Most of the strongest hits identified in our screen are transcription factors and/or
romatinmodifiers that regulate transcriptional processes. Modulation of transcription
activity requires the interaction of transcription factors, the Pol II basal transcription
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mainery, and factors regulating romatin structure. e enriment of transcription
factors andromatin modifiers on the one hand highlights the crucial role of transcrip-
tion regulation on ESC fate decision and, on the other hand, offers an opportunity to
unravel the interactions between transcription factors, romatin modifiers, and their
target DNA for the maintenance of ESC identity. Here we focused on the Paf1C was
osen because we had two independent, highly significant, starting hits, and also we
were excited by the potential discovery of a novel regulatory meanism.
e Paf1C was originally identified in yeast as a specific Pol II-associated protein
complex bioemically distinct from the Srb/Med-containing Pol II holoenzyme (Shi
et al., 1997). Further genetic and bioemical studies showed that the Paf1C is implicated
in transcript start site selection (Stolinski et al., 1997), initiation and elongation (Costa &
Arndt, 2000; Mueller & Jaehning, 2002), poly(A) site utilization (Penheiter et al., 2005),
and histone methylation (Krogan et al., 2003), suggesting a complex role of the Paf1C for
gene regulation in yeast. In metazoans, the Paf1C has additionally been implicated in
Not and Wnt signaling, indicating that this protein complex participates in biological
processes su as oncogenesis and embryogenesis (Akanuma et al., 2007; Mosimann
et al., 2006; Tenney et al., 2006).
is apter demonstrates an important role of the Paf1C for the maintenance of
mouse ESC identity. Knodown of all known complex subunits led to a decreased
expression of Oct4 and other pluripotency markers, accompanied by a loss of ESC self-
renewal and subsequent differentiation. ese phenotypic consequences could be res-
cued by physiological expression of the human Paf1C components. Global gene expres-
sion analysis aer Paf1C depletion revealed a ange in the expression of specific genes,
with most known pluripotency genes being downregulated. is observation was sub-
stantiated by ChIP studies, where the Paf1C was found to directly bind to the promoters
of many pluripotency genes. Hence, the Paf1C is important for the sustained expression
of pluripotency genes in mouse ESCs. e large overlap of regulated genes upon Oct4,
Nanog, and Ctr9 knodown argues that the Paf1C is an integral part of the Oct4-Nanog
regulatory circuit. Because the Paf1C interacts with the Pol II mainery,it is reason-
able to hypothesize that the Paf1C integrates signals from the pluripotency transcription
factors to establish a specialized Pol II complex that maintains active transcription of
these genes (Figure 4.6G). e observed downregulation of Paf1C components during
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EB formation and the blo of differentiation upon overexpression further supports this
notion.
e recent identification of ‘bivalent’ promoters carrying bothH3K4me3 andH3K27me3
in ESCs identified a subset of genes crucial to lineage commitment decisions. To this
subset, we now add another important subset of genes regulated by the Paf1C, whi
are crucial to self-renewal. Furthermore, our study identifies genes whose downregula-
tion may be essential to initiate differentiation into specific lineages in the developing
embryo.
Because the role of the Paf1C is multifaceted, its role in maintaining pluripotency
may also be complex. Here it is shown that the Paf1C is required for the maintenance
of H3K4me3 on pluripotency genes. e selective binding of the Paf1C to the promoters
of pluripotency genes combined with the synergistic effect of Paf1C knodown with
a key subunit of the Set1 H3K4 methyltransferase complex indicates a direct role of
the Paf1C in the modulation of romatin structure at pluripotency genes in ESCs. In
yeast, the Paf1C is required for recruitment of H3K4 methyltransferase activity to Pol
II (Krogan et al., 2003; Ng et al., 2003b). Our data suggest a similar role of the Paf1C
at pluripotency genes in ESCs. According to this model (Figure 4.6G), depletion of the
Paf1Cwould result in a decrease of the Set1 complex at promoter regions of pluripotency
genes, whi consequently would result in the loss of H3K4 trimethylation. As a result,
expression levels of pluripotency genes would diminish, initiating the differentiation
process.
e proteomic analyses of the Paf1C components support an intricate role of this
protein complex in ESCs. Although Ctr9 and Leo1 pulldowns identified most known
Paf1C components, they also revealed specific interactions with other Pol II-associated
factors. Interestingly, some of these specific interactors have been implicated in ESC
pluripotency. For instance, Tceb3, a Leo1-interacting protein, has been shown to reg-
ulate transcription of a subset of genes linked to cell-cycle progression in mouse ESCs
(Yamazaki et al., 2003).
Lineage-restricted differentiation upon Paf1C depletion was unexpected. Instead
of uniformly exiting from self-renewal into all four alternatives (trophectoderm, en-
doderm, ectoderm, mesoderm), Paf1C-depleted ESCs appear impaired to differentiate
toward endoderm. Furthermore, we note that the promoter region of the endoderm
control gene Gata6 was occupied by the Paf1C before the gene was expressed. Con-
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sequently, we speculate that key endoderm control genes require the Paf1C for the in-
duction of their expression and that Paf1C plays a specific role in early endodermal
commitment.
In practical terms, the lineage-restricted ESC differentiation upon Paf1C and Ube2m
knodowns may be useful for the directed generation of specific cell types from ESCs.
To date, strategies to accomplish this goal mainly rely on overexpression of lineage com-
mitment genes and the use of certain growth-factor-enried media (Turksen, 2001).
Our study suggests that enhanced ESC differentiation protocols can be developed by
combining these protocols with the depletion of certain genes by RNAi. ese experi-
mental modifications should improve the efficiency for generating specific cell types for
experimental or therapeutic transplantation.
In summary, our work provides a global view of ESC pluripotency, revealing that an
integrated analysis of transcription, romatin structure, signaling, and possibly other
biological processes is needed to fully understand ESC pluripotency. By analyzing one
of the protein complexes in more detail, we have begun to uncover specific connections
between these processes, in whi interplay of transcription factors, Pol II-associated
factors, and romatin regulation is needed for maintaining ESC identity. A picture
emerges in whi specific transcription factor combinations work in concert with spe-
cialized Pol II complexes assembled on particularly markedromatin structures to con-
trol the expression of pluripotency genes.
4.5 Methods
4.5.1 Mouse esiRNA Library
e templates for the esiRNA synthesis were generated using the cDNA library Mouse
Unigene Set, RZPD 2.1 (Imagenes, http://www.imagenes-bio.de/products/sets_
libraries/non_redundant_sets). EsiRNAs were synthesized as described previously
(Kiler et al., 2005a) and normalized to 100 ng/µl in 384-well plates for the genome-scale
screen.
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4.5.2 Cell Culture and High-roughput Screen
ESCs (E14TG2a, R1/E, Oct4-Gip Ying et al. (2002), and BAC-transgenic ESC lines) were
cultured on gelatin-coated plates in Glasgow Minimum Essential Medium (Sigma) sup-
plemented with 10 % FBS (Pan biote), 2.2m L-glutamine, 1m sodium pyruvate,
50 µ 2-mercaptoethanol, 1× NEAA (Invitrogen), and LIF (generated in house) as pre-
viously described (Bernstein et al., 2006). ESCs were trypsinized and split every 2 days,
and the medium was anged daily. For the genome-scale screen, reverse transfections
were performed using mixtures of 20 ng esiRNA and 0.075 µl Lipofectamine 2000 (In-
vitrogen) in 10 µl optimum medium (Invitrogen). ESCs were plated in 384-well plates
with a density of 900 cells per well in 60 µl ESC medium. On ea plate, eight negative
controls (Luciferase esiRNA) and eight positive controls (four GFP esiRNAs, four Sox2
esiRNAs) were placed to monitor the transfection efficiency. GFP fluorescence and cell
numbers were measured 96 h posransfection using a FACS Calibur (BD Biosciences)
equipped with an HTS loader for high-throughput readout.
4.5.3 Alkaline Phosphatase Staining
ESCs (2 × 103) were reverse transfected with 50 ng esiRNAs and 0.2 µl Lipofectamine
2000 in 96-well plates. Four days posransfection, ESCs were fixed in 4 % paraformalde-
hyde (Sigma) for 5min at room temperature. Aer two times rinsing with PBS, ESCs
were stained using the Alkaline Phosphatase Red Microwell Substrate (Sigma).
4.5.4 Western Blotting
Oct4-Gip cells (8 × 104) were reverse transfected with 800 ng esiRNAs and 2 µl Lipofec-
tamine 2000 in 6-well plates. Four days posransfection, ESCswere harvested, and 10 µg
of protein extracts were separated using NuPAGE 4%–12 % Bis-Tris protein gels (Invit-
rogen) and bloed to nitrocellulose membrane (Millipore). emembranes were probed
with the primary antibodies against Stat3 (H-190; sc-7179, Santa Cruz), phospho-Stat3
(Tyr705; 44-380G, Invitrogen), and Gapdh (NB300-221, Novus Biologicals).
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4.5.5 RT-qPCR
Total RNA was isolated by using the RNeasy Mini kit (QIAGEN), and 1 µg RNA was
reverse transcribed with SuperScript III Reverse transcriptase (Invitrogen) utilizing an
oligo(dT)18 primer. qPCRs were performed with the SYBR Green qPCR kit (Abgene) on
an MX P3000 qPCR maine (Stratagene). Measured transcript levels were normalized
to Gapdh. Samples were run in triplicate.
4.5.6 Gene Expression Analyses
Oct4-Gip cells (8 × 104) were reverse transfected with 800 ng esiRNAs and 2 µl Lipo-
fectamine 2000 in 6-well plates. Four days posransfection, RNA was prepared using
the RNeasy Mini kit (QIAGEN) and labeled with the One-Cycle Target Labeling and
Control Reagent Paage (Affymetrix), as described in the manufacturer’s instructions.
Extracts from four biological replicated were hybridized to Mouse Genome 430 2.0 ar-
rays (Affymetrix), and the data were analyzed by hierarical clustering using Cluster
3.0 soware. Affymetrix data are accessible through the GEO series under accession
number GSE12078.
4.5.7 Cell-Cycle Profiling
Oct4-Gip cells were transfected as for the gene expression analyses. Aer 96 h, cells were
trypsinized, washed with PBS, and fixed overnight with ice-cold 70 % ethanol. Aer
washing with PBS, cells were stained with PI solution (25 µg/ml PI, 20 µg/mll RNaseA,
0.02 % Triton X-100) for 30min in the dark, and the cell-cycle profiles were acquired by
FACS.
4.5.8 Cross-Species RNAi Rescue
Cross-species RNAi rescue experiments were performed as previously described (Kit-
tler et al., 2005b). Briefly, Oct4-Gip and human BAC-transgenic ESC lines were gen-
erated and transfected with esiRNAs, whi only target the mouse transcripts. Cells
were transfected as for the gene expression analyses. Four days posransfection, cells
were stained with alkaline phosphstase, and RNAs from esiRNA-transfected ESCs were
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prepared by using the RNeasy Mini kit (QIAGEN) and reverse transcribed with Super-
Script III Reverse transcriptase (Invitrogen). qPCRs were performed as described before
to quantify the expression of Cdx2, Fgf5, and Oct4. Samples were run in triplicate, and
measured transcript levels were normalized to Gapdh. To evaluate the specificity and
efficiency of knodowns, cDNA fragments from HeLa cells, WT mouse ESCs, human
BAC-transgenic ESCs, and human BAC-transgenic ESCs transfected with esiRNAswere
PCR amplified with primers that perfectly mat the human and mouse transcripts. To
discriminate the human and mouse transcripts, PCR products for Ctr9, Rtf1, and Leo1
were digested with XhoI, XbaI, and PstI, respectively, and separated on a 2 % agarose
gel.
4.5.9 Chromatin Immunoprecipitation and Protein Identification by
Mass Spectrometry
ChIP assays of mouse ESCs were essentially performed as previously described by Bern-
stein et al. (2006) using antibodies against H3K4 (Ab8580, Abcam) and H3K27 (07-449,
Upstate). LAP tag-based ChIP assays were performed with BAC-transgenic ESC lines
as previously described using a polyclonal goat anti-GFP antibody (Poser et al., 2008).
BAC-transgenic ESC lines Ctr9-LAP, Leo1-LAP, Wdr61-LAP, and Rtf1-LAP were gen-
erated by tagging the BACs RP11-77G5, RP11-56B16, RP11-1132M10, and RP11-16O9,
respectively. Enriments of target genes were quantified by qPCR. Genome-wide loca-
tion analysis was carried out using mouse promoter array 1.0R array (Affymetrix). e
data are accessible through the GEO series accession number GSE14654. GFP-tagged
protein complexes were isolated by immunoaffinity romatography as previously de-
scribed (Poser et al., 2008) and analyzed by mass spectrometry.
4.5.10 Overexpression Studies in Sox1-GFP ESCs
e pSport1-tet/Cmv-Ins-Hygro expression constructs contain full-length cDNAs (Lu-
ciferase, Importin-a5, Ctr9, and Klf5) under the control of a tetracycline-inducible CMV-
minimal promoter. e Sox1-GFP (46C) ESC line (Ying et al., 2003), stably express-
ing a codon-optimized tetracycline activator irtTA (Anastassiadis et al., 2002) from the
CAGGs promoter, was grown in a emically defined medium (ESGRO complete, Milli-
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pore) with BMP4 and LIF. e cells were then trypsinized and plated in RHB-A medium
(Stem Cell Sciences) on gelatin-coated 6-well plates in duplicates and retrotransfected at
day 0 with the tetracycline-inducible plasmids (1 µg ea) plus the normalization plas-
mid ptet-Gaussia Luciferase (200 ng) in the presence or absence of doxycyline (1 µg/ml).
RHB-A medium was anged daily. At day one, the supernatant was collected, and the
Gaussia luciferase activity was measured to normalize for transfection efficiencies. At
day three, cells were collected, fixed in 2 % paraformaldehyde, and analyzed by FACS.
At the same time, RNA was extracted for expression analyses by qRTPCR.
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PhenoFam–gene set enriment
analysis through protein structural
information
With the current tenological advances in high-throughput biology, the necessity to
develop tools that help to analyse the massive amount of data being generated is evident.
A powerful method of inspecting large-scale data sets is gene set enriment analysis
(GSEA) and investigation of protein structural features can guide determining the func-
tion of individual genes. However, a convenient tool that combines these two features
to aid in high-throughput data analysis has not been developed yet. To fill this nie,
we developed the user-friendly, web-based application, PhenoFam.
PhenoFam performs gene set enriment analysis by employing structural and func-
tional information on families of protein domains as annotation terms. My tool is
designed to analyse complete sets of results from quantitative high-throughput stud-
ies (gene expression microarrays, functional RNAi screens, etc.) without prior pre-
filtering or hits-selection steps. PhenoFam utilizes Ensembl databases to link a list of
user-provided identifiers with protein features from the InterPro database, and assesses
whether results associated with individual domains differ significantly from the over-
all population. To demonstrate the utility of PhenoFam, we analysed a genome-wide
RNA interference screen and discovered a novel function of plexins containing the cy-
toplasmic RasGAP domain. Furthermore, a PhenoFam analysis of breast cancer gene
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expression profiles revealed a link between breast carcinoma and altered expression of
PX domain containing proteins.
PhenoFam provides a user-friendly, easily accessible web interface to performGSEA
based on high-throughput data sets and structural-functional protein information, and
therefore aids in functional annotation of genes.
5.1 Baground
Analysis of large sets of results derived from high-throughput experiments is a al-
lenging but promising field of study. Enriment analysis is a very powerful strategy
helping researers in identifying biological processes or pathways related to their stud-
ies. Most of the currently available tools, i.e. Onto-Express (Khatri et al., 2002), DAVID
(Dennis et al., 2003), FatiGO + (Al-Shahrour et al., 2007), ConceptGene (Sartor et al.,
2009) and others reviewed in (Huang et al., 2009), sear for enriment of Gene On-
tology (GO) terms (Ashburner et al., 2000), KEGG pathways (Kanehisa et al., 2010) or
other functional properties in a pre-selected subset of genes by contrasting it with the
baground set, usually a whole genome. is approa strongly relies on a osen hit
selection algorithm and user-defined thresholds. Moreover, the experimental results (i.e.
level of expression or phenotype strength) are not considered. ere are few applica-
tions overcoming these limitations by performing gene set enriment analysis (GSEA)
(Mootha et al., 2003). ey sear for gene annotations enried on the top or the boom
of a complete list of genes ranked by their experimental values. is allows even mild
effects to contribute to the overall enriment score. However, to my knowledge, an-
notations used by available GSEA tools have so far primarily been used in combination
with GO terms, pathways or transcription factors, and only few of these applications
are web-based, e.g.GSEA (Subramanian et al., 2005), FatiScan (Al-Shahrour et al., 2007),
GeneTrail (Keller et al., 2008).
In recent years, access to high-resolution protein structural information has in-
creased considerably. Many new structures reveal the presence of domains known from
other proteins, and the domain composition of a protein can help forming a hypothesis
about its biological function, e.g. a homeodomain fold indicates a transcription factor
activity involved in cellular differentiation (Gehring et al., 1994). Moreover, Hahne et
al. demonstrated, that the domain composition of proteins could be used for predicting
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their pathway membership (Hahne et al., 2008). ere are many databases classify-
ing and providing information about protein families, domains, regions and function-
ally relevant sites. InterPro (Hunter et al., 2009) constitutes a repository that integrates
a number of the most well established sources of data: PROSITE (Hulo et al., 2008),
HAMAP (Lima et al., 2009), Pfam (Finn et al., 2010), PRINTS (Awood et al., 2003),
ProDom (Corpet et al., 2000), SMART (Letunic et al., 2002), TIGRFAMs (Ha et al.,
2003), PIRSF (Wu et al., 2003), SUPERFAMILY (Gough et al., 2001), Gene3D (Pearl et al.,
2005) and PANTHER (Mi et al., 2005). I have developed a GSEAweb application that can
be used for analysing data from large-scale experiments (phenotypes, gene expression,
etc.). My tool combines the experimental results with annotations from the databases in-
tegrated in InterPro (called ‘member databases’), thereby allowing a streamlined struc-
ture/function annotation of proteins. Utilization of information about protein domain
families in GSEA is a novel approa that can be used in parallel to other enriment
analysis applications.
5.2 Implementation
5.2.1 Data management
PhenoFam is a Java web application running on a Tomcat 5.5 server. It uses a MySQL
database to storemappings between various protein, gene or probe names and identifiers
related to member databases of InterPro (Figure 5.1). is database is an easily updat-
able compilation of the current releases of the Ensembl database (Hubbard et al., 2009).
Client-server communication is mainly handled by AJAX tenologies. User-uploaded
data sets and calculation results are stored as session objects on the server side for at
least 30 minutes aer closing the browser window.
5.2.2 Identifiers association
One of the key features of my application is that it accepts as input a wide range of
identifiers used in all genomes integrated in the Ensembl database (Hubbard et al., 2009).
Identifiers provided by the user are translated into respective Ensembl (gene, or tran-
script) identifiers and, using mappings from the InterPro database, linked to none, one
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db
db_id INT(10)
species_id INT(10)
db_name VARCHAR(255)
db_url VARCHAR(255)
priority INT(11)
feature
feature_acc VARCHAR(40)
feature_db_id INT(11)
interpro_acc VARCHAR(40)
display_label VARCHAR(128)
feature2transcript
ensembl_transcript_id VARCHAR(128)
feature_acc VARCHAR(40)
feature_db
feature_db_id INT(10)
feature_db_name VARCHAR(255)
feature_db_url VARCHAR(255)
species
species_id INT(10)
species_name VARCHAR(32)
transcript
ensembl_transcript_id VARCHAR(128)
gene_description VARCHAR(255)
uniprot_id VARCHAR(128)
xref2transcript
db_id INT(10)
species_id INT(10)
primary_acc VARCHAR(40)
display_label VARCHAR(128)
ensembl_transcript_id VARCHAR(128)
1..*
1
1..*1 1..* 1
1..* 1
1..*
1
1..*
1
Figure 5.1: PhenoFam database seme.
Tables species and db are dictionaries carrying information about identifiers available for the users-
uploaded data. Table xref2transcript maps those external identifiers to ensembl transcript IDs (table
transcript). Protein features (table feature) from InterPro member databases (table feature_db) are
linked to Ensembl transcripts with the table feature2transcript.
Domain 1
Domain 2
Domain 3
Gene ID
User Identifier Gene Level Transcript Level InterPro Level
Ensembl Gene Ensembl Transcript 2
Ensembl Transcript 3
Ensembl Transcript 1
Domain 1
Domain 1
Domain 3
Domain 1
Domain 2
Final Mapping
Domain 1
Domain 2
User Identifier Ensembl Transcript InterPro Level
Protein ID Ensembl Transcript 1 Domain 1
Domain 2
Final Mapping
Figure 5.2: Identifier mapping procedure.
Gene-related identifiers (e.g. Gene Names) are mapped to Ensembl Gene IDs and further to all protein-
coding Ensembl Transcript IDs. Ea of the transcripts is associated with protein features from the In-
terPro database. Redundant identifiers are removed in the final mapping. Protein- or transcript-related
identifiers (e.g. UniProt IDs) are directly linked to Ensembl Transcript IDs and then to protein features.
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or several protein domains or features from different InterPro database members (Fig-
ure 5.2). Reversing the mapping, ea protein domain is linked with at least one user
identifier and at least one experimental value.
It must be noted that all identifier mappings are based on contents of the Ensembl
database, whi establishes the links based on sequence similarity of entities stored in
remote databases to sequences stored in Ensembl. is approa provides the highest
quality of associations. However, care must be taken if gene-related identifiers are used.
Due to alternative splicing, different gene products may be composed of different protein
domains or even encode different proteins (i.e. shi in the reading frame). In su cases,
a value associated with the user-provided identifier is mapped to all possible protein
features that can be associated with the gene (Figure 5.2).
5.2.3 Gene set enriment analysis
To test if a set of values associated with a given domain is significantly higher or lower
than the remaining set of values, I use theMann–Whitney𝑈-test. e𝑈-test is themost
powerful nonparametric alternative to the Student’s 𝑡-test. Its main advantage is that
it makes no assumptions about the underlying distributions and is more robust in case
of outliers. e 𝑈-test is also implemented in other popular GSEA tools, i.e. GeneTrail
(Keller et al., 2008) or PANTHER (omas et al., 2003, 2006). Other applications, su
as GOdist (Ben-Shaul et al., 2005) or GSEA (Subramanian et al., 2005), implemented the
Kolmogorov-Smirnov (KS) test, another non-parametric procedure that es whether
two samples (values associated with a given domain and the other values) may be as-
sumed to come from the same distribution. However, the KS test is also sensitive to dif-
ferences in the general shapes of the distributions, whi limits its use for my PhenoFam
application. Parametric analysis, whi was proposed by Kim et al. and implemented in
PAGE (Kim & Volsky, 2005), is also not suitable for GSEA of protein domains because
many domains are associated with small number of proteins (< 10). In those cases, the
normality criteria required for parametric tests might not be satisfied.
Adjustment for multiple testing is done using the false discovery rate (FDR) con-
trol procedure designed by Benjamini and Hoberg (Benjamini & Hoberg, 1995) and
resulting 𝑞-values are obtained by applying Storey’s algorithm (Storey, 2002; Storey &
Tibshirani, 2003). Additionally, I calculate a Herrnstein’s 𝜌 statistic (Hernstein et al.,
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1976), whi is an unbiasedmeasure of the overlap between distributions of values in the
two compared sets. It can rea values between 0 and 1, where 0.5 indicates a complete
overlap of the two distributions and both extreme values show a complete separation.
is statistic shows how mu a median of domain-associated values differs from a me-
dian of the other values, and together with the 𝑝-value can help identifying domains of
interest. I recommend using it for sorting results that passed the significance-threshold
criteria.
Due to the fact that InterPro is a collection of partially redundant databases, the en-
riment analysis and the adjustment for multiple testing procedure are performed for
ea database independently. Otherwise, treating InterPro as a uniform set of annota-
tions would lead to a significant underestimation of the results.
5.2.4 User interface
To implement the user interface and to ensure compatibility with all major browsers, I
used the Google Web Toolkit (GWT) framework. I designed a simple and user-friendly
data management system for storing uploaded data sets and the analysis results. It
allows users to investigate and compare multiple data sets at the same time.
My GSEA algorithm reports the following information: a member database identi-
fier, the domain description, a number of user identifiers associated with the domain, a
median of the values, a 𝑝-value reported by the Mann–Whitney𝑈-test, a FDR corrected
𝑝-value, a 𝜌 statistic and the InterPro identifier. e results associated with one of the
selected InterPro member databases are displayed in a pageable table (Figure 5.3) that
can be sorted and filtered. I also provide a possibility to sear for specific domains.
For ea selected domain, I also show a table of associated values together with original
identifiers, UniProt accessions and descriptions.
5.3 Results
PhenoFam allows many data sets as the starting point, su as results of microarray
studies, systematic RNA interference (RNAi) screens, ChIP-Chip/ChIP-Seq experiments
or comparative mass-spectrometry (i.e. SILAC) results. To test the utility of PhenoFam,
I analysed a data-set derived from a genome-scale cell cycle progression RNAi screen
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Filtering and analysis results panel
Working set panel
Data upload panel
Figure 5.3: PhenoFam web interface.
e main user interface display is divided into three panels. e ‘Data upload panel’ allows uploading
data sets for the GSEA analysis either by pasting the data or by selecting a text file. All uploaded data sets
are displayed in the ‘Working set panel’, where the user can submit data for the analysis, view the results
in the browser or send them by e-mail. e sortable table with results is displayed in the ‘Filtering and
analysis results panel’. e top section of the panel contains a form that provides searing and filtering
functionality. e displayed table contains a list of significantly enried PRINTS domains.
(Kiler et al., 2007a). In this screen, a genome-wide study of genes was carried out
providing 𝑧-scores for cell cycle progression phenotypes (i.e. cells in G1, S, G2/M phases
and polyploidy) for ea knodown.
A PhenoFam analysis of the complete RNAi data-set revealed that plexins containing
a cytoplasmic RasGAP domain were enried (𝑝 < 0. 005) for polyploidy phenotypes
(Figure 5.4A, Table 5.1). Knodown of most transcripts encoding these genes resulted
in an increase of polyploidy cells. Although in the published RNAi screen (Kiler et al.,
2007a) only genes with the strongest polyploidy phenotypes of 𝑧-score> 6were selected
for further investigation, the PhenoFam analysis suggests that plexins not passing this
criteria might also have a function in cytokinesis.
Moreover, based on this result I predicted that knodown of the gene PLXNB3,
whi belongs to the same family, but had not been tested in the screen, would also
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Figure 5.4: Plexins are enried for polyploidy RNAi phenotypes.
(A) Cell cycle phenotypic profiles aer knodown of plexins. e top heatmap shows data extracted
from the genome-wide RNAi screen (Kiler et al., 2007a), and the boom heatmap shows the cell cycle
profile aer kno-down of PLXNB3. e PLXNB3 profile was obtained from the automated analysis
of microscopy images, whi quantifies proportions of cells in different phases of the cell cycle. 𝑧-scores
were calculated by normalization to the mean and standard deviation of respective values obtained from
the analysis of negative control images. (B) Fluorescence microscopy images of HeLa cells 48 h aer
transfection of esiRNA (endoribonuclease-prepared siRNA) against Rluc (negative control) and PLXNB3.
e images show DAPI-stained nuclei, and arrows indicate cells with polyploidy phenotype. e scale
bar represents 10µm. Investigation of both images shows that the kno-down of PLXNB3 results in
a polyploidy phenotype compared to the negative control condition. (C) antification of the image
analysis of polyploidy phenotypes among cells treated by different silencing triggers (≈ 5000 cells per
replicate). Error bars represent one SD. Student’s 𝑡-test confirmed that the ratio of polyploid cells is
significantly increased aer kno-down of indicated plexins, compared to the control condition (Rluc).
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Table 5.1: Normalized values of polyploidy RNAi phenotypes of plexins, from the pri-
mary cell cycle progression screen
Ensembl ID Gene Polyploidy (𝑧-score)
ENSG00000114554 PLXNA1 13.15
ENSG00000076356 PLXNA2 4.05
ENSG00000130827 PLXNA3 2.72
ENSG00000164050 PLXNB1 3.14
ENSG00000196576 PLXNB2 3.33
ENSG00000004399 PLXND1 1.45
ENSG00000136040 PLXNC1 0.32
increase the degree of polyploidy. Indeed, an increased number of polyploid cells were
measured aer PLXNB3 knodown (Figure 5.4), indicating that depletion of this gene,
like other plexins with cytoplasmic RasGAP domains, influences proper cytokinesis.
is example demonstrates that PhenoFam can be a valuable support for selecting hits
from the RNAi screens.
To show that PhenoFam is also suitable for analysis of other large-scale data-sets,
I examined publicly available gene expression data that compares transcriptomes of
human breast carcinoma and healthy tissue (Cheng et al., 2008). GSEA of this data-
set using GeneTrail (Keller et al., 2008) showed that genes whose expression is altered
in breast cancer are significantly enried with the ‘signal transduction’ and ‘cell dif-
ferentiation’ gene ontologies, highlighting the importance of these biological processes
during cellular transformation (data not shown). However, the analysis with GeneTrail
did not provide information of enriment of certain protein domains. In contrast, anal-
ysis of the same data-set with PhenoFam showed that among differentially expressed
genes, Ras-family proteins and phox (PX) domain-containing proteins were enried
(𝑝 < 0. 001, data not shown).
Ras GTPases are known to play a role in breast cancer development (Li & Sparano,
2003) and, therefore, it is not surprising that this group of proteins was enried in this
set. Proteins containing a PX domain are involved in cell signalling, vesicular traffiing,
protein sorting and lipid modification, and are primarily found in sorting nexins (Worby
& Dixon, 2002). Previous studies suggest that various sorting nexins are involved in
leukemia (Fus et al., 2001), colon tumorigenesis (Nguyen et al., 2006) and, in general,
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contribute to cell cycle progression in mammalian cells (Fuster et al., 2010). However,
their role in breast cancer has not been described so far. is PhenoFam analysis suggests
that proteins with PX domains are frequently misregulated in breast cancer. Hence, I
propose that these proteins should be investigated for a possible role in breast cancer
development.
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Discussion
It is clear that a systematic approa to all aspects of biology will play an increasingly
important role. Complete reconstruction of regulatory networks in cells, tissues and or-
ganisms will be possible only through integration of various ‘omics’ data. us, further
development of the data analysis methods, whi utilize partial information provided
by different experiments, is indespensable. However, the experience shows that devel-
opment of a single and universal methodology, most probably, will not be feasible. Ea
biological question has to be treated individually and the analysis algorithms, as well
as used data sets, have to be osen accordingly. With an increasing number and vol-
ume of data sets used in analysis pipelines, the role of data management systems will
increase, making the use of databases a critical part of any experimental workflow.
6.1 High-throughput data integration
DSViewer, as described in Chapter 2, is a flexible and user-friendly database of sys-
tematic RNAi screens. is web-accessible application organizes results of the primary
genome-wide experiments, as well as data coming from secondary assays and final lists
of hits annotated with confirmed phenotype labels. It proved to be especially useful for
selecting hits and comparing outcomes of different screening projects.
DSViewer was implemented in J2EE tenology, as a platform-independed web ap-
plication that uses a freely-available MySQL relational database for data management.
Relational databases are currently the most efficient systems for storing and querying
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information. ey organize data in structured ways, in a form of fixed set of tables,
where ea table stores a fixed set of aributes describing physical objects or concepts.
e main allenge of the database design was to elaborate a rigid seme of tables that
would be flexible enough to be capable of holding experimental results generated by dif-
ferent assays and algorithms and, in consequence, containing different sets of aributes
(i.e. phenotypic read-outs and annotations) per entry.
is problem was solved by partial separation of aributes from data sets. By treat-
ing ea assay-reported value and ea annotation as properties of respective silencing
triggers, it became possible to store all information in a single table. is approa al-
lowed creating a centralised repository of RNAi libraries and systematic screenings.
Moreover, the database seme of DSViewer also allows storage of gene expression
data, as well as any other gene-centered information. anks to the user interface of
DSViewer, whi allows data integration and flexible property filtering, a scientist can
take advantage of data generated by various experiments and query for genes having
very specific phenotypic and expression profiles.
6.2 Novel hit selection algorithms
Results of high-throughput RNAi experiments are a subject to high noise, and to keep
a low false-positive rate, hit lists extracted from single data sets consist of the genes
associated only with the strongest effects. Many of those genes are already well arac-
terized ‘hub proteins’ that are involved in various, previously studied, cellular processes
(Wang et al., 2007). During the follow-up experiments, researers focus on single or
few unaracterised genes, trying to uncover their molecular function in investigated
biological process. In many cases, the other screening results remain unused. However,
even the most elaborate assays are not able to measure neither complete cellular states,
nor report information about dynamics of all cellular processes. us, a combination
of data sets coming from different experiments can not only increase the power of hit
selection procedures, but also make full use of previously generated results.
Chapter 3 presents a knowledge-directed hit selection methodology based on hier-
arical clustering of two genome-wide RNAi screenings, a cell-cycle screen and a cell
viability screen. e combined analysis of the two experiments identified many known
and previously unaracterised mitosis-related genes. A detailed experimental verifica-
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tion andaracterisation of one of them, lead to a discovery that C13orf3 is a component
of the Ska complex required for mammalian cell division.
Applied methodologies of non-parametric normalisation of phenotypes and vari-
able weighting, whi accounts for influence of information introduced by different
experiments, can be extended to any set of high-throughput results, regardless of the
underlying distribution of values. e hierarical clustering, combined with cluster
selection based on gene ontology enriment analysis, proved to be a powerful tool for
selecting genes for follow-up experiments performed in my laboratory.
Chapter 4 describes a novel algorithm for hits selection procedure based on a com-
bined analysis of systematic RNAi screening results and time-course gene expression
data. e aim of the RNAi screen was to identify genes involved in pluripotency main-
tenance of mouse embryonic stem cells. However, a differentiation phenotype upon
silencing of a particular gene does not necessary imply its role in pluripotency mainte-
nance. By introducing time-course microarray data, whi measures anges of gene
expression during embryonic body formation, it was possible to filter the phenotypic
data for genes being downregulated upon differentiation, whi suggests their relevance
for the pluripotent and not for differentiated cells.
Recent study combining an RNAi screen performed in C. elegans with gene expres-
sion data (Mabon et al., 2009), as well as results showed in this thesis, indicate that intro-
ducing additional experimental data in hit selection procedures increases specificity and
reduces false positive rates, thereby refining lists of genes used for the follow-up studies.
In perspective, integration of biological data obtained from different high-throughput
experiments shall contribute to comprehensive picture of cellular biology.
6.3 Enriment analysis
As described in Chapter 3 and 4, enriment analysis is a powerful tenique for descrip-
tive analysis of sets of genes. It is usually used for examining results of high-throughput
experiments. For example, a list of hits from RNAi screen investigating a certain biolog-
ical process should be enried with genes being aracterized with annotation terms
related do that process. Enriment analysis result can also be used as an evidence sup-
porting a biological hypothesis. If a protein is assumed to be a transcriptional regulator
of genes involved in given cellular processes, then a list of genes whose expression is
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modified by altering abundance of the protein (e.g. by RNAi or over-expression) should
also be enried with genes related to these processes.
Although current functional annotations of genomes are still incomplete (e.g. in case
of human genome, over 20 % of protein-coding genes are missing GO annotations), with
continued annotation efforts, enriment analysis tools will become more and more ac-
curate. Moreover, assuming low error rate of already curated GO annotations, whi,
according to Jones et al. (2007), was between 13 % and 18 %, it is reasonable to con-
clude that currently calculated enriment significance levels might be, in many cases,
underestimated.
Enriment analysis does not have to be limited to investigating overrepresentation
of GO terms or pathway annotations among a set of genes. By performing analysis
that uses cis-regulatory motifs or structural features of proteins as annotation terms, a
researer can obtain results complementing GO-based enriment analysis and there-
fore aieve a higher coverage of the whole knowledge space. Moreover, in case of less
annotated genomes, su as X. tropicalis or D. rerio, widely used vertebrate models for
developmental biology, the GO annotations are currently mapped to only 3 % and 15 %
of the protein coding genes, respectively. In cases like these, it becomes necessary to
make use of information derived from sequence and structure homology.
Chapter 5 introduces PhenoFam, a novel application performing gene set enriment
analysis by employing structural and functional information on families of protein do-
mains as annotation terms. Using a specific example, it was shown that the application
can be used as an additional hit selection tool for functional screens. Typical hit selec-
tion procedures (i.e. 𝑧-score or quantile-based normalization) apply thresholds that can
be passed only by genes showing the strongest phenotypes, whi oen leads to a high
false-negatives rate. In case of the implemented GSEA method, a domain may appear
to be significantly enried despite moderate phenotypes of the associated genes. From
the potential relationship between the domain and the investigated biological process,
genes with moderate phenotypic scores are considered in the list of hits selected from
the screen, thereby reducing the false-negative rate.
Notably, it was demonstrated that PhenoFam can help forming novel hypothesis
based on gene expression data. Accordingly, PhenoFam should be useful in analysing
results of other high-throughput experiments, su as ChIP-Chip/ChIP-Seq and compar-
ative mass-spectrometry. Complementing other enriment analysis tools, PhenoFam
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can assist in annotating genes of unknown function and in discovering new functions
of already aracterised genes. In addition, since the possibility of targeting protein-
protein interactions with specific drugs raises expectations of huge impact in the ther-
apeutics field (Fuentes et al., 2009), protein domains that PhenoFam finds enried in
results of disease-related experiments might be of special interest for potential drug dis-
covery efforts.
6.4 Outlook
To enable automatic and unambiguous interpretation of experimental results stored
in web-accessible repositories, the data sets have to be accompanied by complete and
maine-understandable descriptions of the experiments and data acquisition teniques.
A standard for presenting and exanging su information already exist for microar-
ray experiments and is widely known as Minimum Information About a Microarray
Experiment (MIAME) (Brazma et al., 2001). Similar standards for cellular asssays, or
RNAi experiments in particular, are in development (Brazma et al., 2006) and future
implementations of DSViewer, and similar soware, should definitely implement them.
With current trends in application development, more and more databases and anal-
ysis tools become accessible on-line and newly developed pipelines may take an ad-
vantage of this fact. By creating distributed applications having different elements of
the analysis algorithm spread all over the world, where ea of them is developed and
maintained by a group of experts in a particular field, we can utilize global tenical and
intellectual resources. Platforms that support creation of data analysis pipelines based
on distributed resources are being currently developed, one good example is KNIME,
the ‘information miner’ developed at the University of Konstanz (Berthold et al., 2007).
However, the main prerequisite for building global analysis networks is a proper imple-
mentation of individual web services, whi have to provide a programmatic interface
to their resources, su as Simple Object Access Protocol (SOAP).
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6.5 Conclusions
e soware applications described in this thesis were tailored to become a comprehen-
sive, versatile and user-friendly tools for data management and analysis. Introduced
data mining teniques proved to be useful to unveil meaningful biological information
and demonstrated the necessity of heterogenous data integration.
Eventually, these investigations aempt to provide the resear community with a
markedly improved repertoire of computational tools and methods that facilitate the
systematic analysis of accumulated information obtained from high-throughput studies
into novel biological insights.
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